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Abstract. 
Nine new bidentate chelating heterocyclic ligands, namely 4,4'-bis-t-butyl-2,2'-
bipyrimidine (41), 2,2' -bi-(5S, 8R)-5 ,6,7 ,8-tetrahydro-8, 9 ,9-trimethy 1-5,8-methanoquinazoline 
(42), 2,4-bis-(1-pyrazolyl)pyrimidine (53), I-methyl-2-(2-pyridinyJ)perimidine (94), 2-(2-
pyrimidinyl)perimidine (95), 2,6-bis-[6-(2-pyridinyl)-4-pyrimidinyl]pyddine (110), 2,6-bis-(1-
pyrazolyl)-1,5-naphthyridine (132), 2,2'-bis-(1-pyrazolyl)-4,4'-bipyridine (144) and 2,2'-bis-(3,5-
dimethyl-l-pyrazolyl)-4,4'-bipyridine (145), have been prepared and characterised by NMR 
spectroscopy and mass spectrometry and, in some cases, by elemental analyses. X-Ray crystal 
structures have been determined for the two 4,4'-bipyridine derivatives, 144 and 145. A new 
synthesis for the known ligand 4,4'-dimethyl-2,2'-bipyrimidine (40) is also reported. 
The coordination chemistry of the above ligands, the known bridging ligand 
2,2':4',4":2",2'''-quaterpyridine (25) and two known compounds, 2-(2-pyridinyl)perimidine (93) 
and 4,6-bis-(2-pyridinyl)pyrimidine (109), has been investigated. Complexes with the metals 
copper(l), palladium(II) and molybdenum(O) are described for some of the ligands, including an 
X-ray crystal structure for the palladium(II) complex of 94. The majority of the complexes 
described are of ruthenium(II). These include monoruthenium complexes {RuBL(L)z2+ with 
BL=bidentate chelating ligand and L=4,4'-bipyridine (bpy) or 4,4'-dimethyl-2,2'-bipyridine 
(dmb)}, biruthenium complexes {(LhRu( Il-BL)Ru(L')z4+ with Il-BL=doubly bidentate bridging 
ligand and L=bpy or dmb and L'=bpy or dmb} and tetraruthenium complexes {Ru[(I1-
BL)Ru(bpyhh8+}. 1 H NMR spectroscopy, electronic absorption spectroscopy and cyclic 
voltammetry have been used to study the nature of the metal-ligand and metal-metal interactions 
in these complexes. With the seven different bridging ligands (40,109, 110, 25,144, 145 and 
132), the metal-metal distance in the biruthellium complexes has been varied systematically, in 
the order shown, resulting in a general trend of increasing metal-metal distance and decreasing 
metal-metal interaction 
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Chapter 1 
Introductiol1 
Introduction 
Aromatic nitrogen heterocycles represent an important class of ligands for transition metal 
coordination chemistry.1 On the basis of ring size aromatic nitrogen heterocycles may be divided 
into two main groups, namely six-membered azines (e.g. pyridine) and five-membered azoles 
(e.g. pyrazole). The azines are n-deficient with relatively low lying n* orbitals and hence form 
stable complexes with transition metals due to metal-ligand back-bonding from the metal d-orbitals 
to the n system of the ligand, whilst the five-membered azines are n-excessive n-donors and can 
also form anionic ligands by deprotonation of acidic N-H groups in the free ligand. Heterocycles 
can also have more than one nitrogen atom in six-membered (diazines, triazines etc) rings and 
five-membered (diazoles, triazoles etc) rings and in general these ligands have quite different 
electronic properties from those of pyridine. 1,2,3 
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Figure 1.1 
2,2'-Bipyridine (bpy, 1) (Figure 1.1) was synthesised over 100 years ag04 and is the most 
well studied chelating heterocyclic ligand. This ligand has been used extensively in preparative 
and analytical chemistry because of the stable complexes it forms with transition metals.S In 
particular there has been a thorough examination of the redox and photophysical properties of the 
complex Ru(bpy))2+, with emphasis on the electron-transfer processes involved in the 
photochemical decomposition of water.6-9 This has led to the synthesis of many new complexes 
in which one or more of the bpy ligands in the complex is replaced by a different chelating ligand 
with one or more azole or azine rings. Such ligands form complexes with properties which 
depend markedly on the choice of ligand, and in this manner it is possible to tune the ground and 
excited-state properties of the complex by the appropriate choice of ligand.6 For example, recent 
studies of the complexes of 2 10 and 3 11 ,12,13 (Figure 1.1) have shown that replacement of a 
pyridine of 1 with a pyrazole or a pyrimidine ring results in significant changes in the 
physicochemical properties of the complexes, relative to those of Ru(bpYh2+. Thus metal-ligand 
interactions are governed by the specific metal and ligand involved and many such ligands are 
available. 1,2,3 
2 
Many aromatic nitrogen heterocycles have more than one nitrogen atom per ring. Ligands 
of this class which possess multiple coordination sites are potentially capable of bridging more 
than one metal centre and, in recent years, there has been much interest in binuclear and 
multinuclear complexes incorporating one or more of these ligands in a bridging mode. 
Complexes of this type can exhibit metal-metal interactions in the form of energy or electron 
transfer, magnetic coupling and intervalence transfer and the study of these compounds has been 
important in developing our understanding of these processes. 14 These interactions are mediated 
by the bridging aromatic heterocycle, with communication between the metal centres generally 
taking place via the re system of the ligand. In general, the electronic coupling between the metal 
centres varies strongly with the distance between the metals and is dependent on the nature of the 
ligand, on the degree of conjugation between the metals, and the charge and re-donor/acceptor 
properties of the bridging ligand. Binuclear and multinuclear complexes of this type have also 
been used to model important bio-inorganic systems, such as metalloproteins, and there is much 
interest in their role as molecular components in the construction of supramolecular assemblies.3 
Components with suitable redox potentials and/or excited state levels are fundamental building 
blocks for the design of photochemical molecular devices capable of performing important 
functions such as information storage, solar energy conversion and multielectron catalysis.l5,16 
Electron transfer is an important process insupramolecular assemblies and many studies 
have been directed toward intramolecular electron transfer by the use of different bridges between 
the metal ions in binuclear and multinuclear complexes. The most common bridging ligands are 
those that coordinate to both metal centres in a monodentate manner, such as pyrazine (4) in the 
well studied mixed-valence Creutz-Taube complex [(NH)5Ru(4)Ru(NH)5]5+) 7,18 In this 
complex two ruthenium atoms are bridged by pyrazine which has relatively low energy re* orbitals 
and hence is an excellent re-acceptor of metal d-orbital electron density, facilitating strong 
re-communication across the short bridge. 
Bidentate coordination of bridging ligands is desirable because of the chelate effect on 
complex stability and the enhanced metal dre-bridging ligand pre-metal dre electronic interaction.l9 
Numerous binucleating ligands that coordinate in a bidentate manner to both metal centres have 
been used to bridge metals in both homobinuclear, heterobinuclear and polynuclear complexes.3 
Much attention is presently focused on systems based on (N-N)zM-~-M(N-N)zn+ incorporating 
a doubly bidentate aromatic heterocycle as the bridging ligand (~) between two metals M, more 
often of the second or third transition row (in particular, Ru(II) and Os(II)), each with two 
3 
additional N-N bidentate ligands. This choice of ligands is understandable given the useful 
excited-state and redox properties of the M(bpY)3n+ complexes.6,8 The following discussion 
gives an overview of the most well known doubly bidentate binucleating ligands, with particular 
reference to the degree of metal-metal communication that they facilitate. Mention is also made of 
related complexes containing a doubly tridentate bridging ligand and tridentate peripheral ligands, 
which may also have a role to playas molecular components in the design of nanomachines.20 
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Figure 1.2 
The most well studied doubly bidentate chelating bridging ligand is 2,2'-bipyrimidine (5).3 
Numerous homo- and heterobinuclear complexes in which the 1t-acceptor 5 bridges two metals 
have been reported, with ruthenium complexes being particularly well studied.21-59 The short 
inter-metal separation (5.5A) in such complexes facilitates relatively strong metal-metal interactions 
with the possibility of direct d-orbital overlap contributing to this interaction. In comparison, 
complexes in which metals are bridged by 2,2'-bibenzimidazolate (6) and 2,2'-biimidazolate 
(7)60-62 dianions have a similar coordination geometry and inter-metal separation. A wide range 
of metals have been bridged by these ligands in both homobimetallic63-76 and heterobimetallic 
complexes.77-81 Ruthenium, osmium, cobalt, and nickel complexes of 6 have been shown to be 
more stable and to exhibit a stronger metal-metal interaction than similar complexes of 5.72 This 
has been attributed to the superior donor properties of these ligands, which are 1t-donors, and to 
the reduction in electrostatic repulsion between the positive metal centres when bridged by the 
dian ionic forms of 6 and 7. 
Stronger interactions are possible in complexes where the bridging ligand (Figure 1.3) 
allows for a shorter inter-metal separation than in complexes of 5. This is apparent in the dicopper 
and other heterobimetallic complexes of 3,6-bis-(2-pyridinyl)-pyridazine (8) where strong 
interactions such as antiferromagnetic exchange occur. 82-92 The inter-metal separation is typically 
3.35A in complexes of 8 and the related ligands 9 and 10.93-96 In binuclear complexes of 
six-membered chelate ligands, such as the dicopper complex of 11, the inter-metal separation is 
4 
shorter (2.99-3.22A) due to the greater conformational flexibility which is possible in 
six-membered chelating Iigands.97-102 The inter-metal separation can be increased to 4.oA by 
replacement of the central pyridazine ring with an azole ring as in binuclear copper and nickel 
complexes of 12, 13 and 14.103-106 However, the same short inter-metal separation is not 
observed in homo-and heterobinuclear bis(2,2'-bipyridine) ruthenium(II), iridium(I) and 
rhodium(I) complexes of the triazole 14 in which steric restraints force the ligand to adopt Nl ,N4 
coordination in the bridging mode rather than N1-N2 coordination.107-113 Thus of the ligands in 
Figure 1.3 only 14 has been shown to form binuclear ruthenium(m complexes. 
8 
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Chelating bridging ligands that contain a pyrazine ring which is able to bridge two metals in 
a similar manner to the pyrazine bridge in the Creutz-Taube complex, but with the advantage of 
enhanced complex stability and electronic interactions due to the chelate effect, have been much 
studied in recent years (Figure 1.4). 2,3-Bis-(2-pyridinyl)-pyrazine (15) 114 and 
2,S-bis-(2-pyridinyl)-pyrazine (16) 115 are the most well used of these binucleating ligands and 
many complexes of 1515,22-24,114,116-139 and 1629-33 ,119,127,131,133 have been prepared. 
Ruthenium and osmium complexes, in particular, have been shown to exhibit strong metal-metal 
interactions despite the greater inter-metal separation (6.7-6.9A) relative to binuclear complexes of 
5. This is not surprising given that pyrazine is an excellent 1t-acceptor of metal d-orbital electron 
density, thus permitting 1t-communication between the metals. In particular, 15 has been used 
extensi vely in the preparation of supramolecular polynuclear Ru(II) or Os(II) 
complexes)5,124,125,131-133,136,137 Included in Figure 1.4 are other structurally related ligands 
which have been employed as binucleating ligands. Binuclear complexes of 17,117,140 
1825,26,117,129,130,134,135,141,14219129.130,134,135 and 2019,143-145 have been reported and 
5 
exhibit strong metal-metal interactions similar to 15 and 16. Similarly, binuclear complexes of 21 
show strong metal-metal interactions.29-34,146-150 The use of related substituted pyrimidines as 
bridging ligands has been much less common with binuclear complexes of only 4,6-bis-(1-
pyrazolyl)-pyrimidine (22) and its 3,5-dimethylpyrazolyl analogue (23) being reported.96,151 
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The ligand 2,6-bis-(2...:pyridinyl)-benzodiimidazole (24) (Figure 1.5) is an excellent 
example of a bridging ligand which increases the distance between the metals whilst maintaining 
the rigid and well defined orientation of the metals that exists in the complexes of the ligands 
discussed thus far. The bridging ligand 24 can still facilitate electronic communication through its 
1t-network, as has been shown in the diruthenium(II) complex of 24 which exhibits a weaker 
metal-metal interaction than the diruthenium complexes of 5, 15 etc, where the metals are much 
closer together. 152 
The ability of the 1t-network of the bridging ligand to mediate metal-metal interactions is 
lessened in the biruthenium complex of the ligand 2,2':4',4":2",2"'-quaterpyridine (25). 
Rotation about the 4,4'-inter-ring bond reduces the conjugation within the 1t-network of the bridge 
6 
26 
Figure 1.5 
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and, with the greater inter-metal separation, complexes of 2S show a weak but detectable 
interaction.153 Similarly, in binuclear complexes of 2,2'-bis-(2-pyridinyl)-6,6'-bibenzimidazole 
(26) there is free rotation about the 6,6' inter-ring bond.154-156 This accounts for the weaker 
metal-metal interaction in the diruthenium complex of 26, relative to the diruthenium complex of 
its ring fused analogue 24. 
Considerable latitude in the proximity of the metals in binuclear complexes can also be 
achieved by the inclusion of flexible groups between bipyridine-like units in the bridging ligand 
such as in the polyaza shaped ligands 27-29. Binuclear bis-(2,2'-bipyridine)ruthenium 
complexes of 27-29 have been shown to behave much like their independent mononuclear 
components. 157, 158 
Numerous other bridging ligands incorporating flexible tethers or spacers are known, 
many of which have been shown to form homonuclear and heteronuclear supramolecular helical 
complexes with numerous metals (Figure 1.6) .159 For example, the ligand 30 has been shown by 
X-ray crystallography to form a triple helical structure with octahedral cobalt(II) in the complex 
[C02(30)3J[CI04J4,16D whilst double helical structures and even a trefoil knot have been observed 
in the tetrahedral metal complexes of a number of oligobipyridine/oligophenanthroline ligands, 
which contain a linking spacer group such as 31.161-164 The oligopyridines 32 and 33 have also 
been used in helical self-assemblies with a number of different metals.l 59 More recently a large 
7 
bidentate-tridentate-bidentate segmental ligand has been shown to exhibit strict self-assembly of 
supramolecular complexes with a number of different metals. This ligand incorporates 
pyridylbenzimidazole fragments structurally related to 26.165 
31 
Figure 1.6 
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An important aspect of bidentate chelation to octahedral metals is the potential for the 
formation of stereo or geometric isomers. For homoleptic complexes of symmetrical bidentate 
ligands such as Ru(bpyh2+ only the two enantiomeric A and A fonns exist, but in homoleptic 
complexes with an unsymmetricalligand meridonal (mer) and facial (fac) isomers are possible 
(Figure 1.7). Binuclear complexes exist as two diastereoisomers, the ANAA racemic form and 
the I1A meso form (Figure 1.8). Such diastereoisomers were first distinguished in the IH NMR 
spectrum of (bpyhRu(16)Ru(bpyh4+.32 The early studies of (bpyhRu(5)Ru(bpyh4+ did not 
address this aspect of the complex, since the isomers are indistinguishable by electrochemical or 
electronic absorption studies, although the preparation and 1 H NMR spectrum of optically pure 
8 
AA-(phenhRu(5)Ru(phenh4+ (phen=1,10-phenanthroline) has been described.1 66 More 
recently both diastereoisomers have been identified and separated in biruthenium complexes 
bridged by 5 and with non identical tenninalligands.167 
Recently a number of ligands have been described which coordinate in a tridentate manner 
to both metal centres.20 ,168-171 In particular polymetallic ruthenium(II) and osmium(II) 
complexes have been prepared using tridentate terpyridine type ligands 34-36 and with terpyridine 
(37) terminal ligands (Figure 1.9).20,171 These rod-like complexes exhibit a decreasing metal-
metal interaction in the order n=O, 1,2 corresponding to inter-metal separations of 11, 155 and 
20A respectively and have important applications to long range electron transfer in photochemical 
supramolecular devices. A result of the tridentate coordination of the ligands in octahedral 
complexes of 34~36 is the absence of the geometric and/or optical isomerism seen in bidentate 
complexes. For this reason some researchers20 have proposed that tridentate rod like complexes 
are more suitable building blocks in the controlled design of advanced materials. However, with 
bidentate ligands there exists the possibility of assembling advanced materials in more than one 
dimension and with a greater variety of structures. 
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Figure 1.9 
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The present work describes studies of new and known compounds which can be used as 
bidentate ligands, with particular emphasis on the role of these compounds as doubly bidentate 
binucleating ligands. Included are the syntheses and attempted syntheses of a number of such 
ligands and their mono, bi, and multinuclear complexes, particularly of ruthenium(II). All the 
complexes described are five-membered chelates. In the binuclear complexes a general trend of 
increasing metal-metal distance and hence decreasing metal-metal interaction will be revealed. This 
was achieved by synthesising a range of ligands that successively increase the inter-metal 
separation in their binuclear complexes. 
9 
Ligands and complexes are characterised by nuclear magnetic resonance spectroscopy, 
with assignments based on a combination of one and two dimensional correlation techniques. 
High resolution mass spectrometry and elemental analysis are also used to characterise the ligands 
and complexes. Cyclic voltammetry and UVNIS absorption spectroscopy of the ruthenium(II) 
complexes and some molybdenum(O) complexes are also discussed. These techniques reveal the 
energy of electron transfer processes in the complexes and the degree of metal-metal interaction in 
the binuclear complexes. The X-ray crystal structures of one complex and two ligands are also 
included. 
lO 
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Chapter 2 
2,2'-Bipyrimidine Ligands and Complexes. 
2,2'-Bipyrimidine Ligands and Complexes. 
2.1. Introduction. 
As mentioned in chapter 1, the most well studied doubly bidentate binucleating ligand is 
the commercially available ligand 2,2'~bipyrimidine (bpm, 5). Many homo- aJJd heteronuclear 
complexes of bpm have been described21-59 including X-ray crystal structures of a dicoba1t(II),50 
a diiron(II),51 a distannacarborane52 and several copper(II)53-55 complexes. In these structures 
the metal-metal separation is typically 5.5A, thus facilitating relatively strong metal-metal 
interactions mediated by the bridging ligand. 
38 
Ru(bpY)2 
/ "-() C~ () 
39 
Figure 2.1 
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Many ruthenium(II) complexes of bpm have been studied,25,26,32,33,35-38 including mixed 
valence examples32 and a tetranuclear complex with a central ruthenium(II) core surrounded by 
three bridging bpm ligands.26,35 The biruthenium(II) complex (bpYhRu(5)Ru(bpYh4+ (38) 
(Figure 2.1) is the earliest example of a binuclear complex containing a doubly bidentate bridging 
ligand and was first described by Hunziker and Ludi.35 The complex has been the subject of 
several spectroscopic and electrochemical studies25,35,36,46,172-174 which have indicated a strong 
interaction between the tuthenium(II) atoms. More recently the complete assignment of the eight 
individual reduction steps has been achieved.175 However, these studies have failed to detect the 
stereoisomerism of 38 (c.f. Figure 1.8), since the electrochemical and spectroscopic differences 
between the diastereoisomers are very small. Meso (M) and racemic (f1N AA) forms have been 
shown, by IH NMR spectroscopy, to exist in the related complex (bpYhRu(16)Ru(bpyh4+ 
(39).32 Similar IH NMR studies of 38 have not been reported for binuclear complexes of 5, 
with the exception of a reported preparation166 of optically pure AA-Ru(phenhbpmRu(phenh4+ 
from optically pure A-[Ru(phenh(pyh]2+ and rac-Ru(phenhCb (phen=1,1O-phenanthroline, 
py=pyridine). However, Keene and Reitsma167 have now shown that the diastereoisomers of 
12 
complexes of the type [(LthRu(Lb)Ru(Lt'h] {Lb=bpm or 2,3-bis-(2-pyridinyl)pyrazine and Lt. 
L t ' are typically bpy, phen or tmbpy (3,3',4,4'-tetramethyl-2,2'bipyridine), with Lt:;i:Lt '} can be 
both distinguished by 1 H NMR and separated by sephadex ion-exchange chromatography. 
A 
Figure 2.2 
Substituted 2,2'-bipyrimidine ligands as mono and binucleating ligands have been less 
well studied. In general, up to three different bidentate coordination modes would be possible for 
a symmetrically disubstituted bipyrimidine ligand on coordination to a metal. Which mode of 
coordination is used is likely to depend on the size of the substituent and the coordination 
geometry of the metal. Figure 2.2 shows these modes of coordination in the isomers A, Band C 
for a mononuclear complex and D and E for a homo binuclear complex. The coordination 
geometry of tetrahedral metals is such that only two ligands may be coplanar. Hence metals such 
as copper(I) would not be expected to significantly restrict the coordination mode and 
conformation of the ligand. However, octahedral metals, such as ruthenium(II), and square-
planar metals such as palladium(II), have four coplanar ligands and would be expected to restrict 
the mode of ligand coordination. This is shown in Figure 2.2 where coordination through N3-
N3' (A) gives rise to the most sterically demanding environment for the metal whereas 
coordination through Nt-NT (B) or Nt-NI' (C) is less so. Such octahedral mononuclear 
complexes could be expected to be a mixture of the transoid isomer, B, and cisoid isomer, C, with 
C becoming the only isomer observed as the size of the R4/R4' substituent increases. It follows 
that a binuclear octahedral complex is likely to have the ligand in the transoid conformation, as in 
E, and this complex must form by the coordination of a second metal to B. A large R4/R4' group 
thus restricts the ligand to mononuclear complexes since coordination of an octahedral metal to 
isomer C cannot occur. 
13 
An early report of the complex 3836 also described the absorption and luminescence 
spectroscopy and the electrochemical oxidations of structurally related complexes of the ligand 
4,4'-dimethyl-2,2'-bipyrimidine (40) (Figure 2.3). In this chapter we describe a new synthesis 
of the binucleating ligand 40 and include a study of its coordination chemistry with tetrahedral 
copper(I), octahedral molybdenum(O) and square-planar palladium(II), followed by a more 
detailed spectroscopic and electrochemical study of its ruthenium(II) complexes. It will be shown 
that the coordination chemistry of 40 confonns to the general pattern of stereoisomerism proposed 
above (Figure 2.2). The synthesis of two new substituted bipyrimidine ligands, 41 and 42 
(Figure 2.3), of which 42 is chiral, and a study of their ruthenium(II), palladium(II) and 
molybdenum(O) complexes is also described. The larger R groups of 41 and 42 will be shown to 
restrict the ligand to mononuclear octahedral coordination. 
CH3 
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Figure 2.3 
Bidentate ligands which contain azole rings have been the subject of recent study.176 
Ruthenium(I1) complexes of bidentate ligands incorporating an azole ring with two (43),11-13 
three (44),177,178 or four (45)176 nitrogens have shown that the azole ring causes significant 
changes in the physicochemical properties of the complex in comparison to the more widely used 
Ru(bpYh2+ (Figure 2.4). In the case of 44 and 45 the presence of an acidic N-H proton allows 
additional pH control of the properties of the complex, since the deprotonated and protonated 
forms of the ligand have very different electronic properties.176-178 
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I () {j 
44 
Figure 2.4 
H 
I ().(] 
45 
14 
Planar tridentate terheteroaromatic analogues of 2,2':6',2"-terpyridine (terpy, 37) are less 
common, although recently the syntheses and complexes of 46179 and 47180,181 (Figure 2.5) 
have been reported in which the pyrazole rings have a significant effect on the absorption spectra 
and electrochemical properties relative to terpy. In these complexes the first reduction potential 
and the energy of the MLCT absorption were both increased, reflecting the higher energies of the 
n*-LUMO of the ligands relative to Ru(terpyh2+. 
47 A 
48 N N eN NO 
49 50 
Figure 2.5 
Bidentate and tridentate ligands which incorporate methylene bridges between the azole 
and azine rings such as in the ligands 48,182,183 49179 and 50184-186 (Figure 2.5), have also 
been described in recent years. Such ligands form a six membered chelate ring on coordination to 
a metal which has additional conformational flexibility, since such six-membered rings exist in a 
boat conformation)87 The methylene bridge also prevents the possibility of conjugation between 
the component heterocyclic rings. 
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Complexes of the ligands 51 (Figure 2.6) should show similar interesting properties to 
43-47. Two attempted syntheses of 51, which has the potential to exhibit bis-tridentate 
coordination, are described. A brief discussion of the attempted synthesis of its methylene 
15 
bridged analogue 52 is also included. Although both syntheses were unsuccessful the new ligand 
53, which was the major product of the attempted synthesis of 51, is described, along with a 
detailed study of its ruthenium(II) complexes. 
2.2 Results and Discussion 
The first ligand investigated was 40, the synthesis of which is outlined in Scheme 2.1. 
The method for converting commercially available 2-amino-4-methylpyrimidine (54) to a mixture 
of 2-chloro-4-methylpyrimidine (56) and 2-hydroxy-4-methylpyrimidine (55) (step I) using 
NaN02 in cone HCI at -lo°C was derived from diazotization of the related compound 2-arnino-4-
(t-butyl)pyrimidine (see later).1 88 The mixture of 55 and 56 was then separated by radial 
chromatography on silica. Chlorination of 55 in refluxing POCb afforded additional 56 which 
was purified in a similar manner. In step II the catalyst Nio(PPh3h was prepared in situ in 
deoxygenated DMF at 50°C from NiCl2 and PPh3. Purified 56 was then coupled by the red Nio 
catalyst to produce the desired ligand 40 in reasonable yield. Nasielski et al. have used this 
method to couple other heteroaryl halides)89 The previous synthesis36 of 40 involved the 
coupling of 2-bromo-4-methylpyrimidine using a copper catalyst. 
~}-OH 
_N\__ NaN02 55 ) POCI ~ rNH2 3 
\\ N concHCI 
54 ~ h CI )II 
N DMFIN2/50°C 
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Scheme 2.1 
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The 1 Hand 13C NMR spectra of 40 were obtained in CDCh, CD3CN and DMSO-d6. 
Two aromatic doublets are observed in the IH NMR spectrum of 40 corresponding to H5 and 
H6. The more upfield doublet was assigned to H5, given that in a pyrimidine ring the 5-position 
is more electron rich than the 6-position. Similarly, C5 and C6 were assigned in the 13C NMR 
spectrum of 40 whilst C4 and C2 were distinguished on the basis that C2 has the greater 
downfield shift relative to 56 on substitution by a pyrimidinyl group. 
As discussed in 2.1 the formation of binuclear complexes of 40 with tetrahedral metals is 
expected to be facile. The ligand 5 has been shown to bridge two tetrahedral Cu(l) atoms in a 
16 
binuclear complex 190 and we have found that 40 forms an analogous complex. The reaction of 
40 with two equivalents of a copper(I) solution and four equivalents of triphenylphosphine gave a 
yellow complex which was shown by elemental analysis to be the binuclear complex 57 (Scheme 
2.2). The IH spectrum of 57 showed that the two pyrimidine rings are equivalent as are all the 
triphenylphosphine ligands. This supports the structure shown in Scheme 2.2, in which the 
bridging ligand is transoid (NI-N3', Nl'-N3) and all the auxiliary ligands are related by the C2h 
symmetry of the complex. The contrasting cisoid structure of 57 would have C2v symmetry and 
hence two non-equivalent triphenylphosphine ligands. 
Scheme 2.2 
2Cu(CI04h 
Cu°,4PPh3 ... 
MeOH 
2+ 
57 
Having demonstrated that 40 forms a binuclear complex with tetrahedral Cu(I), its 
coordination chemistry with molybdenum(O) and palladium(II) was investigated. The 
mononuclear molybdenum(O) complex 58 (Scheme 2.2) was prepared by reacting one equivalent 
of the complex MO(CO)4(1l4-C7HS) with 40. The complex Mo(CO)4(1l4-C7HS) has been used 
previously to prepare structurally related complexes.44,191 The 1H NMR spectrum of 58 in 
CDCl3 indicated a symmetrical complex in which the ligand most probably coordinates to 
molybdenum(O) in the NI-Nl' mode, since N3-N3' coordination would be more sterically 
demanding. This assumption is supported by the reaction of 40 with two equivalents of 
MO(CO)4(1l4-C7HS), which gave the same mononuclear complex. The IH NMR spectrum of 58 
showed evidence of dissociation to the free ligand after only a few minutes in solution. The 
complex was also unstable in the solid state and hence, no elemental analysis was obtained. 
The reaction of 40 with one equivalent of PdCl2 in conc HCI gave a yellow complex 
which was shown by elemental analysis to be mononuclear. The 1 H NMR spectrum of the 
17 
complex in DMSO-d6 shows two doublets corresponding to H5 and H6. This indicates that the 
ligand coordinates symmetrically to p all adium (II) , therefore excluding transoid N1-N3' 
coordination. Furthermore, the reaction of 40 with two equivalents of PdCh also gave the same 
mononuclear complex. This implies that the complex has the structure 59 (Scheme 2.2), in which 
the ligand again coordinates in the N1-N1' mode with a non-coordinated N3-N3', which is too 
sterically demanding to allow coordination of a second palladium(II). The lack of N3-N3' 
coordination contrasts with the sterically hindered coordination mode observed in the 
molybdenum(O) complex of 6,6'-dimethyl-2,2'-bipyridine, for which an X-ray structure has 
recently been deterrnined.192 However in the latter case the ligand is forced to coordinate in this 
mode, because there are only two nitro gens which can chelate to molybdenum(O). 
Table 2.11 H NMR Chemical Shiftsa and Coordination Induced Shiftsb of 40 and 59. 
4-CH3 H5 H6 
59 2.82 7.95 9.24 
40 2.66 7.61 8.91 
CISb 0.16 0.34 0.33 
a For deuterated dimethylsulphoxide solutions. b CIS = Ocomplex-Oligand. 
When a ligand forms a transition metal complex, subtle or even dramatic differences in the 
NMR spectra of the ligand and complex are observed. For example, in the I H NMR spectrum of 
40 and 59 (Table 2.1) the H5, H6 and 4-CH3 protons are shifted downfield from their positions 
in the spectrum of the free ligand by 0.34, 0.33 and 0.16ppm, respectively. These downfield 
shifts are described as coordination induced shifts (CIS=ocomplex-Oliganct) and they reflect the 0'-
donation of electron density from the ligand to the metal and, also for H6, the deshielding effect of 
the nearby chlorine atom. Previously, a number offactors have been identified which contribute 
to the sign and magnitude of CIS values in ruthenium(II) complexes. These include ligand-to-
metal 0' donation (analogous to the palladium(II) complex 59), metal-to-ligand 7t back donation, 
chelation imposed conformational changes, coordinative disruption of inter-ring conjugation and 
interligand through-space ring-current anisotropy effects. 11 ,176, 179,193 The contribution of these 
factors to the CIS values of the series of complexes L2Ru(40)(RuL2)n (L=2,2-bipyridine (bpy) or 
L=4,4'-dimethyl-2,2'-bipyridine (dmb), n=O,l) is included in the discussion which follows. 
The reaction of 40 with one equivalent of bis-(2,2'-bipyridine)-dichlororuthenium(II) in 
3:1 ethanol/water afforded, in good yield, the complex Ru(40)(bpyh2+ which was isolated as a 
hexafluorophosphate salt and characterised by FAB mass spectrometry (Scheme 2.3). Elemental 
analyses for this compound, and others to be described, were often unreliable due to traces of 
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NH4,PF6 or ruthenium(III) impurities and the formation of metal carbides in the analysis process. 
Other workers have reported similar problems with structurally related complexes. 194 In 
anticipation that the IH NMR spectrum of Ru(40)(bpy)z2+ might be difficult to assign, the 
complex Ru(40)(dmb)z2+ (Scheme 2.3) was prepared by an analogous procedure from 40 and 
bis-(4,4'-dimethyl-2,2'-bipyridine)-dichlororuthenium(II) and characterised by FAB mass 
spectrometry. Previously the preparation of a related RuL(dmb)z2+ complex has been found to 
assist in the assignment of the L ligand in the 1 H NMR spectra of the complexes.l 76 The 
replacement of the bpyH4 protons (8ppm) with methyl groups (2.6ppm), and the subsequent 
removal of 3J and 4J coupling associated with bpyH4, considerably simplifies the spectra. An 
alternative procedure for simplifying the overlapping 1 H NMR spectra of ruthenium(II) complexes 
completely eliminates the bpy signals by replacing the bpy ligands with fully deuterated bpy 
ligands (dg-bpy).195 However, apart from the prohibitive cost of dg-bpy, this technique sacrifices 
the infonnation contained in the chemical shifts of the bpy protons. 
61 L=bpy 
63L=dmb 
Scheme 2.3 
64L=bpy 
65L=dmb 
By examination of its 1 H NMR spectrum, the complex Ru(40)(bpy)z2+ was found to exist 
as a 1: 1 mixture of the symmetrical (60) and unsymmetrical (61) isomers (Scheme 2.3), 
Similarly, a 1:1 mixture of (62) and (63) is observed for Ru(40)(dmb)z2+ (Scheme 2.3). Th( 
1 H NMR spectra of the mixtures, herein referred to as 60/61, for the mixture of 60 and 61, anf 
62/63, for the mixture of 62 and 63, are shown in Figure 2.7 and summarised in Table 2.2. 
lY 
In the symmetrica1 isomer both pyrimidine rings and the bpy ligands are equivalent, 
whereas in the unsymmetrical isomer all six rings are non-equivalent. Hence, the 1 H NMR 
spectrum of 60/61 (top of Figure 2.7) consists of 30 non-equiva1ent aromatic protons, 10 
corresponding to 60 and 20 corresponding to 61. Not shown are the three methyl singlets, in a 
6:3:3 ratio, corresponding to 4-CH3 of 60 and the 4-CH3 and 4'-CH3 of 61. These were easily 
assigned from their relative integrals and with the methyl groups of 61 differentiated on the basis 
that 4'-CH3 is shielded by a pyridine ring and therefore exhibits a large negative CIS. The 
assignment of the aromatic protons of 60/61 is more difficult, since some of the signals of 60 
and 61 overlap with each other and the bpyHS signals in the region 7.38-7.S6ppm. Despite this, 
the protons H6(60) and H6(61) and H6'(61) can be distinguished by their multipHcity in the 
spectrum and assigned from their observed CIS values. In this case H6'(61) exhibits a downfield 
shift (8.99ppm) due to the net positive effect of ligand-to-metal cr donation and metal-to-ligand 1t 
back donation, whilst H6(60) and H6(61) (at 7.87 and 7.70ppm, respectively) are shifted upfield 
as a result of interligand through-space ring-current anisotropy. 
The spectrum of 62/63 was then used to assign the three HS protons of 60/61. The 
spectrum of 62/63 (bottom of Figure 2.7) consists of 24 non-equivalent aromatic protons, 8 
corresponding to 62, and 16 corresponding to 63. Unlike the spectrum of 60/61, the signals for 
HS/H6(62), HS/HS'/H6/H6'(63) and the dmbH6's are all clearly visible in the spectrum of 
62/63. 
The protons HS(62) and HS/HS'(63) were assigned by correlation to the H6(62) and 
H6/H6'(63) signals using the homonuclear 2D COSY spectrum shown in Figure 2.8. 
Correlation of the doublet H6(62) at 7.86ppm to the doublet at 7.42ppm locates HS(62), thus 
completely assigning the pyrimidine spin system of 62 and hence, by comparison, of 60. 
Similarly, HS'(63) can be assigned to the doublet at 7.52ppm by its correlation to the H6'(63) 
doublet at 8.97ppm, whilst HS(63) is located at 7.37ppm by correlation to the H6(63) at 
7.68ppm. Hence, 61 can be assigned by comparison with 63. The advantage of the dmb 
substitution is evident from this last assignment, since HS(61) is completely overlapped by the 
bpyHS signals in the spectrum of 60/61. 
The assignment of the dmb pyridine ring spin systems (excluding methyl groups), but not 
the individual rings in the complex, is also possible using a COSY spectrum (Figure 2.8). For 
example, the dmbH6 at 7.90ppm shows a correlation to the HS proton at 7.34ppm which in tum 
exhibits a long-range coupling to the H3 singlet at 8.41ppm. In contrast, complete assignment of 
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Figure 2.7 IH NMR Spectra of 60/61 (top), 62/63 (bottom). 
the bpy pyridine ring spin systems was prevented by the closely spaced H4bpy protons in the 
spectrum of 60/61, although the bpy protons were located using a similar COSY spectrum to that 
shown in Figure 2.8. 
Figure 2.8 also shows the 1 H NMR spectrum of the symmetrical isomer 62. The reaction 
of 62/63 with one equivalent of Ru( dmb hCb gave a 1: 1 mixture of the biruthenium(II) complex 
65 and unreacted 62, the latter of which is too sterically demanding for N3-N3' coordination of a 
second ruthenium(IT) (Scheme 2.3). Similarly 64 and unreacted 60 were obtained from the 
reaction of 60/61 with Ru(bpYhCb. In both cases, the mixture of the binuclear and symmetrical 
mononuclear complexes was separated on C-25 sephadex. The IH NMR spectra of 60 and 62, 
once determined, provided confirmation of our previous assignments. The binuclear complexes 
are discussed in detail later. 
Table 2.2 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for Ru(40)L22+. 
Ligand=40 Ligand=L 
4-CH3 H5 H6 4'-CH3 H5' H6' H3 H4 H5 H6 
40 2.64 7.42 8.83 
60 2.77 7.44 7.87 - - - 8.55 8.14 7.49 7.93 
CISb +0.13 +0.02 -0.96 - - - 8.55 8.11 7.45 7.75 
61 2.76 7.40 7.70 1.90 7.54 8.99 8.53d 8.06d 7.39d 7.83d 
8.54d 8.13d 7.40d 7.81d 
CISb +0.12 -0.02 -1.13 -0.74 +0.12 +0.16 8.58d 8.16d 7.41d 7.54d 
8.59d 8.17d 7.51d 7.46d 
62 2.77 7.42 7.86 - - - 8.39 2.59c 7.29 7.72 
CISb +0.13 +0.00 -0.97 - - - 8.39 2.58c 7.31 7.55 
63 2.76 7.37 7.68 1.90 7.52 8.97 8.41 2.61c 7.34 7.90 
8.41 2.60c 7.33 7.62 
CISb +0.12 -0.05 -0.95 -0.74 +0.10 +0.17 8.37 2.56c 7.22 7.60 
8.37 2.54c 7.22 7.34 
a For deuterated acetonitrile solutions. b CIS = Ocomplex·Oligand. c Methyl group d Not assigned. 
The 1 H NMR chemical shifts and CIS values for 60-63 are summarised in Table 2.2. 
Small differences are observed between the ligand signals of the two mixtures, which can be 
attributed to the electron donating effect of the methyl groups of the dmb ligands. The small CIS 
values for all H5 and H6' protons of the ligands indicates the presence of strong metal-to-ligand 1t 
back-donation into the low lying 1t* orbitals of the ligand, which reduces the strong positive CIS 
effect of ligand-to-metal cr donation. The other important CIS effects have already been 
discussed. 
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Figure 2.8 2D CPSY Spectrum (top) of 62/63 and IH NMR Spectrum of 62 (bottom). 
The UV /VIS spectra of 60/61 and its dmb equivalent 62/63 consist of strong ligand 
ntred absorptions at A<300nm and a MLCT absorption at A>400nm. The spectrum of 60/61 is 
good agreement with that previously reported by Wilson et al.,36 with the maxima for both 
)mplexes appearing at 438nm. Unsymmetrical absorptions in this region of the spectrum 
:present a combination of low energy transitions (d1t-1t*(40)) from the metal (HOMO) to the 1t* 
rbitals (LUMO) of 40 and slightly higher energy transitions (d1t-1t*bpy) from the metal to the 
py 1t* orbitals (SUMO). The d1t-1t*(40) transition of 60/61 is undoubtedly at higher energy 
han the d1t-1t*(5) transition of Ru(5)(bpyh2+ due to de stabilisation of the ligand 1t* orbitals by 
he electron donating methyl groups. In 62/63 this transition appears as a shoulder at lower 
~nergy (482nm) as a result of additional metal d orbital destabilisation by the dmb methyl groups. 
Wilson et al. have described the oxidations of 60/61.36 In this study we describe the 
complete electrochemistry (oxidations and reductions) of 60/61, the new complex 62/63 and the 
ligand 40 (reductions). The cyclic voltammograms of 60/61 and 62/63 are shown in Figure 
2.9, whilst Table 2.3 summarises the redox potentials of these and related complexes. 
The complex mixture 60/61 exhibits a reversible one electron oxidation at +1.28V and 
three reversible one electron reductions at -1.19, -1.56 and -1.81 V. A fourth irreversible one 
electron reduction is also observed at -2.17V. In comparison the mixture 62/63 exhibits a one 
electron oxidation at + 1.19V and four similar reductions at -1.20, -1.65, -1.87 and -2.17V. 
Destabilisation of the metal d orbitals (HOMO) by the electron donating methyl groups of 
40, as described above, makes 60/61 and 62/63 easier to oxidise (Table 2.3) than 
Ru(5)(bpYh2+. Also, the introduction of methyl groups in the dmb substituted complex 62/63 
further increases the ease of oxidation by 0.09V relative to 60/61. It has been previously noted 
for structurally related complexes that methyl groups decrease oxidation potentials by 
approximately 0.025V per methyl group.180 
The first reduction potentials of 60/61 (l.19V) and 62/63 (l.20V) were both assigned to 
the reduction of 40 since the 1t* orbitals of 40 are at lower energy than those of bpy, as shown 
by the reductions of the free ligands at -2.00V for 40 and -2.18VlO for bpy. Both complexes are 
therefore harder to reduce than Ru(5)(bpYh2+ again reflecting the 1t* orbital destabilisation of 40 
(complex-LUMO) by the methyl groups, arid which is mirrored by the free ligand reductions for 
40 and 5 (-1.80V).1O Subsequent reductions can be readily assigned to the bpy or dmb ligands 
except the fourth reduction, which again is constant for 60/61 and 61/62 and therefore most 
likely to be a second irreversible reduction of the ligand 40. The LiEox-red values in Table 2.3 
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Ru(5)(bpYh2+ 422,480sh +1.40 -1.02 -1.45 c 
60/61 438 +1.28 -1.19 -1.56 1.81 
62/63 438,482sh +1.19 -1.20 -1.65 -1.87 
a In nanornetres. b In volts vs seE in acetonitrile. C Not observed. d Irreversible. 
ov 
Cyclic Voltammogram for 60/61 
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Cyclic Voltammogram for 62/63 
Figure 2.9. 
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-2.17d 2.47 
-2.17d 2.40 
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reflect the HOMO-LUMO energy gap in the complexes and are consistent with the lowest energy 
MLCT absorptions of the complexes for which the same orbitals are involved.6 The value of 
2.47V for 60/61 is larger than the value for Ru(5)(bpYh2+ (2.42V) for the reasons described 
above, but smaller for 62/63 (2.40V) reflecting the additional metal d orbital destabilisation of the 
electron donating dmb ligands. 
The reactions of one equivalent of Ru(bpyhCh with 60/61 and one equivalent of 
Ru(dmbhCi2 with 62/63 gave mixtures of symmetrical mononuclear and binuclear ruthenium(IT) 
complexes 60/64 and 62/65 (Scheme 2.3). Separations of the mixtures are facile on ion-
25 
exchange C-2S sephadex by simply eluting with 0.1M NaCl to remove the dication followed by 
O.SM NaCl to remove the tetracation. Once purified by chromatography, the binuclear complexes 
64 and 65 were characterised by mass spectrometry. 
As already discussed birutheniumCII) complexes which contain two Ru(bpYh2+ units 
bridged by a doubly bidentate ligand should exists as two diastereoisomers, viz. the meso (AL1) 
and racemic CAAIL1L1) foans (Figure 1.8, chapter 1). Such isomerism has been detected by IH 
NMR for the birutheniumCII) complexes of 2,S-bis-(2-pyridinyl)pyrazine32 and more recently, 
2,2'-bipyrimidine. 167 In such cases the two diastereoisomers are generally observed in a 1: 1 
ratio. 
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Figure 2.10 1 H NMR Spectrum of 64. 
For the complex 64 we have found this ratio ranges from 4: 1 to S: 1. Figure 2.1 0 shows 
the aromatic region of the 1 H NMR spectrum for 64 after several fractional recrystallisations 
from ether/acetonitrile. As a result of the coordination of a second Ru(bpYh unit, the downfield 
H6' of 61 disappears in the 1 H NMR spectrum of 64, since both pyrimidine rings are now 
equivalent, a result of the C2 symmetry of 64. The bridging ligand protons HS and H6 can be 
easily distinguished and were assigned by comparison with the spectra of 60/61. These two 
protons exhibit coordination induced shifts of +0.04 and -1.0Sppm, respectively, for reasons 
already described. 
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One dimensional total correlation spectroscopy (lD TOCSy)196,197 can often allow 
dramatic spectral simplification by editing a complex IH NMR spectrum into a set of simpler 
subspectra,l98 thus allowing isolation of individual spin systems. The method requires at least 
one multiplet to be sufficiently isolated that it can be inverted by a selective 1800 pulse; the 
magnetization of this inverted spin then propagates through the network of spins coupled to it. 198 
. In this research we have found this technique particularily useful for isolating multiplets which are 
overlapped by other signals and hence allowing assignment of the spin systems of individual 
aromatic rings. 
All the bpy protons in the spectrum of 64 were located using ID TOCSY spectra (Figure 
2.11). Trace I, II and III show the effect of irradiating the bpy H3 multiplet and allowing the 
magnetization to propagate further through the spin system. At 0.02s (Trace I) the bpyH4 signals 
are prominent, whilst signals for bpyH5 and bpyH6 are developing. With increasing mixing time, 
signals for bpyH5 (trace II-O.o4s) and bpyH6 (trace III-0.08s) predominate. The traces clearly 
show the large spread of signals for the bpy protons, particularly for bpyH6. 
Table 2,4 1 H NMR Chemical shiftsa and Coordination Induced Shiftsb for 64 and 65 
4-CH3 H5 H6 H3 H4 H5 H6 
64 (b.A) 1.95 7.46 7.78 8.55 8.21 7.63 7.87 
CISb 
-0.69 +0.04 -1.105 8.55 8.26 7.79 8.35 
8.58 8.11 7.45 7.51 
8.58 8.15 7.47 7.82 
65 (b.A) 1.94 7.42 7.75 8.43 2.68c,d 7.46 8.15 
CISb 
-0.70 +0.00 -1.08 8.43d 2.58c,d 7.62d 7.66d 
8.39d 2.64c,d 7.28d 7.62d 
8.39d 2.67c,d 7.32d 7.31d 
a For deuterated acetonitrile solutions. b CIS=bcomplex-bligand. c Methyl group. d Spin system not assigned. 
In some cases where a proton is well isolated the individual rings can be assigned. For 
example, by irradiating the bpyH5 at 7.63ppm (trace IV), signals for bpyH3, bpyH4 and bpyH6 
develop with extended mixing time (trace IV, V and VI). Similar subspectra for a second pyridine 
spin system can be obtained by irradiating the bpyH6 at 8.35ppm. This proton is the most 
downfield of all the bpyH6 protons and its unique chemical shift implies that the major 
diastereoisomer is the meso form (M) (see Figure 1.8). Molecular models show that this proton 
is deshielded (relative to the racemic form (AN M) ) by through-space anisotropy effects. This 
effect has recently been observed for structurally related complexes of 5.167 The spin systems for 
the other two non-equivalent bpy pyridine rings were assigned by a 2D COSY spectrum. The 
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Figure 2.11 lD TOCSY Spectra of 64. 
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minor racemic form (AAII1I1) was not isolated in pure form but its IH NMR spectrum was 
tentatively assigned from the mixture. 
The meso form (AI1) was also found to be the major isomer for 65 in a 3: 1 ratio with the 
racemic form (AAlI1I1), but neither could be separated by fractional recrystallisation. The meso 
form was assigned by ID TOCSY spectra in an analogous manner to 64, with the racemic form 
being tentatively assigned from the mixture of the diastereoisomers. The 1 H NMR chemical shifts 
of the major isomers of 64 and 65 are summarised in Table 2.4. 
The UVNIS spectra of 64 and 65 are summarised in Table 2.5. The spectrum of 64 was 
found to be in agreement with that previously described by Wilson et al. 36 Below 300nm both 
complexes display strong ligand centred transitions. The lowest energy absorptions of 64 and 65 
can be assigned as a MLCT transition into the bridging ligand (d1t-1t*(40)). The large red shift of 
these MLCT absorptions, relative to the monoruthenium(II) complexes, has been observed for bi-
ruthenium complexes of related ligands, including 535,36,37, and 2,3-bis-(2-pyridinyl)pyrazine 
(2,3-dpp-15),116,126 and is attributed to a lowering of the 1t* orbitals of the bridging ligand by 
coordination of the second Ru(bpYh2+. Similarly, the weaker shoulders at 544nm in 64 and 
558nm in 65 have been detected in other binuclear complexes and numerous explanations have 
been offered for these weaker transitions.30,33 The higher energy absorptions around 412nm for 
64 has been previously assigned as a d1t-1t*bpy with the observed blue shift relative to the 
mononuclear complex rationalised by assuming a small additional electrostatic energy required to 
remove the optical electron from one Ru2+ ion to an adjacent bpy and thus further from the other 
Ru2+. 36 This blue shift is also observed for the d1t-dmb1t* transition of 65, whilst the dmb 
electron donating methyl groups also lower the d1t-1t*(40) transition (596nm) further by metal d 
orbital destabilisation. 
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A Eox2 Eoxl Bredl Eroo2 Ered3 &004 l1Eox-red 
38 411,545sh,594 +1.69 +1.53 -0.41 -1.08 c c 1.94 
64 412,544sh,578 +1.68 +1.48 -0.55 -1.21 -1.63d c 2.03 
65 414,558sh,596 +1.59 +1.39 -0.59 -1.25 -1.72d -2.17 1.98 
a In nanometres. b In volts vs SeE in acetonitrile. c Not observed. d Two electrons 
Ligand bridged binuclear complexes such as 64 and 65 also show metal-metal interactions 
which are mediated by the 1t-system of the bridging ligand and depend on the metal-metal 
distance, the extent of conjugation between the coordination sites and the charge and 
1t-donor/acceptor properties of the bridging ligand. Molecular modelling studies using 
29 
CHEM3D-PLUS found the inter-metal separation of the two complexes to be 5.6A, which is 
comparable with the inter-metal separation observed in bipyrimidine bridged complexes.50-55 On 
this basis 64, 65 and 38 would be expected to exhibit similar metal-metal interactions. 
OV +1V 
Figure 2.12 Cyclic Voltammogram of 64. 
The degree of metal-metal interaction can be shown in the splitting of the metal-based 
oxidation potentials (Lllild, which is illustrated in the cyclic voltammogram of 64 (Figure 2.12) 
and in Table 2.5, which summarises the electrochemistry of 64 and 65. For the binuclear 
complex 64 the metal-based oxidations are split into two reversible oxidations, with EoxF1.48V 
and Eox2= 1.68V (~E1I2=200m V), indicating a strong interaction. The splitting of oxidation 
potentials of binuclear complexes is an indication oflhe stability of the mixed valence intermediate 
(bpyhRu(II)(40)Ru(llI)(bpyh5+,18 In related complexes this has been attributed to strong back:-
donation by the electron-rich ruthenium(II) into the bridging ligand n* orbitals (LUMO) causing 
an increase in ligand field strength at the other coordination centre,199 thus lowering the reduction 
potential for the ruthenium(III) fragment and increasing the difference between both 
potentials.32,33 The reduction potential of the Ru(III) fragment or the mixed valence 
Ru(ll)Ru(III) state, equates with the first oxidation, Eoxl, in Table 2.5. For 64 this potential is 
50mV lower than for the related complex [Ru(bpyhh(5)4+ (38) (1.53V); thus in 64 there is a 
stronger metal-metal interaction (~Ell2=200mV) than in 38 (~Ell2=160mV). The greater 
electron density electron at the n* LUMO of the bridge, which is due to the electron donating 
methyl groups of 40, accounts for this additional stabilisation of the Ru(II)/Ru(IlI) state of 64. 
This is consistent with the work of Kaim et al., who have demonstrated conclusively, for a group 
of structurally related binuclear complexes, that the electron density at the coordination centres in 
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the LUMO of the bridging 1t ligand correlates with Kc,32,33 Like ilEl/2, the comproportionation 
constant Kc is a measure of the stability of the mixed valence state and is related to E1I2 by the 
equation Kc=exp[LlEl/2 (mV)125.69mVJ. In 65 the dmb ligands cause the oxidation at each metal 
centre (Table 2.5) to be ""lOOmV less than the same oxidations of 64, for reasons already 
described. 
The coordination of a second polarizing Ru(bpyh2+ fragment constitutes a strong 
perturbation to the 1t system of the bridging ligand33 and thus decreases the electron density of 
40. The reduction of the bridging ligand in 64 and 65, which is represented by the first 
reversible one electron reductions at -0.55 and -0.59V respectively (Table 2.5), is therefore easier 
than reduction of 40 in the corresponding monoruthenium(II) complexes. This result is reflected 
in the large red shift of the lowest energy MLCT of 64 and 65 (Table 2.5). The second reversible 
reduction of 64 and 65 is attributed to a second one electron reduction of the bridging ligand. 
Successive reductions of the terminal ligands occur at more negative potentials with closely spaced 
reductions often appearing as two-electron waves. For example, the third and fourth reductions 
of 64 (Figure 2.12) appear as one reversible two-electron wave L1Ep=140m V. 
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The second ligand investigated was 41 and Scheme 2.4 details its synthesis from 
pinacolone (66) in which the first three steps are known literature procedures.200,201,188 In an 
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analogous manner to that used in the synthesis of 40, the side product 69 was chlorinated in 
refluxing POC13 to yield additional 70. The compound NiO(PPh3h was generated from the 
reduction of Niil(PPh3hCh202 by Zn in oxygen free DMF and used to coup1e 70 to give 41 in 
low yield. This method has been used to couple related heteroaryl halides)53,203,194 The related 
coupling method successfully used in the synthesis of 40 was completely ineffective at coupling 
70, whilst the coupling reaction in Scheme 2.4 was found to be very irreproducible. 
The ligand 41 was characterised by mass spectrometry and its 1 Hand l3C NMR spectra 
assigned by comparison with the related ligand 40. A study of the coordination chemistry of 41 
was begun by synthesising a monomolybdenum(O) complex (Scheme 2.5). Reaction of 41 with 
either one or two equivalents of MO(CO)4(114-C7H8) gave the same red complex which was 
shown by 1 H NMR spectroscopy to have the structure 71 in which the ligand exhibits 
symmetrical NI-NI' coordination to molybdenum(O), similar to 58. Hence the large substituents 
of 41 have significantly restricted the choice of coordination sites for octahedral metals. Like 58, 
the complex 41 was also unstable and therefore no elemental analysis was obtained. 
2+ 
Scheme 2.5 
The reaction of 41 with one equivalent of Ru(dmbhCb gave, in good yield, a red 
complex which was isolated as a hexafluorophosphate salt. This complex was shown by mass 
spectrometry to be mononuclear and from its IH NMR spectrum was assigned the structure 72, in 
which the octahedral metal occupies the most sterically accessible Nl-Nl' coordination sites. The 
IH NMR spectrum was readily assigned by comparison with the spectrum of 60. The 13C NMR 
spectrum of 72 was assigned by comparison with the l3C NMR spectra of related complexes. 11 
Thus, unlike the corresponding reaction of 40, which gave a mixture of isomers 62/63, the 
ligand 41 gave a single complex as a result of the greater steric demand of the t-butyl substituents. 
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In the UVNIS spectrum of 72 the unsymmetrical absorption (A>400nm) is a combination 
of a higher energy d1t-1t*(dmb) MLCT (442nm) and a lower energy d1t-1t*(41) MLCT, which 
shows up as a shoulder (480nm). This behaviour is similar to that observed in the UV NIS 
spectrum of 62/63. Analogous to 62/63, the cyclic voltammogram of 72 consists of a reversible 
one-electron oxidation (1.17V), reversible reduction of 41 (-1.23V), two successive reversible 
dmb reductions (-1.68 and -1.90V) and finally irreversible reduction of 41 (-2.11 V). The slight 
increase in the ease of oxidation and decrease in the ease of reduction, relative to 62/63, reflects 
the differences in the electron donating abilities of the t-butyl and methyl groups. 
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The synthesis of a third disubstituted bipyrimidine, 42, is shown in Scheme 2.6. The 
amine 74 was formed by heating formyl camphor (73) with guanidine carbonate at 120° in the 
first step. The diazotization method described in Schemes 2.1 and 2.4 was then applied to 74 to 
give a mixture of 75 and 76 which were separated by chromatography on silica. Additional 76 
was obtained from 75 in refluxing POCI3. The coupling of 76 to give 42 was found to be more 
successful than the coupling of 70 (Scheme 2.4), and was accomplished using in situ generated 
Nio(PPh3h189 as described above for the synthesis of 40. 
The ligand 42 was characterised by mass spectrometry and its 1 Hand BC NMR spectra 
were assigned by comparison with the spectra of 40 and related chiral ligands containing a 
camphor group.204 
Reaction of 42 with one equivalent of PdC12 in hot HCI gave a yellow complex which was 
characterised by elemental analysis (Scheme 2.7). Although the complex was found to be 
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insoluble in common NMR solvents, its structure is most likely 77 given the large size of the 
camphor substituents. The proposed structure 77 is supported by the observed structure of the 
mono-molybdenum(O) complex 78, which was prepared from reaction of 42 with either one or 
two equivalents of MO(CO)4(114-C7HS). The I H NMR spectrum of 78 indicated the symmetrical 
mononuclear structure shown. Again no elemental analysis of 78 was obtained because of the 
instability of the complex. 
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The ruthenium(II) complex 79 was prepared by reaction of 42 with one equivalent of 
Ru(dmbhCl2 and isolated as a red hexafluorophosphate salt. Analysis by mass spectrometry 
confirmed that this complex was mononuclear, whilst the symmetrical NI-Nl' coordination 
shown was confirmed by the IH and l3C NMR spectra which were assigned by comparison with 
the spectra of 62, 72, and with the spectra of related free ligands204 and complexes. I I 
For a complex of the form RuL(dmbh2+ with an achiral bidentate ligand L, the d and A 
forms are enantiomeric and hence equivalent in the 1 H NMR spectrum. As a consequence of the 
chirality of 42, the ~ and A forms of the complex 79 are diastereoisomeric and therefore 
distinguished in the IH NMR spectrum (Figure 2.13). For example, the H4 protons of the 
diastereoisomers are observed as two singlets at 7.65 and 7.68ppm. Only the two most upfield 
singlets could be unambiguously assigned to the ~ and A forms. In this case the ~-syn-9-CH3 
proton (O.36ppm) is positioned above a pyridine ring and more shielded relative to the A-syn-9-
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CH3 proton (O.77ppm) which is coplanar to a pyridine ring. The complete assignment of the IH 
NMR spectrum of the mixture of diastereoisomers of 79 can only be achieved by physical 
separation of the !:1 and A forms. No attempt was made to separate these diastereoisomers. 
A-syn-9-CH3 
!:1-syn-9-CH3 
'1" • ., •• 11", 
2.4 2.2 
Figure 2.13 1 H NMR Spectrum of 79. 
The complex 79 exhibits an absorption centred around 456nm, which is at lower energy 
and appears more symmetrical than those of 62/63 and 72, with no shoulder corresponding to 
d1t-1t*(42) visible at lower energy. Again, as seen previously, this absorption is probably a 
combination of MLCT transitions into the ligand 42 and the dmb ligands. 
The cyclic voltammogram of 79 comprises a reversible one-electron oxidation (1. 12V) and 
three reversible one-electron reductions (-1.39, -1.69 and -1.92V). The fourth irreversible 
reduction, seen in the voltammograms of 62/63 and 72, was not observed for this complex. 
This complex is slightly easier to oxidise than 62/63 and 72 but harder to reduce, which reflects 
increased metal d orbital destabilisation and even greater destabilisation of the 1t* orbitals of 42 by 
having one more substituent per pyrimidine ring relative to 40 and 41. 
A heterobinuclear complex was also synthesised (Scheme 2.8). Treatment of the complex 
79, in dichloromethane, with one equivalent of HgCl2, in acetone, gave a red solid, the IH NMR 
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spectrum of which showed very small differences in chemical shift relative to the 1 H NMR 
spectrum of 79. This is interpreted in terms of a heterobinuclear complex 80, with tetrahedral 
N3-N3' coordination of mercury and octahedral Nt-Nt' coordination of ruthenium(II) to the 
bridging ligand. However, 80 gave an unsatisfactory elemental analysis due to the presence of 
mercury salt impurities whilst mass spectrometry of 80 was inconclusive, due to the extreme 
lability of the Hg-N bond. 
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The quaterheterocycle 51 was the next ligand to be investigated, for which two possible 
synthetic routes were envisaged. It was hoped that the coupling of 2,4-dichloropyrimidine (81) 
using NiO(PPh3h would produce 4,4'-dichloro-2,2'-bipyrimidine (82) (Scheme 2.9), which 
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could then be reacted with two equivalents of potassium pyrazolate to give 51. However all 
attempts to couple 81 using the NiII(PPh3hCh precursor or by generating Nio(PPh3h in situ 
from NiCl2 and PPh3 were unsuccessful. Alternatively (Scheme 2.9), we intended to synthesise 
2-chloro-4-(l-pyrazolyl)pyrimidine (83) by reaction of 81 with one equivalent of potassium 
pyrazolate followed by NiO(PPh3h catalysed coupling of 83 to give 51. 
The potassium pyrazolate salt was prepared by reacting pyrazole with potassium in dry 
DMF at 70°C and reacted with 81 under reflux. Analysis of the crude reaction mixture by IH 
NMR indicated a complex mixture of products which was then separated by radial 
chromatography on silica. The major product from this reaction was found to be 2,4-bis-(1-
pyrazolyl)pyrimidine (53), whilst the desired product 2-chloro-4-(1-pyrazolyl)pyrimidine 83 was 
obtained in very low yield. Presumably substitution of the first chlorine with a pyrazole activates 
the second chlorine toward substitution. Additionally, the structural isomer of 83, 4-chloro-2-(l-
pyrazolyl)pyrimidine (84), was also obtained in very low yield. 
Alternative preparations in which 81 was reacted with pyrazole and NaH in either glyme, 
THF or acetone also failed to give 83. Because of these failures and the low yield of 83 in 
Scheme 2.9, the synthesis of 51 was abandoned. 
eN ~ I N 
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The two structural isomers, 83 and 84, were characterised by mass spectrometry and 
distinguished by their 1 H NMR spectra in CDCb. For both compounds the pyrazole ring can be 
easily assigned given that the H4' proton is a doublet of doublets and of the two doublets, H3' 
and HS', H3' has a smaller coupling constant to H4' than does HS'. Of the two pyrimidine ring 
protons, the more electron deficient H6 proton was assigned to the downfield doublet. There 
exists a significant difference in the chemical shift of the HS proton which is at 7.2Sppm in 84 but 
is further downfield at 7.87ppm in 83 and these were assigned by comparison with the spectra of 
the related known ligands 85 and 86.205 In this case the HS (7.87ppm) of 85 has the same 
chemical shift as HS (7.87ppm) of 83, whilst the HS (7.2Sppm) of 84 is O.06ppm downfield of 
HS (7. 19ppm) of 86, due to the effect of the chlorine in the 4-position. 
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To synthesise 52, the methylene bridged analogue of 51, the methyl groups of 40 needed 
to be functionalised. However, attempts at the radical bromination of 40 using light initiated or 
dibenzoyl peroxide initiated N-bromosuccinamide were unsuccessful. Given this result and the 
unsuccessful attempts at oxidation and brominations of 40, reported in a contemporary paper,206 
the synthesis of 52 was also abandoned. 
The major product 53 of the above reaction is, however, a potentially useful ligand, which 
was characterised by mass spectrometry and 1 Hand l3C NMR spectroscopy. In the 1 H NMR 
(CD3CN) spectrum of 53, H5 (7.84ppm) and H6 (8.83ppm) were easily located, whilst the 
pyrazole ring systems were assigned by homonuc1ear decouplings of the pyrazole H4 protons. 
This, however, did not assign the position of each pyrazole ring system on the pyrimidine ring. 
No nOe could be observed from either of the pyrazole H5's to the pyrimidine H5, nor could the 
long-range C4 to H5 1t or C2-H5' couplings be detected in an HMBC experiment. However, the 
13C NMR spectrum of 53 was assigned by comparison with the 13C NMR spectra of 85 and 
86.205 This result enabled assignment of the pyrazole rings protons in the IH NMR spectrum by 
correlation to the pyrazole carbons using a 2D HMQC spectrum. In this manner, the pyrazole ring 
system with the lowest chemical shifts for each proton was assigned as H3', H4' and H5' (Table 
2.6). The 13C NMR spectrum was assigned by correlation to the 1 H NMR spectrum in an 
HMQC experiment. 
The coordination chemistry of 53 with ruthenium(ll) was investigated by preparing the 
complexes 87 and 88 in an analogous manner to the ruthenium(ll) complexes already described 
(Scheme 2.10). The complexes were obtained, in good yields, as yellow solids and characterised 
by mass spectrometry. 
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The IH NMR spectrum (Figure 2.14) of 87 consists of 24 non-equivalent protons some 
of which are overlapping. The ruthenium(II) coordinates through the most accessible NI-N2' 
nitrogens of the ligand, which was confirmed by the absence of an nOe from H5" to H5. Any 
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Figure 2.14 IH NMR Spectrum of 87. 
enhancement of HS would denote N3-N2" coordination of ruthenium(II), but the absence of an 
nOe implies that the 4-pyrazole ring is in the non-chelating orientation shown in the structure 87. 
In the spectrum of 87, the H4' and HS' protons would be expected to be downfield of the H4" 
and HS" protons, reflecting the a-donation of electron density from the coordinated pyrazole ring 
to the metal, relative to the free pyrazole ring. The H3', which is above a pyridine ring, would be 
expected to be upfield of H3" as a result of interligand through-space ring current anisotropy. 
The 1 D TOCSY experiment (Figure 2.1S) confinns this. Irradiation of the HS' doublet (9.06ppm) 
(trace I) shows'up the H4' doublet of doublets (6.89ppm) and the H3' doublet (7.S0ppm), thus 
locating the coordinated pyrazole ring and demonstrating the substantial coordination induced 
shifts of H3' (-O.38pprn), H4' (+O.27ppm) and HS' (+O.29ppm). Similarly the spin system of 
the non-coordinated ring can be located as HS" at 8.90ppm (+O.12ppm), H4" at 6.78ppm 
(+0.11ppm) and H3" at 8.01ppm (+O.09ppm) by irradiating HS" (trace II). The AB quartet at 
7.79ppm (-O.OSppm) and 7.86ppm (-O.97ppm) was assigned to the H5 and H6 protons 
respectively. Molecular models show that the H6 proton is much closer to a pyridine ring than HS 
and therefore exhibits a greater CIS. The small positive CIS of HS reflects the combined effects of 
a-donation and ring-current anisotropy. The spectrum of 87 is summarised in Table 2.6. The ID 
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Figure 2.15 lD TOCSY Spectra of 87 
TOCSY spectra also demonstrate the effect of the ligand 53 on the chemical shift of the bpy 
ligands and resolves these protons from overlapping multiplets (trace III and IV). For example, 
the bpyH6 protons (trace IV) are spread out in the spectrum due to the varied ring current effects 
of pyridine, pyrimidine and pyrazole rings. Once located by ID TOCSY spectra the pyridine ring 
systems, but not the individual rings, were assigned using a COSY spectrum. 
The 1 H NMR spectrum of the complex 88 was similarly assigned by ID TOCSY and 
COSY spectra and is summarised in Table 2.6. A homoleptic complex Ru(53h 2+ (89) was 
synthesised by reacting three equivalents of 53 with Ru(DMSO)4Ch and was isolated as a yellow 
hexafluorophosphate salt. The complex 89 was characterised by mass spectrometry and IH 
NMR spectroscopy. 
Table 2.6. IH NMR Chemical shiftsa and Coordination Induced Shiftsb of 53,87 and 88 
HS H6 H3' H4' HS' H3" H4" HS" 
53 7.84 8.83 7.88 6.62 8.77 7.92 6.67 8.78 
87 7.79 7.86 7.S0 6.89 9.06 8.01 6.78 8.90 
CISb -O.OS -0.97 -0.38 +0.27 +0.29 +0.09 +0.11 +0.12 
Bpy ligands 
H3 H4 HS H6 
8.S3 8.10 7.42 7.79 
8.S6 8.13 7.46 7.83 
8.S6 8.17 7.SS 8.24 
8.S6 8.17 7.S7 8.02 
88 7.79 7.87 7.47 6.88 9.04 8.00 6.78 8.89 
CISb 
-O.OS -0.96 -0.41 +0.26 +0.27 +0.08 +0.11 +0.11 
Dmbligands 
H3 4-CH3c HS H6 
8.37 2.62c 7.2S 7.S9 
8.40 2.61c 7.29 7.62 
8.40 2.S9c 7.34 8.03 
8.40 2.S8c 7.38 7.82 
a For deuterated acetonitrile solutions. b CIS=Ocomplex-Oligand. c Methyl group not assigned 
The IH NMR spectrum of 89 was complicated by the presence of two isomers. In such 
complexes the coordination of three unsymmetrical ligands produces the meridonal (mer) and 
facial (fac) isomers in a statistical ratio (mer:fac) of 3:1. This ratio is observed for 89 in the IH 
NMR spectrum, which was tentatively assigned by comparison with the spectra of 53 and 87. 
Table 2.7 summarises the UVNIS spectra and cyclic voltammetry of 87, 88 and 89. 
Included in the table are data for the related complexes Ru(bpY)32+ and Ru(86)(bpyh2+.6,207,ll 
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All complexes show strong ligand centred absorptions at less than 300nm. The heteroleptic 
complexes have low energy absorptions with maxima at 412 nm and 418nm respectively with 
shoulders either side of the maxima. These absorptions were assigned as MLCT bands and are at 
higher energy than the MLCT of Ru(bpYh2+ (451nm). Also the spectra of 87 and 88 were 
found to resemble the spectra of the ruthenium(II) complexes of structurally related ligands that 
contain a pyrazole ring.ll The homoleptic complex has a symmetrical absorption (384nm) 
analogous to that of Ru(bpyh2+ (451nm) but, as for 87 and 88, at much higher energy. These 
results show that electron transfer from metal to ligand is more difficult for 87-89 than for 
Ru(bpYh2+, which reflects the higher energy of the 1t* orbitals of 53 relative to bpy . 
T bl 27 Ab a e .. sorption M . a dRd P axlma an e ox . al b f 87 88 d 89 otent! s or , an 
Complex A Eoxl Bredl Ered2 Ered3 Bred4 .1Eox-red i 
Ru(bpyh2+ 451 +1.27 -1.31 -1.50 -1.77 c 2.58 
Ru(86)(bpYh2+ 370,410,430 +1.30 -1.36e c c c 2.66 
87 386,412,430 +1.26 -1.39d -1.58e -1.88e c 2.65 
88 386,418,428 +1.17 -l.44d -1.65e -1.91 e c 2.61 
89 386 +1.35 -1.46d -1.61 e -1.80e -2.l2e 2.81 
a In nanometres. b In volts vs SeE in acetonitrile. c Not observed. d Irreversible. e Quasi-irreversible 
The complex 87 exhibits a reversible one electron oxidation (+ 1.26V) and three one 
electron reductions (-1.39, -1.58, and -1.88V) and is therefore as easy to oxidise as Ru(bpY)32+ 
but slightly harder to reduce. The first reduction is irreversible and occurs at slightly more 
negative potential than the first reduction of Ru(86)(bpy)z2+ which is also irreversible'! 1 
Reduction of pyrazole-containing ligands is known to lead to ligand dissociation. l2 The oxidation 
of 88 is 0.09V lower than the oxidation of 87 and its reductions are more negative, an effect 
which has been previously been described for other RuL(dmb)z2+ complexes in this work. The 
homoleptic complex 89 exhibits a reversible one electron oxidation at + 1.35V and a first reduction 
at -1.46V. Relative to Ru(bpYh2+ the increase in oxidation potential implies a lowering of the 
metal d1t orbitals of 89, whilst the increase in the reduction potential implies raising of the 1t* 
LUMG. Thus the complex is both harder to oxidise and harder to reduce than Ru(bpYh2+ and the 
Eox-red value of 2.81 is consistent with the observed higher energy of the MLCT of 89 (386nm), 
since the same orbitals are known6 to be involved. 
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Chapter 3 
2-Substituted Perimidine Ligands and 
Complexes. 
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2-Substituted Perimidine Ligands and Complexes. 
3.1. Introduction. 
Binuclear complexes incorporating a bipyrirnidine bridge exhibit strong metal-metal 
interactions, due to the short (s.sA) inter-metal separation. For example, a strong interaction 
(6.E 1/2=160mV) is observed between the ruthenium(II) atoms of the complex 
[Ru(bpYhhbpm4+.25 Direct overlap of the dyz orbitals, which point toward each other in 
binuclear bipyrirnidine complexes, has been described, by others,33 as contributing to this 
interaction. The larger interaction (6.El/2=200mV) in the complex 64 has already been described 
in chapter 2. 
By decreasing the charge repulsion in bridged binuclear complexes, the degree of metal-
metal interaction may be increased. This has been demonstrated in the complexes of 2,2-
bibenzimidazolate (bibzm-6).n The charge repulsion of the ruthenium(II) atoms of the complex 
[Ru(bpyhhbibzm2+,65,n,76 is much less than in the complex [Ru(bpYhhbpm4+, and in 
combination with the stronger (j donor property of bibzim, contributes to a stronger metal-metal 
interaction (Llli 1/2=290m V). 
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Benzo-fusion in bidentate ligands has the effect of lowering the energy of the rr* orbitals. 
For example, the rr* orbitals of 2,2'-biquinoline (90) (Figure 3.1), are lower in energy than those 
of bpy. As a consequence, the ruthenium complexes of 90 have properties which are significantly 
different to those of Ru(bpy)}2+.207 Furthermore, benzo-fused bridging ligands should be able to 
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form binuclear complexes with interesting properties. Since the electron density in the LUMO of 
the bridging ligand at the coordination centres has been shown to be a major contributor to the 
metal-metal interactions,32 ring fusion to a bipyrimidine-like bridging ligand should have the 
desirable effect of increasing the interaction, by lowering the energy and increasing the electron 
density of the 1t* LUMO. 
The known compound 2,2'-biperimidine (bipH2, 91)208,209,210 (Figure 3.1) is a potential 
bridging ligand which would incorporate the properties described above. To act as a bridge, 
bipH2 requires double deprotonation to give the dianion (92), which would significantly decrease 
the inter-metal charge repulsion. In addition, the four fused rings of bip lower the energy of the 
1t* orbitals of the ligand relative to bpm, thus increasing the electron density of the bridge at the 
coordination centres. 
2,2'-Biperimidine was first synthesised by Sachs208 in 1909 and two further syntheses 
have since been described.209,21O A number of substituted monoperimidines have also been 
reported,211-214 including 2-(2-pyridinyl)perimidine211 (93), which is a potential mononucleating 
bidentate ligand. Recent interest has been shown in the tautomerism213,214 and potential DNA 
intercalating ability213 of perimidine derivatives. 
We begin this chapter with a detailed study of the mononuclear palladium(II) and 
ruthenium(II) complexes of 93 (Figure 3.1), as a preliminary to a study of 2-substituted 
perimidines as binucleating ligands. The syntheses of two new perimidine ligands, 94 and 9S 
(Figure 3.1), and a study of their palladium(II) and ruthenium(II) complexes are included, whilst 
attempts to form ruthenium(II) complexes with 91 are also discussed. 
3.2. Results and Discussion. 
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Scheme 3.1 
2-(2-Pyridinyl)perimidine (93) was prepared by reacting 1,8-diaminonaphthalene with 2-
cyanopyridine in a sodium ethoxide solution at room temperature (pH 5-7) (Scheme 3.1), as has 
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been described by Browne.212 An intra-molecular hydrogen bond between NIH and NT of 93 
allows coplanarity of the pyridine and perirnidine rings, hence the n-electron density is delocalised 
throughout the molecule. This conjugation lowers the energy of the n* orbital of 93, resulting in 
the deep red colour of the ligand. 
The 13C NMR spectrum of 93 in CD3CN was assigned by comparison with the 13C NMR 
spectra of structurally related compounds.213,214 In general, C9 is upfield of C4 in the 13C NMR 
of known unsymmetrical perimidines and in the spectrum of 93 these carbons were assigned as 
C9 (l03.2ppm) and C4 (115.2ppm). These assignments could then be correlated, using an 
HMQC spectrum, to the doublets (6.61ppm) and (6.S4ppm) in the IH NMR spectrum (Figure 
3.1), thus locating H9 and H4. 
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Figure 3.1 IH NMR Spectrum of 93. 
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The four remaining naphthalene protons of 93 were assigned using ID TOCSY spectra 
(Figure 3.2). By irradiating H4 (trace I), both H5 (7.2Sppm), and H6 (7.17ppm) can be located 
and similarly irradiating H9 (trace II) locatesHS (7.19ppm) and H7 (7.17ppm). The H5-H6 
coupling constant of a pyridine ring is generally smaller than the H3-H4 coupling constant. This 
allowed for straight-forward assignment of the pyridine ring protons in the IH NMR spectrum of 
93 as H3' (S.39ppm), H4' (S,Olppm), H5' (7.60ppm) and H6' (S.73ppm). 
Reaction of 93 with one equivalent of PdCl2 in hot HCI gave a brown solid, which was 
characterised by elemental analysis and proposed to be the complex 96 (Scheme 3.2). The 
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Figure 3.2 ID TOCSY Spectra of 93 
complex was sufficiently soluble in DMSO to be analysed by IH NMR, but rapidly dissociated in 
solution with release of the free ligand by cleavage of the Pd-N bonds. The dissociation of 96 is 
probably assisted by the lability of the N-H bond and caused significant broadening of the signals 
in the IH NMR, hence only tentative assignments of the individual protons were possible. 
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The molybdenum(O) complex 97 was prepared from a 1:1 mixture of 93 and Mo(CO)6 in 
degassed and refluxing toluene (Scheme 3.2). This method, which has recently been used by 
Ruminski et ai.19 to prepare structurally related complexes, differs from the previous syntheses of 
58, 71 and 78 using MO(CO)4(114-C7H8), as described in the previous chapter. Ruminski et ai. 
also described purification of the monomolybdenum(O) and dimolybdenum(O) complexes of dpop 
(20) by chromatography on alumina (eluent=acetone). We have found that 97 undergoes 
dissociation to the free ligand under these conditions, even with neutral or acidified alumina. In 
addition purification by recrystallisation in acetone/ether or THF/ether caused dissociation of the 
complex. 
The 1 H NMR spectrum (DMSO-d6) of the crude reaction mixture of 97 was assigned by 
comparison with the spectrum of the free ligand in the same solvent. Relative to the spectrum of 
the free ligand, all protons move downfield on coordination. Specifically, the CIS values of 97 
are +0.43ppm (HI), +0.74ppm (H4), +O.17ppm (HS), +0.23ppm (H6), +0.2Sppm (H7), +0.14 
(H8), +0.09ppm (H9), +0.30ppm (H3'), +0.30ppm (H4'), +0.2Sppm (HS'), 0.37ppm (H6') , all 
of which reflect the donation of a-electron density from the ligand to the metal. The shifts of the 
naphthalene ring protons imply that delocalised electron density from the fused rings has a 
significant contribution to the ligand-metal bonding, whilst the CIS values of H6' and H4 are 
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particularily large due to their close proximity to the deshielding carbonyl groups. In addition, 
after only five minutes, signals for the free ligand were observed in the IH NMR spectrum of 97, 
implying dissociation of the complex (approximately 50%). 
The reaction of 93 with Ru(bpyhCb gave the complex 98 (Scheme 3.2). The 1 H NMR 
spectrum of 98 was complicated by the overlap of signals, and by the dissociation of the complex 
and thus could not be assigned. To assist in the assignment of 98, the complex 99 was prepared, 
in which the bpy ligands are replaced with dmb (Scheme 3.2). 
i 'i,," if. cit .111'" ii'''I l!jli"I""';"'I" i li',II""I"I'" ."''1".1,111 j' • 1111\, ••• ".", •••• ,,1"1"'" • "I""'" 'I 
e.6 B.4 8.2 8.0 1.8 1.6 1.4 1.2 1.0 6.8 6.6 6.4 6.2 6.0 PI"" 
Figure 3.3 IH NMR Spectrum of 99. 
The 1 H NMR spectrum of 99 (Figure 3.3) consists of 22 non-equivalent aromatic protons. 
Spectra obtained after leaving the complex in solution for 5-10 minutes were too complicated to 
assign and showed evidence of complex dissociation. The NIH proton is absent in the spectrum 
implying a monocation, although th'is could not be confinned, either by elemental analysis or by 
mass spectrometry. 
The complex was stable long enough (5-lOminutes) to acquire a series of ID TOCSY 
spectra from which the protons of 93 were assigned (Figure 3.4). Briefly, the pyridine ring spin 
system of 93 were located by irradiation of H4' (S.16ppm) (trace Ill), whilst the two naphthalene 
spin systems were assigned by irradiation of H9 (6.89ppm) (trace II) and H4 (5.96ppm) (trace I). 
The chemical shifts and CIS values of these protons are summarised in Table 3.1. The increasing 
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negative CIS values, in the order H5', H5, H4 and H6', reflect their proximity to a shielding dmb 
pyridine ring. The remaining protons show positive CIS values, reflecting the net donation of 
electron density from ligand to metal and also, in the case of H3', the change in conformation 
about the inter-ring bond required for metal chelation. 
The dmb H3, H5 and H6 protons, but not the methyl groups, were tentatively located 
using ID TOCSY spectra similar to those shown in Figure 3.4. These results are summarised in 
Table 3.1. The spectrum of 98 was then tentatively assigned by comparison with the spectrum of 
99. An interesting feature in the IH NMR spectrum of 99 is the downfield position (8.61 ppm) of 
one of the dmbH6 protons. This proton lies above the aromatic (NHl-N3) ring of 93 and is 
therefore deshielded, relative to the three remaining dmbH6 protons, which lie above pyridine 
rings. 
Table 3.1. IH NMR chemical shiftsa of 99 and 93. Coordination Induced Shiftsb of 99. 
HI H4 H5 H6 H7 H8 H9 H3' H4' H5' H6' 
99 c 5.96 6.70 7.17 7.22 7.29 6.89 8.58 8.16 7.47 7.66 
93 9.78 6.84 7.28 7.19 7.12 7.19 6.61 8.39 8.01 7.60 8.73 
CIS c -0.88 -0.58 -0.02 +0.10 +0.10 +0.28 +0.19 +0.15 -0.13 -1.07 
DMBLigands 
H3 4-CH3d H5 H6 
8.40 2.56 7.19 7.41 
8.31 2.57 7.27 7.52 
8.33 2.58 7.38 7.65 
8.45 2.63 7.40 8.61 
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. c Not observed. d Not assigned. 
An attempt to prepare the homoleptic complex Ru(93h2+ by reacting three equivalents of 
the ligand with Ru(DMSO)4C12 gave a black solid. The IH NMR spectrum of this solid was 
extremely complicated and the complex, which was found to be very unstable, was not further 
investigated. 
The complexes of 93 were found to be consistently unstable in solution which can be 
explained by a coordination induced weakening of the NI-H bond. This proton is easily removed 
in solution resulting in dissociation of the ligand from the metaL A solution to this problem might 
be to stabilise the complexes by using the ligand 94, in which Nl is methylated. 
The synthesis of the new ligand is shown in Scheme 3.3 and is based on alkylation 
reactions with related perimidines, as described by Paragamanian et al.211 The ligand 93 was 
deprotonated in a suspension of NaH in 1,2-dimethoxyethane and treated with MeL This gave a 
yellow coloured compound 94 which was recrystallised from petroleum ether. 
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In the 1 H NMR spectrum of 94, H4 and H9 were distinguished by the observed nOe 
between the methyl group and H9. Thus the two naphthalene spin systems could then be assigned 
using ID TOCSY spectra, analogous to those in Figure 3.1. The methyl group prevents the 
conjugation of the perimidine and pyridine rings and accounts for the absence of the deep red 
colour observed for 93. The l3C NMR spectrum of 94 was assigned by comparison with the 
spectra of 93 and structurally related complexes.213,214 
The reaction of 94 with one equivalent of PdCb, in hot HCl, gave the complex 100 
(Scheme 3.4) as a brown solid. Recrystallisation, by slow diffusion of a layer of methanol into a 
saturated solution of the solid in DMF, gave crystals of sufficient quality for the structure of 100 
to be determined by X-ray crystallography. 
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Figure 3.5a shows a perspective view and atom labelling of the structure of 100. Table 
3.2 lists the bond lengths and bond angles with least-squares-estimated standard deviations in 
parentheses. This structure determination confirms not only the structures of the ligand and 
complex, but also the bidentate mode of coordination of the ligand. Figure 3.5b shows a 
perspective view of 100 perpendicular to the plane of the naphthalene unit of the perimidine 
system. This shows that the complex deviates significantly from planarity. Specifically, the 
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Figure 3.5a. Perspective view and atom labelling of the structure of 100. 
Figure 3.5b. View perpendicular to the plane of the naphthalene unit. 
54 
Table 3.2. Bond lengths (A) and angles (0) for 100. 
Pd(1)-N(1') 2.023(7) Pd(l)-N(3) 2.085(7) 
Pd( 1 )-CI(2) 2.296(2) Pd( 1 )-Cl( 1) 2.298(2) 
C(1)-N(1) 1.466(11) N(l)-C(2) 1.370(10) 
N(1)-C(9A) 1.418(11) C(2)-N(3) 1.343(11) 
C(2)-C(2') 1.488(11) N(3)-C(3A) 1.411(10) 
C(3A)-C(4) 1.380(12) C(3A)-C(9B) 1.427(12) 
C(4)-C(5) 1.400(12) C(5)-C(6) 1.372(14) 
C(6)-C(6A) 1.428(14) C(6A)-C(9B) 1.418(12) 
C(6A)-C(7) 1.437(14) C(7)-C(8) 1.33(2) 
C(8)-C(9) 1.426(14) C(9)-C(9A) 1.383(12) 
C(9A)-C(9B) 1.424(13) NO')-C(6') 1.327(10) 
N (1 ')-C(2 ') 1.360(10) C(2')-C(3') 1.399(11) 
C(3')-C( 4') l.365(12) C(4')-C(5') 1.378(12) 
C(5')-C(6') l.398(11) 
N(1')-Pd(1)-N(3) 80.7(3) N (1')-Pd( 1 )-CI(2) 176.2(2 
N(3)-Pd(1)-Cl(2) 97.8(2) N(1')-Pd(1 )-Cl( 1) 93.1(2) 
N(3)-Pd(1)-Cl(1) 173.6(2) Cl(2)-Pd( l)-Cl( 1) 88.3(1) 
C(2)-N(I)-C(9A) 119.6(7) C(2)-N(1)-C(1) 122.8(7) 
C(9A)-N(I)-C(1) 117.2(7) N(3)-C(2)-N(l) 124.0(7) 
N(3)-C(2)-C(2') 114.6(7) N(1)-C(2)-C(2') 121.3(7) 
C(2)-N(3)-C(3A) 118.7(7) C(2)-N(3)-Pd(l) 107.8(5) 
C(3A)-N(3)-Pd(1) 131.0(6) C(4)-C(3A)-N(3) 120.4(8) 
C( 4 )-C(3A)-C(9B) 121.2(8) N(3)-C(3A)-C(9B) 118.4(8) 
C(3A)-C(4)-C(5) 120.1(9) C( 6)-C( 5)-C( 4) 120.3(10) 
C( 5)-C( 6)-C( 6A) 12l.1(9) C(9B)-C(6A)-C(6) 118.9(9) 
C(9B)-C(6A)-C(7) 116.5(10) C(6)-C(6A)-C(7) 124.5(9) 
C(8)-C(7)-C(6A) 122.5(10) C(7)-C(8 )-C(9) 121.1(10) 
C(9A)-C(9)-C(8) 119.3(10) C(9)-C(9A)-N(1) 123.1(9) 
C(9)-C(9A)-C(9B) 119.7(8) N(1)-C(9A)-C(9B) 117.2(7) 
C(6A)-C(9B)-C(9 A) 120.7(8) C(6A)-C(9B)-C(3A) 118.3(9) 
C(9A)-C(9B)-C(3A) 120.9(8) C(6')-N(1 ')-C(2') 120.0(7) 
C(6')-N(1')-Pd(1) 127.0(6) C(2')-N (1')-Pd( 1) 112.8(6) 
N( 1 ')-C(2')-C(3') 120.3(8) N(I')-C(2')-C(2) 114.3(7) 
C(3')-C(2')-C(2) 124.9(7) C( 4')-C(3 ')-C(2') 1] 9.6(8) 
C(3')-C( 4')-C(5') 119.4(8) C( 4')-C(5')-C(6') 119.2(8) 
N (1')-C( 6')-C( 5') 121.2(8) 
pyridine ring is both twisted out of the plane of the perimidine unit (angle between the respective 
meanplanes = 35.8°) and, along with C2, displaced below the plane of the perimidine unit. These 
distortions presumably occur to relieve a steric interaction between the methyl group and the C3' 
hydrogen. As expected the coordination geometry at the palladium atom is square planar. The 
molecular packing of 100 (not shown) is controlled by 1t-1t stacking interactions between the 
naphthalene units of adjacent molecules related by a crystallographic centre of inversion. These are 
separated by approximately 3.5A. 
In the lH NMR spectrum of 100 (DMSO-d6) the pyridine ring was unambiguously 
assigned as H3' (8. 12ppm), H4' (8.30ppm), H5' (7.89ppm), H6' (8.98ppm), with the CIS 
values of +0.25, +0.19, +0.23, +0. 19ppm all reflecting the donation of (J electron density from 
the ligand to the metal. The naphthalene ring protons showed similar positive coordination 
induced shifts, but the two spin systems were overlapping in the lH NMR, and hence, could not 
be definitively assigned. 
The reaction of 94 with one equivalent of Ru(dmb)2CI2 gave the complex 101 
(Scheme3.4), which was characterised by mass spectrometry and IH and 13C NMR. Unlike 98 
and 99, which were unstable in solution, the complex showed no evidence of dissociation, even 
after being in solution for more than 24 hours. 
Table 3.3. IH NMR chemical shiftsa of 101 and 94. Coordination Induced Shiftsb of 101. 
1-CH3 H4 H5 H6 H7 H8 H9 H3' H4' H5' H6' 
101 3.74 6.13 6.77 7.25 7.31 7.39 6.71 8.33 8.08 7.40 7.69 
94 3.15 6.84 7.34 7.29 7.25 7.32 6.47 7.76 8.00 7.54 8.73 
CISb +0.59 -0.71 -0.57 -0.04 +0.06 +0.07 +0.24 +0.57 +0.08 -0.14 -1.04 
DMBLigands 
H3 4-CH3c H5 H6 
8.46 2.54 7.19 7.48 
8.25 2.58 7.28 7.62 
8.30 2.58 7.46 7.92 
8.51 2.64 7.36 8.41 
a For deuterated acetonitrile solutions. b CIS == 0complex-Oligand. c Not assigned. 
The 1 H NMR spectrum of 101 (Figure 3.6) is similar to that of 99 (Figure 3.3). 1D 
TOCSY spectra, analogous to those displayed in Figure 3.4, were used to assign all the pyridine 
and perimidine protons of the complex. In addition, the assignment of the individual dmb spin 
systems was achieved using the 2D COSY spectrum also shown in Figure 3.6. In this spectrum, a 
long range correlation can be observed from each of the dmbH3 protons to a dmbH5 in the region 
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Figure 3.6 IH NMR and 2D COSY Spectra of 101. 
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of extensive overlap from 7. 18-7.5ppm. Thus located, the dmbH5 protons can tl1en be correlated 
to the corresponding dmbH6. The IH NMR spectrum of 101 is summarised in Table 3.3. 
Throll:gh-space interligand ring-current anisotropy, (j donation and 1t back-donation of 
electron density and coordinative disruption of inter-ring conjugation were all invoked to describe 
the CIS values of 99. These factors can also account for the observed CIS values of 101 in Table 
3.3, although chelation ind~ced conformational change cause a greater deshielding of H3' 
(+0.57ppm) than in 99 (+0. 19ppm) due to the greater sterk demand of the Nl methyl group. 
Figure 3.7 IH NMR Spectrum of 102. 
The complex Ru(DMSO)4Ch was reacted with three equivalents of the ligand 94 to give a 
dark purple solid. After purification by chromatography on alumina, the resultant complex (102) 
(Scheme 3.5) was characterised by IH NMR and mass spectrometry. The IH NMR spectrum of 
102 has 30 non-equivalent aromatic protons (Figure 3.7), thus indicating that the complex has 
three non-equivalent ligands in a 1:1:1 ratio. Homoleptic complexes of the form Ru(L-L'h2+ 
generally exist as a mixture of the mer and fac isomers in a 3: 1 ratio and, thus, have four non-
equivalent ligands, three corresponding to the mer isomer and one corresponding to the fac isomer. 
Keene et al. have recently reported the separation of such isomers in structurally related homoleptic 
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complexes.215 If the complex 102 has the homoleptic structure Ru(94h2+, the spectrum implies 
that only the mer isomer has formed, and not a mixture of mer and fac. 
All three pyridine rings were assigned from ID TOCSY irradiations of the four most 
downfield doublets, whilst similar irradiation of the three most upfield doublets located almost all 
of the naphthalene spin systems, with the exception of H7 and H8 which show considerable 
overlap. The pyridine and perimidine rings of each ligand were correlated by an nOe from the 
appropriate NI-CH3 (not shown in Figure 3.7), which showed enhancement of the relevant H3' 
and H9 protons. For example, the deshielded H3' (9.02ppm) was correlated to the deshielded 
H6' (8.88ppm) by a ID TOCSY experiment, and by an nOe to the strongly deshielded methyl 
group (4.33ppm) which in turn is correlated by an nOe to an H9 of a naphthalene ring. In this 
manner nearly all of the protons of the three ligands could be assigned. 
Given that the complex was shown, by mass spectrometry, to contain a chlorine atom, the 
novel structure for 102 (Scheme 3.5) was proposed. In this case, one ligand exhibits 
mono dentate coordination through the pyridine ring, with the N l-CH3 of the ligand deshielded by 
an adjacent chlorine atom which is coordinated to ruthenium(II), whilst the H6' is deshielded by a 
perimidine ring of another ligand. The two other ligands exhibit bidentate coordination to 
ruthenium(II), with the H6' of one deshielded by the coordinated chlorine atom, whilst the H6' of 
the other is adjacent to and in the deshielding region of the monodentate coordinated pyridine ring. 
On reflection, this complex is more likely to form than the homoleptic Ru(L-L'h2+ complex 
because of the steric demand of the bulky perimidine ring of 94. 
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Table 3.4 summarises the UVNIS spectra and cyclic voltammetry of 101 and 102. 
MLCT transitions occur at 454 and 504nm for 101 and at lower energy (496 and 530nm) for 
102. Thus electron transfer from metal to ligand is easier for these complexes than in the case of 
Ru(bpY)32+ (451nm). Oxidation and reduction of the complexes is also easier than for 
Ru(bpYh2+; hence the values for mox-red are much smaller, which correlates with the low energy 
MLCT bands and reflects the smaller HOMO-LUMO gap in the complexes. The chlorine of 102 
and dmb ligands of 101 also contribute to a lowering of the oxidation potential by destabilising the 
metal d orbitals. The cyclic voltammogram of 102 is shown in Figure 3.8. 
Table 3.4. Absorption Maximaa and Redox Potentfalsb of 101 and 102. 
Complex A Box E:recil Erect2 Ereru Ered4 mox-red 
Ru(bpYh2+ 451 +1.27 -1.31 -1.50 -1.77 - 2.58 
101 454,504sh +1.22 -1.25 -1.68 -1.87 -2.20c 2.47 
102 496, 530 +0.84 -1.14 -1.31 -1.57 -2.00 1.98 
a In nanometres. b In volts vs SeE in acetonitrile. c Irreversible. 
OV +1V 
Figure 3.8 Cyclic Voltammogram for 102. 
Methylation of 93 has produced the new ligand 94. With the exchangeable proton 
removed, this ligand has been shown to form much more stable complexes than 93. However, 
neither ligand has the potential to form binuclear complexes, the study of which is the major 
objective of this research. To this end, the potentially binucleating ligand 91 was synthesised 
using the method of Patschorke et al.,209 in which two equivalents of 1,8-diaminonaphthalene 
were condensed with one equivalent of ethyl oxalate at 220°C (Scheme 3.6). The compound 91 is 
insoluble in most common solvents, although a IH NMR spectrum was obtained in DMSO-d6. 
Haga65 has described the synthesis of [Ru(bpyhhbibzm2+ from Ru(bpYhbibzmH22+, in 
which the formation of the dianion in solution, by double deprotonation of Ru(bpyhbibzmH22+, 
is facile because the N-H bond is weakened by coordination of the first ruthenium(II). We 
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intended to use this approach in the synthesis of the biruthenium(II) complex 104 by initially 
preparing the monoruthenium(lI) complex 103 (Scheme 3.7). 
H H 
NH2 ~ ~ NH2 
+ EtO-C-C-OEt + 
I I 
N N 
H 
N N 
91 
Scheme 3.6 
The reaction of 91 with one equivalent of Ru( dmb hCl2 in refluxing ethanollwater failed to 
give a mononuclear complex due to the insolubility of the ligand. Instead, the reaction was 
performed in refluxing ethylene glycol. This was more successful in coordinating 91 to 
ruthenium(II), although the product of the reaction was a mixture of complexes, with the ligand 
adopting a monodentate coordination mode. Attempts to separate the resulting mixture of 
complexes by chromatography on alumina were unsuccessful. In mononuclear complexes 91 is 
therefore more likely to exhibit monodentate coordination rather than the more sterically demanding 
bidentate mode of 103. Failure to synthesise 103 effectively prevented a synthesis of 104, using 
this approach. 
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An attempt was made to synthesise a biruthenium(II) complex directly, by reacting 91 with 
K2C03 and two equivalents of Ru(dmbhCh in refluxing ethylene glycol. This also gave a 
mixture of complexes which could be neither separated by chromatography on alumina, nor 
60 
identified by IH NMR. The complexes may also have decomposed in this reaction, since N-
unsubstituted perimidines are known to decompose under basic conditions,211 which also 
discouraged the use of a stronger base in any further reactions. In fact neutral alumina was used in 
the purification attempts to avoid decompositon of the complexes in the mixture. 
The compound 91 has proved to be unsuitable as a bidentate bridging ligand for 
ruthenium(II) because of its insolubility, inability to form a bidentate monoruthenium(II) complex 
and tendency to decompose rapidly in base. Instead, 95 was proposed as an alternative to 91, 
which should be more soluble and less sterically demanding, and hence, be able to form mono-
and binuclear complexes, given that similar mononuclear complexes of 93 and 94 have been 
prepared. 
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The compound 95 was synthesised under the same reaction conditions as for the synthesis 
of 93, but with the exception that 2-cyanopyridine was replaced by 2-cyanopyrimidine (Scheme 
3.8). The new ligand was then characterised by mass spectrometry and its IH NMR spectrum was 
assigned by comparison with the spectra of 93 and 94. 
A palladium(II) complex (105) (Scheme 3.9) was prepared by reacting the ligand with 
PdCh in hot HCI, but was found to be insoluble in common solvents. In addition the elemental 
analysis of this complex was found to be unsatisfactory. Given the structure of previous 
complexes 96 and 100, the complex was tentatively assigned the structure shown. 
The reaction of 95 with one equivalent of Ru(dmbhCh, which gave the complex 106, 
was more successful (Scheme 3.9). Mass spectrometry of the complex confirmed that the Nl 
nitrogen was protonated, although this proton was not observed in the 1 H NMR spectrum. The 
spectrum of 106, which consists of 25 non-equivalent aromatic protons, was assigned in an 
analogous manner to the spectra of 99 and 101 using ID TOCSY spectra. Most chemical shifts 
and CIS values were similar to those in the spectrum of 99, including the deshielded dmbH6 
proton, which lies above the non-aromatic perimidine ring of 95. The major difference in the 
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spectrum of 106 is the absence of an H3' pyridine proton and, as a consequence of complex 
formation, the equivalent H4' and H6' of 95 become non-equivalent, with H4' exhibiting a 
positive CIS and H6' exhibiting a negative CIS for reasons already described for the pyridine rings 
of 99 and 10l. 
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Unfortunately, attempts to prepare the binuclear complex 107 were less successfuL 
Firstly, a mixture of complexes was obtained from the reaction of 106 with one equivalents of 
Ru(dmb)ZCh. No binuclear complex could be distinguished in the 1H NMR spectrum of the 
mixture. The mononuclear complex 106, but not the binuclear complex, was isolated from this 
mixture by either chromatography on alumina, or by ion-exchange chromatography on C-25 
sephadex. The reaction wa'l repeated in the presence of K2C03 to effect deprotonation of the N 1 
nitrogen. Again a mixture of complexes, with an even more complicated 1H NMR spectrum wa'l 
obtained from which no binuclear complex could be isolated by chromatography. Similarly, 
reacting the ligand (95) with two equivalent of Ru( dmb )zCl2, both with, and without, K2C03 was 
successful in generating 106, but not 107. In retrospect it seems that NH perimidines are not 
suitable ligands for the preparation of binuclear complexes. 
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Chapter 4 
Complexes of 
4,6-Bis-(2-pyridinyl)pyrimidine. 
Complexes of 4.6-Bis-(2-pyridinyl)pyrimidine. 
4.1. Introduction. 
In chapter 2 a strong metal-metal interaction (L1El/2=200m V) was reported for biruthenium 
complexes 64 and 65 containing a 4,4'-dimethyl-2,2'-bipyrimidine (40) bridge. Stronger inter-
metal communication has been described by others in biruthenium complexes with biimidazolate 
(7)77 or bibenzimadazolate (6)65,72,76 bridges, in which the anionic ligand decreases the repulsion 
between the metals. Two perimidine compounds were proposed as anionic bridging ligands in this 
work, but were found to be unsuitable for reasons already described in chapter 3. 
Alternatively, two metals may be bridged by a pyrazine ring which allows strong inter-
metal communication, as in the well known Creutz-Taube complex.17,18 The stability of such 
complexes can be increased by using a chelating bridging ligand which incorporates a pyrazine 
ring. For example, substitution of two pyridine rings at, either the 2,3 or the 2,5 positions of a 
pyrazine ring, produces the bridging ligands 2,3-bis-(2-pyridinyl)pyrazine (2,3-dpp, 15)114 and 
2,5-bis-(2-pyridinyl)pyrazine (2,5-dpp, 16) 115 respectively. Other bridging ligands structurally 
related to 15 and 16 have been described, particularly the ring fused analogues 
18,25,26,117,129,130,134,135,141,142 19129,130,134,135 and 20. 19,143-145 
The ligands 15 and 16 have been particularly well studied and their 
diruthenium(II)32,33,1 16,119,126-128 complexes have been shown to exhibit strong metal-metal 
interactions. For example, the separation of the first and second oxidation potentials (L1E1/2) in the 
diruthenium complexes of 15 and 16 is typically 170mV. Also, a number of polynuclear 
ruthenium(ll) complexes of 15 have been prepared containing up to 22 metal atoms. 
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Complexes of 16 are planar, since there are no steric interactions between the pyridine 
rings. However, this is not the case for binuclear complexes of 15, in which considerable 
twisting is required, within the bridging ligand, to relieve the steric interaction between the. 
pyridine rings. Although no X-ray structures of binuclear complexes of 15 have been determined, 
such twisting has been observed in the crystal structure of a doubly cyclopalladated complex of a 
ligand isoelectronic to 15.216 Similarly, variable-temperature NMR studies of the diplatinum(IV) 
complexes of 15 have detected twisting of the pyridine rings,24 whilst, more recently, an X-ray 
crystal structure of the free ligand 15 has been determined.217 The inter-metal separation in such 
complexes of 15 is typically 6.7 A.216 
In contrast, there are very few examples of chelating binucleating ligands that bridge two 
metals with a pyrimidine ring. Although the two dipyridylpyrimidines 108 and 109 have been 
known for nearly 30 years,2Ig there has been no study of their coordination chemistry, with the 
exception of a discussion of their iron(ll) complexes in the original report of the preparations of the 
ligands. It was proposed that 108 would form mononuclear complexes with tridentate 
coordination analogous to that of 2,2',6',2"-terpyridine. Bidentate coordination of 108 should 
also be possible, as was observed for the related dipyrazolylpyrimidine 53 in Chapter 2. 
However, studies of 53, in this work, imply that 108 would be unable to form binuclear 
complexes with octahedral metals, such as ruthenium(II), since the N3, Nl" coordination sites are 
less accessible, relative to the Nl, Nl' sites. 
108 
N 
~I 
109 110 
Figure 4.1 
The dipyrazolyl (22) and 3,5-dimethylpyrazolyl (23) analogues of 109 have been used as 
bridging ligands96,15I and, given that the two bidentate sites of 109 are equally accessible, it is 
surprising that there have been no reports of binuclear complexes of this ligand. On the basis of an 
X-ray crystal structure of a cyclopalladated analogue,219 two metals coordinated to 109 would be 
separated by about 5.9A,much closer than in the binuclear complexes of the pyrazine containing 
ligands 15 and 16; thus a larger interaction may be possible in binuclear complexes of 109. In 
this chapter a study of the coordination chemistry of 109 is described, with particular emphasis on 
ruthenium(II) complexes. The synthesis and biruthenium(II) complex of the related new ligand 
110 is also described. 
4.2. Results and Discussion. 
4,6-Bis-(2-pyridinyl)pyrimidine was prepared in two steps. Firstly, Claisen condensation 
of 2-methoxycarbonylpyridine (111) and 2-acetylpyridine (112) gave the compound 1,3-(2-
pyridinyl)-1,3-propanedione (113), from which the pyrimidine ring of 109 was readily formed 
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by refluxing in formamide (Scheme 4.1). Literature procedures were used in both 
reactions.218,220 
o 
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EtON a toluene 
o 0 
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4' 
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Scheme 4.1 
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The pyridine rings, in the 1 H NMR spectrum of 109 (Figure 4.2), were readily assigned, 
due to the smaller coupling constant of HS'-H6' relative to that of H3'-H4'. Differentiation of H2 
and HS, which are close in chemical shift, was more difficult. No nOe was observable from H3' 
to HS, thus implying that the ligand has a conformation in which the inter-ring bonds are transoid 
with respect to the nitrogens. However, in the 13C NMR spectrum (CD3CN) of 109, C2 
(1S9.Oppm) is well downfield of the more electron rich CS (113.2ppm). Correlation of C2 and CS 
to proton signals at 9.38ppm and 9.43ppm respectively, by an HMQC spectrum, enabled H2 and 
HS to be assigned. 
The first complexes of 109 that were prepared were of palladium(II). As shown in 
Scheme 4.2, the binuclear complex 115 was prepared by reacting 109 with two equivalents of 
PdCh in HCI. This complex was found to be insoluble in common solvents, but was 
characterised by elemental analysis and assigned the structure shown. Reaction of 109 with one 
equivalent of PdCl2 gave an insoluble yellow solid, which was estimated, by elemental analysis, to 
66 
~,...,......~ •• ~.' T " " • " 
8.4 
Figure 4.2 IH NMR Spectrum of 109. 
be a mixture of the mono- and binuclear complexes 114 and 115. Thus formation of the 
binuclear complex is facile, even with one equivalent of PdCh. 
The reaction of 109 with one equivalent of Mo(CO)6, in refluxing toluene, gave the purple 
mononuclear complex 116 (Scheme 4.2). Similarly, reaction with two equivalents of MO(CO)6 
gave the blue binuclear complex 117. Both complexes were purified by chromatography on 
alumina and characterised by elemental analysis. 
1 H NMR spectra of 116 and 117 in coordinating solvents, such as d6-DMSO or CD3CN, 
showed evidence of complex dissociation. The complexes were found to be more stable in d6-
acetone and their l H NMR spectra are summarised in Table 4.1. The protons H2 and H5 were 
assigned by an nOe from H3' to H5, since, unlike the free ligand, the inter-ring bond has a cisoid 
orientation of the nitrogens as a result of the chelate ring, in both 116 and 117. The pyridine 
rings were assigned by their coupling constants, as in the spectrum of 109, whilst the coordinated 
(H3'-H6') and non-coordinated (H3"-H6") rings of 116, were distinguished by their relative 
positions, with (H3'-H6') exhibiting the greater coordination induced shifts. Almost all the CIS 
values for 116 and 117 are positive which reflects the donation of a-electron density from ligand 
to metal. In addition, H6' (116), H2 (116) and H6'(117) are held coplanar to, and hence 
deshielded by, an adjacent carbonyl group, whilst H2 (117) is deshielded by two carbonyls, and 
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thus exhibits a CIS twice as large as that of H2 (116). Finally, the CIS values of H5, and H3', in 
both complexes, reflect the change in conformation about the inter-ring bond that is required for 
metal chelation. 
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Table 4.1. IH NMR Chemical Shiftsa of 116,117 and 109. Coordination Induced Shiftsb of 
116 and 117. 
H2 H5 H3' H4' H5' H6' H3" H41f H5" H6" 
116 9.85 9.51 9.10 8.46 7.95 9.36 8.78 8.25 7.80 8.98 
109 9.47 9.64 8.73 8.17 7.71 8.94 
CISb +0.47 -0.13 +0.37 +0.29 +0.24 +0.42 +0.05 +0.08 +0.09 +0.04 
117 10.37 9.73 ~ 9.22 8.47 7.98 9.38 
CISb +0.90 +0.09 +0.49 +0.30 +0.27 +0.44 
a For deuterated acetone solutions. b CIS = Ocomplex-Oligand' 
Both 116 and 117 exhibit strong ligand centred absorptions in their UV/VIS spectra 
(Figures 4.3a and 4.3b). Symmetrical absorption in the visible region of the spectra of 116 
{A.max=520nm) and 117 (Amax=572nm) can be assigned to the MLCT transition drt-rt*(109). 
Thus the MLCT transition shifts to lower energy in the binuclear complex (Figure 4.3b) relative to 
the mononuclear complex (Figure 4.3a). This effect has also been observed in structurally related 
complexes of dpop (20) for which the lower binuclear MLCT energy has been explained as being 
due to both, a stabilisation of the dpop prt*-LUMO when bonded to a second rt withdrawing 
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Mo(CO)4 fragment, and formation of a Mo d1t-dpop p1t-Mo d1t (non-bonding) HOMO, resulting 
in a lower energy HOMO-LUMO transition.19 
The reaction of 109 with three equivalents of a cupric chloride solution in methanol gave a 
green solid, which was found by elemental analysis to have the stoichiometry 
CU2(109)CJ4.2H20. This contrasts with a recent report, by Thompson et al.,221 of the reaction of 
4,6-bis-(2-pyridinythio )-pyrimidine (118) with cupric chloride, to give a binuclear complex of the 
stoichiometry CU2(118hC14. X-ray crystallographic analysis showed that the complex 
CU2(118hC14 has a structure in which each pentacoordinate Cu(II) is coordinated, in a 
monodentate manner, to the flexible thiopyridine group of one ligand, whilst forming a six-
membered chelate ring with the pyridine and pyrimidine rings of the other ligand. Unfortunately, 
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the complex CU2(109)CI4 was found to be insoluble in common solvents and thus could not be 
analysed in this manner. 
118 
Figure 4.4 
Thompson et al. also described the reaction of 118 with CU(CI04h in acetonitrile, which 
gave a complex with a metal to ligand stoichiometry of 1: 1. The reaction of 109 with two 
equivalents of CU(CI04h.6H20 gave a blue solid, which was shown, by elemental analysis, to 
have the stoichiometry Cu(109)(CI04h(H20h. The complex was found to be quite insoluble and 
crystals, suitable for X-ray analysis, could not be obtained. Similarly, reaction of 109 with two 
equivalents of Ni(C104h.6H20 gave an insoluble yellow solid which was found to have the 
stoichiometry Ni(109)(CI04h(H20h, Studies with molecular models clearly show that the Ni(II) 
and Cu(II) complexes of 109 are unlikely to have a structure analogous to that of CU2(118hCl4, 
since five-membered chelation of 109 is less flexible than the six.,membered chelation of 118. 
Alternatively, a polymeric structure for the complexes may be possible. 
2+ 
119 L=bpy 
RuLzClz / 120 L=dmb ~ RUL'zClz 
/ EtOHJHzO EtOHlHzO ~ 
2xRuLzClz 
EtOHlHzO 
123 L=109 
Scheme 4.3 
121 L=L'=bpy 
122 L=L'=dmb 
124 L=dmb, L'=bpy 
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The mono-ruthenium(II) complexes of 109 were prepared in a similar manner to ruthenium 
complexes already described in chapters 2 and 3. Both the bis-2,2'-bipyridinyl complex (119), 
and the bis-4,4'-dimethyl-2,2'-bipyridinyl complex (120), were purified by chromatography on 
alumina to remove traces of the corresponding binuclear complexes 121 and 122, which also 
formed in the reactions (Scheme 4.3). The red monoruthenium complexes were then characterised 
by elemental analysis and mass spectrometry. 
Table 4.2. IH NMR Chemical Shiftsa of 119, 120 and 109. Coordination Induced Shiftsb of 
119 and 120. 
H2 H5 H3' H4' H5' H6' H3" H4/1 H5 " H6" 
119 8.54 9.42 8.89 8.20 7.59 7.90 8.51 8.06 7.65 8.88 
109 9.38 9.43 8.61 8.05 7.60 8.86 
CISb -0.84 -0.01 +0.28 +0.15 -0.01 -0.96 -0.10 +0.01 +0.05 +0.02 
Bpy ligands 
H3 H4 H5c H6c 
8.58 8.14 7.47 8.01 
8.58 8.14 7.49 7.84 
8.58 8.14 7.48 7.78 
8.58 8.14 7.48 7.78 
H2 H5 H3' H4' H5' H6' H3" H4" H5" H6" 
120 8.52 9.39 8.86 8.17 7.57 7.90 8.51 8.06 7.65 8.89 
109 9.39 9.43 8.61 8.05 7.60 8.86 
CISb 
-0.87 -0.04 +0.25 +0.12 -0.03 -0.96 -0.10 +0.01 +0.05 +0.03 
Dmb ligands 
H3 4-CH3c H5c H6c 
8.42 2.60 7.32 7.79 
8.42 2.60 7.32 7.64 
8.42 2.58 7.28 7.59 
8.42 2.58 7.28 7.57 
a For deuterated acetonitrile solutions. b CIS =:;; Ocomplex-Oligand. c Not assigned 
The IH NMR spectra of the monoruthenium complexes 119 and 120 are shown in 
Figures 4.4, whilst the chemical and coordination induced shifts of the protons are summarised in 
Table 4.2. The pyridine rings in the complexes are non-equivalent, with one ring coordinating and 
the other non-coordinating. Thus the spectrum of 119 (Figure 4.4 top) consists of 26 non-
equivalent protons. Although the replacement of bpy ligands with dmb ligands can assist in 
assignment of some protons, the change in chemical shift of the auxiliary ligand protons can 
generate additional overlap. For example (Figure 4.4 bottom), replacement of bpy with dmb 
allows isolation of H4' and H4", but also results in overlap of H5' and H5" with three of the 
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Figure 4.5 ID TOCSY Spectra of 120 
dmbH6 protons. Nevertheless, the ligand 109 in each of the complexes was assigned on the basis 
of coupling constants and chemical shifts and with the assistance of 10 TOCSY or 20 COSY 
spectra. For example (Figure 4.5), 10 TOCSY irradiation of the isolated triplets, H4' and H4", 
in the spectrum of 120, produces individual sub-spectra corresponding to the two pyridine ring 
spin systems (trace II and III). Thus, by the characteristic position of the anisotropically shielded 
H6', which lies over a pyridine ring, the coordinated (H3'-H6') and non-coordinated (H3"-H6") 
rings may be distinguished. Similarly, the long-range coupling (1.5Hz) of the pyrimidine ring 
protons, H2 and H5, allows location of H2 by irradiation of H5 (trace I). In this case, H2 is the 
more upfield doublet, since this proton is also shielded by a pyridine ring. Also, by irradiating the 
dmbH3 protons, all the dmbH5 and dmbH6 protons may be located (trace IV). The IH NMR 
spectrum of 119 was readily assigned by comparision with the spectrum of 120, and with the 
assistance of 10 TOCSY and 20 COSY spectra. 20 COSY spectra of either complex could not 
unambiguously assign the dmb or bpy spins systems. 
In summary, the CIS values in the complexes 119 and 120 reflect ring current anisotropy 
effects (H2 and H6'), the net effect of metal to ligand a-donation and 1t-back donation (H4' and 
H5'), and chelation induced conformational changes (H3' and H3"). 
A homoleptic ruthenium(II) complex, 123, was prepared from the reaction of three 
equivalents of 109 with Ru(OMSO)4Cl2. The IH NMR spectrum (C03CN) of 123 was assigned 
by comparison with the spectra of 119, and by 10 TOCSY spectra. As a consequence of the 
trisbidentate coordination of the unsymmetrical ligand, the complex exists as a 3: 1 mixture of the 
geometrical isomers mer and fac. Hence there are four non-equivalent ligands (40 non-equivalent 
protons) in the spectrum, with all three ligands of the fac complex (10 non-equivalent protons) 
related by a C3 axis of rotation. The pyridine and pyrimidine protons were readily assigned by 
comparison with the spectra of 119 and 120, although the mer and fac isomers could not be 
distinguished in the spectrum. Attempts to separate the-lie isomers on sephadex were unsuccessful. 
As mentioned previously, Keene et al. have recently separated the mer and fac isomers of 
structurally related complexes by sephadex ion-exchange chromatography.215 
13C NMR spectra were recorded for the three mononuclear complexes 119,120 and 123. 
The spectra were assigned by comparison with the spectra of structurally related complexes and the 
chemical shifts are listed in Chapter 8.3. 
The effect of the ligand 109 on the electronic properties of the complexes can be seen in the 
UVNIS spectra of 119, 120 and 123 which are summarised in Table 4.3. The complexes 
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exhibit strong ligand centred absorptions at A<400nm and MLCT absorption bands at A>400nm. 
The lowest energy absorptions (492nm (119), 506nm (120) and 488nm (123)) correspond to 
d1t-1t*(109) transitions, since the pyrimidine containing ligand has lower lying 1t* orbitals than 
does bpy. Hence electron transfer, from metal to ligand, is easier in 119, 120 and 123 than in 
Ru(bpY)32+. The second highest energy MLCT transitions for 119 and 120, 438nm and 436nm 
respectively, are likely to be due to electron transfer into the 1t*bpy orbitals. The lowest energy 
MLCT of 119 is also at lower energy than that of Ru(15)(bpyh2+, an effect which is paralleled in 
the relative energies of the lowest MLCT of 123 and Ru(15)]2+. A similar trend can be seen in 
the .1Eox-red values, which show a smaller HOMO-LUMO gap in the complexes of 109, 
particularly in the homoleptic complexes 123 (2.38V) and Ru(15)]2+ (2.63V). Pyrimidine is a 
poorer 1t-acceptor than pyrazine but is still better than pyridine, in line with the relative energies of 
the LUMO 1t* orbitals.3,222,223 Hence the ligand 109 is less efficient than pyrazine at stabilising 
the metal d orbitals, by 1t back-bonding, than is 15 thus giving rise to a smaller HOMO-LUMO 
gap in the complexes of 109. The lowest MLCT band of 123 (488nm) is not as symmetrical as 
that of Ru(bpy)]2+ and has a shoulder at 464nm. This absorption is likely to be a combination of 
d1t-1t* transitions into the pyrimidine ring (488nm) and into one of the pyridine rings (464nm) of 
109. 
T bl 43 Ab a e .. sorotlOn M . a dRd P axlma an e ox . I b f 119 120 d 123 otentIa s 0 , an 
A Eox Bredl Ered2 Ered3 Bred4 .1Eox-red 
Ru(bpy)]2+ 451 +1.27 -1.31 -1.50 -1.77 - 2.58 
Ru(15)(bpyh2+ 475 +1.31 -1.06 -1.55 -1.74 - 2.37 
Ru(15)]2+ 455 +1.68 -0.95 -1.12 -1.39 - 2.63 
119 408sh,438,492 +1.28 -1.03 -1.55 -1.76 - 2.31 
120 406sh,436,506 +1.18 -1.07 -1.64 -1.85 - 2.25 
123 464sh,488 +1.39 -0.99 -1.13 -1.33 -1.92 2.38 
a In nanometres. b In volts vs SeE in acetonitrile. 
Further insight into the properties of the complexes can be obtained from the redox 
potentials of 109,119,120 and 123, as determined by cyclic voltammetry. The ligand exhibits 
two reversible one electron reductions; firstly, reduction of the pyrimidine ring at -1.76V and, 
secondly, reduction of a pyridine ring at -2.26V. These reductions are shown in Figure 6.4 (top). 
Figure 6.4 also shows the cyclic voltammograms of two of the mononuclear complexes 120 
(middle of Figure) and 123 (bottom of Figure) whilst the redox potentials for all three 
mononuclear complexes are summarised in Table 4.3. The complexes each exhibit a reversible 
one electron oxidation and three (four in the case of 123) reversible one electron reductions. The 
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Figure 4.6 Cyclic Voltammograms of 109 (top), 120 (middle) and 123 (bottom). 
first reduction of 119 and 120, and the first, second and third reductions of 123, were assigned 
to reduction of the pyrimidine ring of 109. The second and third reductions of 119 and 120 are 
localised in the bipyridine ligands, whilst the fourth reduction of 123 may be attributed to a 
reduction of a pyridine ring of 109. The different oxidations of the complexes 119, 120 and 
123 indicate the relative energies of the metal d orbitals of the complexes. Relative to 119, the d 
orbitals of 120 are destabilised by the electron donating methyl groups of 120. In the case of 
123, the d orbitals are stabilised by all three 109 ligands, which are better 1t-acceptors than bpy. 
The electrochemistry of 119 is comparable to that of Ru(15)(bpYh2+. However, 123 is more 
easily oxidised than Ru(15h2+, reflecting the weaker 1t-acceptor ability of 109 relative to 15, 
although the complex has a similar first reduction potential. Thus the HOMO-LUMO gap of 123 
is smaller than that of Ru(15h2+, which is manifest in both the smaller value of AEox-red and the 
lower energy MLCT of 123. 
Having surveyed mono-ruthenium complexes of 109, three homobinuclear complexes of 
the ligand were then prepared and analysed. The symmetrical biruthenium(ll) complexes 121 and 
122 were readily prepared by reacting the ligand with two equivalents of the corresponding 
ruthenium complex and, as discussed earlier, were also obtained, as by-products, in the reaction of 
the ligand with one equivalent of ruthenium(ll) (Scheme 4.3). Complex 124 was prepared by 
reacting 120 with one equivalent of Ru(bpyhCl2 (Scheme 4.3). The binuclear complexes are 
dark purple in solution, compared to the mononuclear complexes which are red. This is indicative 
of a strong metal-metal interaction, with the absorption of the binuclear complex shifting to lower 
energy. 
The complex 121 has the structure shown in Scheme 4.3 in which the ligand forms a bis-
bidentate bridge between two ruthenium(II) centres. This was confirmed by mass spectrometry 
and IH NMR spectroscopy. As has been discussed previously, complexes containing two chiral 
octahedral ruthenium(II) centres should exist as both the racemic (AA/AA) and meso(AA) 
diastereoisomers, which are non-equivalent and therefore distinguishable by 1 H NMR. Such 
stereoisomerism exists in 121 and is demonstrated in the 1 H NMR spectrum of the complex 
(Figure 4.7). 
The spectrum consists of 44 non-equivalent protons; 22 protons corresponding to the 
racemic isomer and 22 for the meso isomer. Unlike the mononuclear complexes, the pyridine 
rings of the bridging ligand are equivalent, since in the racemic isomer the rings are related by 
rotational symmetry, whilst in the meso isomer, they are related by a mirror plane. Many of the 
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Figure 4.7 IH NMR Spectrum of 121. 
bridging ligand signals are overlapped by the mass of bpy signals, but were readily located using 
the ID-TOCSY spectra shown in Figure 4.8. For example, irradiation of the closely spaced H5 
doublets (9.33 and 9.35ppm) of the two non-equivalent pyrimidine rings locates the two H2 
doublets (7.70 and 7.66ppm) (trace I). Similarly, irradiation of the exposed H3' doublet 
(9.04ppm) successively locates, with extended mixing time, H4' (8.26, 8.30ppm), H5' (7.59, 
7.62ppm) and finally H6' (7.80, 7.87ppm) (trace II-N). 
The ID TOCSY spectra did not, however, distinguish the diastereoisomers of 121. 
Accordingly, attempts were made to separate these two isomers, by chromatography of the 
tetracation on C-25 sephadex, with NaCI (0.3-0.5M) as the eluent. Despite repeated attempts, the 
diastereoisomers could not be separated. Recently, Keene et al. have used ion-exchange to 
separate the diastereoisomers of related binuclear complexes of bpm and 15, although these 
complexes have non-identical terminal ligands, which is crucial in effecting a good separation of 
the diastereoisomers.167 In the present case, fractions of 121 were obtained which were slightly 
enriched in either of the diastereoisomers. Fractional recrystallisation of these fractions failed to 
increase this enrichment. However, by examining the IH NMR spectra of the enriched samples, it 
was possible to assign the bridging ligand protons of the two diastereoisomers and to assign the 
bpy protons (in some cases tentatively). 
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Table 4.4. IH NMR Chemical Shifts a of 121a, 121b and 109. Coordination Induced Shiftsb of 
121a and 121b. 
Ligand 109 Bpy ligands 
H2 H5 H3' H4' H5' H6' H3C H4C H5c H6c 
121a 7.70 9.33 9.04 8.26 7.59 7.80 8.36 7.99 7.13 7.48 
109 9.38 9.43 8.61 8.05 7.60 8.86 8.44 8.08 7.23 7.52 
CISb 
-1.68 -0.10 +0.43 +0.21 -0.01 -1.06 8.53 8.11 7.25 7.55d 
8.55 8.18 7.39 7.55d 
121b 7.66 9.35 9.04 8.30 7.62 7.87 8.48 7.97 7.22 7.60 
109 9.38 9.43 8.61 8.05 7.60 8.86 8.49 8.10 7.23 7.60 
CISb 
-1.72 -0.08 +0.43 +0.25 +0.02 -0.99 8.51 8.12 7.27 7.60d 
8.52 8.20 7.44 7.82 
. . 
a For deuterated acetomtnle solutIOns. b CIS = Dcomplex-Dligand' C Not assIgned. d TentatIve assIgnments . 
The diastereoisomers are referred to as 121a and 121b and their individual spectra are 
summarised in Table 4.4. The H2 proton exhibits a larger negative coordination induced shift than 
was the case in the mononuclear complex, since this proton is now shielded, anisotropically, by 
two pyridine rings. In contrast, H6', and to a lesser extent H5', are shielded by one pyridine ring 
and thus exhibit a smaller CIS. Of the remaining protons, the CIS values of H3' and H5 show the 
effects of chelation induced conformational changes, whereas H4' and H5' show the effect of the 
net donation of electron density from ligand to metal. Molecular modelling studies of the complex 
show that a bpyH6 proton is deshielded in the meso isomer, whereas in the racemic isomer the 
same proton is shielded. A similar effect is known for diruthenium complexes of bpm. 167 In the 
spectrum of 121, the most deshielded bpyH6 (7.82ppm) belongs to the diastereoisomer 121b 
which can therefore be assigned the meso stereochemistry I1.A; thus 121a can be assigned the 
racemic stereochemistry I1.I1./AA. The diastereoisomers exist in 7:6 ratio, in contrast with the 
complex 64, in chapter 2, for which the meso form was the major isomer. 
Two further binuclear ruthenium(II) complexes were also synthesised (Scheme 4.3), 122, 
as mentioned above, and 124, in which 109 is bridging between a Ru(dmbh2+ unit and a 
Ru(bpYh2+ unit. Both complexes were characterised by mass spectrometry and 1 H NMR 
spectroscopy. In a similar manner to the IH NMR spectrum of 121, the bridging ligand protons 
of 122 and 124 were assigned by 1D TOCSY irradiations of H5 and H3', whilst the dmb and/or 
bpy protons were assigned only tentatively. No attempt was made to separate the 
diastereoisomers, which were found to be in a 5:3 ratio in 122, and in a 7:6 ratio in 124. 
The electronic properties of the complexes were examined by UV IVIS absorption 
spectroscopy and cyclic voltammetry. All complexes show strong ligand centred absorptions at 
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A<400nm and exhibit a series of MLCT bands at A> 400nm, the latter of which are listed in Table 
5.4. The bands at (432-434nm) for the complexes can be assigned as an MLCT transitions (dn-
n*) into the bipyridine ligands. The slight increase in the energy of this transition, relative to the 
mononuclear complexes, has already been observed for 64 and 65 and is due to the increase in 
electrostatic attraction toward the optical electron as a result of coordinating a second 
ruthenium(TI). The large red shift of the lowest energy MLCT of the binuclear complexes 
(570-58Onm), relative to the mononuclear complex, indicates a strong metal-metal interaction and 
corresponds to further lowering of the n*-LUMO of the bridge, by back-bonding between the n* 
orbitals of 109 and the d orbitals of the second RuL22+ unit. This red shift can be seen in Figure 
4.9 which shows the UVNIS absorption spectra of 121 (bottom) and 119 (top). The lowest 
MLCT transition exists as a shoulder to a further MLCT band at 532-540nm. Such unsyrrunetrical 
absorptions, have been described for structurally related complexes, for which numerous 
explanations have been provided.3D,33 
Table 4.5 also includes the redox potentials of 121, 122 and 124. Complex 121 has two 
reversible one electron oxidations (+1.36 and +1.52V) separated by 160mV and five reversible 
reductions (Figure 4.10). Cooper et ai. have shown, for a series of binuclear ruthenium 
complexes, that a linear correlation exists between the splitting of the first and second reductions 
(.~Eredl-red2) and the number of bonds in the bridging ligand.224 In the case of 121, the value for 
~Eredl-red2 of O.64V is consistent with this relationship. Hence the first and second reductions 
were assigned to successive one electron reductions of 109. The first reduction is centred on the 
pyrimidine ring and is typically lower than the reduction of 109 in the complex 119. This retlects 
the synergistic lowering of the n* orbitals of the bridge by both metals and parallels the red shift in 
tbe lowest energy MLCT. The second reduction corresponds to reduction of a pyridine ring of the 
bridge. Two successive one-electron reductions (.llEredl-red2=0.50V) of a bridging ligand have 
previously been described for the structurally related complex [Ru(bpyhh(15)4+.126 The known 
twisting of the rings in this complex lessens the conjugation of the bridging ligand, which may 
T bl 45 Ab a e .. sorpnon aXlma an e ox o en la s 0 , an f M . a d R d P t fIb f 121 122 d 124 
Complex A Eox! Eox2 Bred1 Ered2 Ered3 Bred4 Eroos 
[Ru(bpyhh(15)4+ 527 +1.38 +1.55 -0.67 -1.17 -1.57c -1.89c -
121 432,532,570 +1.36 +1.52 -0.59 -1.23 -1.62c -1.89 -2.03 
122 434, 540, 580 +1.27 +1.43 -0.63 -1.27 -1.81 c -1.98c -
124 432, 534, 572 +1.29 +1.50 -0.63 -1.25 -1.63 -1.77 -1.92 
a In nanometres. b In volts vs SeE in acetonitrile. c Two electron. 
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OV +1V 
Figure 4.10 Cyclic Voltammogram of 121 
account for the smaller value of .6Eredl-red2 relative to the present case. In addition, two reversible 
two electron reductions, at more negative potentials, were reported for [Ru(bpyhh(1S)4+ and 
assigned to the successive reduction of couples of bpy coordinated to different metals. In the 
present case, the third reduction of 121 is a two electron process and can thus be assigned to 
reduction of the bpy ligands. The fourth and fifth reductions (fifth and sixth electrons 
respectively) are one electron processes and these are probably centred on the other two bpy 
ligands. One of these last two reductions may be centred on the bridging ligand, although the 
large coulombic repulsion would most likely impede a third reduction of 109 at this potentiaL 
The oxidation potentials in 121 are split by 160mV, indicating that the metals are coupled 
via the 1t system of the ligand. Oxidation of the first metal (+1.36V) stabilises the d orbital of the 
metal and thus prevents back-bonding to the 7t* orbital of 109. This allows additional 
stabilisation of the d orbitals of the second metal, which can now back-bond more efficiently with 
the bridging ligand, thus raising the second oxidation potential (+ 1.52V). Molecular modelling 
studies, using CHEM 3D Plus, suggested values of the inter-metal separation in 121 and 
[Ru(bpyhh(1S)4+ of 6.2A and 6.7 A respectively. Thus, despite the ability of 109 to decrease 
the distance between the metals, there is no increase in the metal-metal interaction, relative to 
[Ru(bpyhh(1S)4+ (Lillll2=170mV). This can be rationalised by the fact that pyrimidine is a 
poorer 7t-acceptor than pyrazine, which counteracts the relative decrease in the inter-metal 
separation of 121. Hence, 121 exhibits a comparable interaction to [Ru(bpYhhbpm4+, in which 
the metals are held at a distance of 5.6A.25,35 
In contrast, 122 exhibits less positive oxidations and more negative reductions, which is 
attributed to the electron donating methyl groups of the dmb ligands. Oxidations are raised by 
approximately 100m V, which is consistent with the oxidation of complexes described earlier in 
this work and with structurally related complexes. 176 The third and fourth reductions are more 
negative than those of 121, which equates with the higher energy of the dmb 7t* orbitals relative to 
bpy. Furthermore, the first and second reductions of 122 occur at similar potentials to those of 
121, thus confinning their assignments as bridging ligands reductions, although the potentials are 
slightly more negative due to the electron donating effect of the dmb ligands. The complex 124, 
has different peripheral ligands on each of the two metals. Hence, the d orbitals of the 
ruthenium(II) bound to the dmb ligands are destabilised, relative to the ruthenium(ll) bound to the 
bpy ligands. This is manifest in the oxidation potentials of the Ru( dmb h 2+ unit (+ 1.29V) and the 
Ru(bpYh2+ unit (+ 1.50V) resulting in an increase in the splitting of the oxidation potentials 
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(ilEl/2=21OmV) relative to 121. Thus the peripheral ligands may cause an apparent increase in 
the degree of metal-metal interaction in the complex. The role of the peripheral ligands in such 
binuclear complexes has been the subject of a recent comprehensive study.225 
A fourth binuclear complex of 109 was prepared in which the ligand bridges two different 
metals, namely ruthenium(II) and palladium(II) (Scheme 4.4). The heterobinuclear complex 125, 
was prepared by reacting 119 with one equivalent of Pd(PhCNhCh in dichloromethane and was 
found to be a deep blue colour in acetonitrile solution. The complex was characterised by 
elemental analysis, mass spectrometry and IH NMR spectroscopy. 
2+ 
EtOHJH20 
109 
2+ 
~ 
N I ~ N 
\ N N / (bpY)zRu-- ~ .......... Mo(CO) 
~ 3' 
6,1 ~ 
N I 
\ N N I 
(bPY)2Ru-- ~ - PdCl2 
126 125 
Ru(109) h 2+ ____ 3_x_R_u....:..,(b...a.p-"-y ..... h ..... C ...... lz"--__ ........ Ru [(109)Ru(bpy hh 8+ 
123 EtOHJH20 127 
Scheme 4.4 
The IH NMR spectrum of 125 is shown in Figure 4.11 and consists of 26 non-equivalent 
protons (Table 4.6). The pyridine rings of 109 were assigned by their coupling constants and 
chemical shifts and the assignments were confirmed by a 2D COSY spectrum (Figure 4.12). An 
nOe from both H3' (8.96ppm) and H3" (8.70ppm) to the signal at 9.42ppm enabled H5 and 
hence H2 (9.1 Oppm) to be assigned (Figure 4.12). This contrasts with the spectrum of 119, in 
which H2 (8.54ppm, CIS = -O.84ppm) is shielded anisotropicaJly by a pyridine ring and is well 
upfield of H5 (9.42ppm). In this case, H2 is shielded by a pyridine ring but deshielded by an 
adjacent chlorine, and hence, exhibits a smaller CIS (-O.28ppm). The CIS values for the H3'-H6' 
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and H3"-H6" rings are also contrasting. The factors which give rise to the CIS values of the 
coordinated pyridine ring in the complex 119 can also account for the CIS values of the H3'-H6' 
ring of 125, although the positive shifts, in 125, are slightly larger due to coordination of the 
electron withdrawing palladium. In contrast, the palladium coordinated ring exhibits larger CIS 
values; due to the a-donation of electron density from ligand to metal (H4" and HS"), the 
deshielding effect of an adjacent chlorine (H6") and chelation induced conformational changes 
(H3"). This last effect also accounts for the upfield shift of HS. 
i ,. 
1.6 
Figure 4.11 1 H NMR Spectrum of 125 
Table 4.6 1 H NMR Chemical Shiftsa and Coordination Induced Shiftsb for 125. 
H2 HS H3' H4'. HS' H6' H3" H4" HS" H6" 
125 9.10 9.0S 8.96 8.29 7.71 7.99 8.70 8.44 7.90 9.26 
109 9.38 9.43 8.61 8.0S 7.60 8.86 
CISb -0.28 -0.38 +0.3S +0.24 +0.11 -0.87 +0.09 +0.39 +0.30 +0.40 
Bpy ligands 
H3c H4c HSc H6c 
8.S9 8.16 7.49 7.76 
8.61 8.19 7.S1 7.78 
8.61 8.19 7.S1 7.80 
8.61 8.22 7.S3 8.04 
a For deuterated acetonitrile solutions. b CIS = bcomplex-bligand. c Not assigned. 
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In the spectrum, the signal for H2 has a smaller integral than the signal for H5, indicating 
that the H2 proton has a longer relaxation time. The integral of H2 becomes equal to that of H5 if 
a delay of 2 seconds is implemented between the excitation pulse and the aquisition step. 
A I3C NMR spectrum of 125 was obtained and was assigned by comparison with the 
spectrum of 119 (see Chapter 8.3). As was found in the IH NMR spectrum (Figure 4.11), the 
carbon signals were found to be more widely spread than in the spectrum of 119. 
The electronic properties of 125 were examined by UV /VIS absorption spectroscopy and 
cyclic voltammetry. Coordination of the pal1adium(II) results in a lowering of the rc* orbital of the 
bridge. This is shown in the lowest energy drc-rc*(109) transition which occurs at 574nm, much 
lower in energy than the equivalent MLCT (492nm) of the mononuclear complex 119. In 
addition, the complex exhibits a second MLCT transition (426nm) which is most likely 
drc-rc*(bpy). 
Electrochemically, the complex exhibits a reversible one electron oxidation (+ 1.38V), a 
reversible one electron reduction (-0.47V) and a second irreversible one electron reduction 
(-l.02V). Oxidation of this complex is more difficult than for the complex 119 (+ 1.28V), since 
the electron, in being removed from the metal d orbital, must contend with the additional 
electrostatic attraction of the palladium(II). As mentioned above, coordination of palladium with 
109 lowers the energy of the MLCT and also accounts for the greater ease of the first reduction, 
which has been assigned to reduction of the bridging ligand. The remaining reduction is most 
probably of the bridging ligand. The value for ilEox-red of 1.85V parallels the lowest energy 
MLCT and indicates that the HOMO-LUMO gap in this complex is slightly smaller than in the 
biruthenium complexes of 109. 
Attempts were also made to prepare a second heterobinuclear complex, 126, by reacting 
the mono-ruthenium complex 119 with one equivalent of Mo(CO)4(1l4-C7Hg) in dichloromethane 
or with one equivalent of MO(CO)6 in refluxing toluene. However, in the former reaction very 
little product had formed after three days stirring, whilst in the latter reaction no product was 
formed at all. 
An interesting tetranuclear species (127) (Scheme 4.4) was prepared by reacting the 
homoleptic complex 123 with three equivalents of Ru(bpybCb. Elemental analysis of 127 was 
unsatisfactory due to the presence of trace amounts of NH4PF6 and Ru(III) salts. The complex 
exists as a number of isomers, as a result of the mer/fac isomerism of the ruthenium core and the 
four chiral centres. Hence, the 1 H NMR spectrum of 127 was too complicated to assign. This 
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problem has previously been described, for structurally related polynuclear complexes of 2,3-dpp' 
(15), by Balzani et al. 126 
Figure 4.13 shows the UVNIS spectrum of 127 and also includes the spectrum of the 
homoleptic complexes 123 which has been previously described. Like the binuclear complexes 
121, 122 and 124, the tetranuclear complex exhibits a large red shift in its lowest energy MLCT, 
relative to the mononuclear case, which indicates a strong metal-metal interaction. An absorption 
at A=430nm corresponds to the transitions from outer metals into the bpy ligands, i.e. MLCT 
dn-n*(bpy). At lower energy, two maxima can be distinguished at A=512nm and A=576nm. 
Different MLCT transitions are possible in the complex. For example, MLCT transitions into the 
bridging ligands 109 can occur from either the central metal or the outer metals. This may account 
for the maxima at 512nm and 576nm, with the lowest energy maxima corresponding to 
dn(outerRu(II))-1t*(109). Similar complexities, in the absorption of structurally related 
polynuclear complexes, have been described by others.126 
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The cyclic voltammogram of 127 consists of reversible trielectronic (+ 1.26V) and 
monoelectronic (+ 1.48V) oxidations. The first of these can be attributed to oxidation of the three 
outer metals, whilst the second corresponds to oxidation of the central ruthenium(II) core, which is 
more difficult. In the corresponding tetranuc1ear complex of 15, oxidation of the central 
ruthenium(II) could not be observed)26 Seven reductions of the complex were also observed. 
One electron reductions of the pyrimidine of each of the three bridging ligands occurs as a triplet of 
reversible one electron reductions (-O.27V, -0.48V, -O.67V), whilst a similar triplet, at more 
negative potentials (-1.23V, -1.37V, -1.50V), corresponds to the reduction of the pyridine rings of 
each of the bridging ligands. The final reduction (-1.60V) is irreversible and corresponds to 
reduction of the peripheral bpy ligands. These results confirm the above assignments of the 
MLCT bands in the UV NIS spectrum. 
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The metal-metal interactions of binuclear complexes of 109 are strong and comparable, 
although slightly weaker, than similar complexes of 15. With a view to extending the separation 
of the metals, the related new ligand 110 was prepared. This ligand appears to incorporate two 
bidentate coordinating sites, analogous to 109, separated by a tridentate coordinating site. The 
synthesis and biruthenium complex of this ligand are described below. 
130 
Figure 4.14 
The ligand 110 was prepared in three steps, with the last two steps similar to the synthesis 
of 109 (Scheme 4.5). The diester 128 was prepared by refluxing the diacid in a solution of 
ethanol and conc.sulphuric acid. Claisen condensation of 128, with two equivalents of 
2-acetylpyridine (112) gave the tetraketone 129, which was recrystallised from ethanol. By 
refluxing 129 in formamide, the two pyrimidine rings were formed to give the ligand 
2,6-bis-[6-(2-pyridinyl)-4-pyrimidinyl]pyridine (110). Trace amounts of the amide (130) were 
obtained in the preparation of 110 (Figure 4.14). The amide may have formed from the 
corresponding acid or ester, which are potential side-products in the second step, as a result of the 
incomplete claisen condensation of 112 and 128. 
Both 129 and 130 were characterised by mass spectrometry and their IH NMR spectra 
were assigned from coupling constants, chemical shifts and by comparison with the spectra of 
109. In addition, lD TOCSY spectra assisted in the assignment of the non-equivalent pyridine 
rings of 130. Similarly, the ligand 110 was characterised by mass spectrometry and, in the IH 
NMR spectrum, the pyridine rings were readily distinguished on the basis of their coupling 
constants. As was the case with 109, no nOe could be detected from H3" and H3/H5 to the 
pyrimidine H5', implying that the ligand predominantly adopts a conformation, in solution, in 
which the inter-ring bonds are transoid with respect to the nitrogens. Instead, H2' (9.45ppm) and 
H5' (9.64ppm) were assigned by comparison with the positions of H2 and H5 in the spectrum of 
the related ligand 109 Cfable 4.7). 
The binuclear complex 131 was prepared by reacting 110 with two equivalents of 
Ru(bpyhCI2, purified by sephadex ion-exchange chromatography (eluent 0.5M NaCl) and 
isolated as a red hexafluorophosphate salt (Scheme 4.6). The complex was characterised by mass 
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spectrometry and its IH NMR spectrum is shown in Figure 4.15. Compared with the spectrum of 
121, the spectrum of 1~1 appears to show no evidence of diastereoisomerism, on first inspection. 
The spectrum consists of 24 non-equivalent protons (Table 4.7) The 1D TOCSY spectra 
(Figure 4.16) conveniently isolates all the spin systems as individual subspectra, and is 
particularly useful in distinguishing the pyridine H6" (7.94ppm) of the bridging ligand from the 
bpyH6 protons, and in isolating the overlapping H4 (8.29ppm) and H4" (8.30ppm) signals, 
which belong to different spin systems (trace IT and III). Irradiation of H5' (9.70ppm) (trace I) 
~ 
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Table 4.7. IH NMR Chemical Shiftsa of 131 and 110. Coordination Induced Shiftsb of 131. 
H3IHS H4 H2' HS' H3" H4" HS" H6" 
131 8.71 8.29 8.61 9.70 9.14 8.30 7.64 7.94 
110 8.76 8.27 9.4S 9.64 8.66 8.09 7.6S 8.9S 
CISb -O.OS +0.02 -0.84 +0.06 +0.48 +0.21 -0.01 -1.01 
Bpy limndsc 
H3 H4 HS H6 
8.60 8.16 7.48 7.79 
8.60 8.16 7.49 7.81 
8.60 8.16 7.49 7.86 
8.60 8.16 7.S0 8.0S (8.03) 
a For deuterated acetonitrile solutions. b CIS = bcomplex-b1igand. C Not assigned to individual rings 
also locates the anisotropic ally shielded H2' (8.61ppm) proton, whilst all the bpy protons can be 
located by irradiating bpyH3 (8.6Oppm), although this does not assign the individual bpy rings. 
The most downfield bpyH6 has the same integral as the other three bpyH6, but appears as two 
overlapping doublets. This may be an indication of the presence of the diastereoisomerism of 
131, which is less pronounced than in 121 due to the greater separation of the chiral trisbidentate 
ruthenium groups. 
The IH NMR spectrum of 131 is summarised in Table 4.7. Coordination induced 
conformational changes account for the CIS values of HS' and H3" and H3IHS, although the 
disubstituted pyridine ring is little effected by the formation of a binuclear complex, since this ring 
is non-coordinated and the complex is still flexible (Figure 4.17) about the 2-4' and 6-4' bonds. 
The CIS values for the remaining protons and the effects which cause them are analogous to those 
of 109 already described. 
Molecular modelling studies with CHEM 3D Plus have shown that the distance between the 
metals varies substantially with the conformation of the ligand. Three conformations, in which all 
rings are coplanar, are shown in Figure 4.17. In the staggered conformation (A), all the inter-ring 
bonds are cisoid, with respect to the nitrogens, and the inter-metal separation is 13.6A. Rotations 
of 1800 , about one or both of the inter-ring bonds to the central pyridine ring, give rise to the two 
other conformations Band C, in which the inter-metal separations are 13.2A and 12.8A 
respectively. With a large separation such as this, the two halves of the complex would be 
expected to behave as independent monomeric units, with little, if any, coupling of the metals. 
The electronic properties of the complex were examined by absorption spectroscopy and 
cyclic voltammetry. In the UV/VIS spectrum the complex shows strong ligand centred 
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absorptions at A<400nm and MLCT absorption bands at A>400nm. Two maxima are observed in 
the MLCT region at A=434nm and at A=504nm. These were assigned, respectively, to the 
transitions d1t-1t*(bpy) and d1t-1t*(llO). 
c 
Figure 4.17. 
The cyclic voltammogram of 131 consists of a reversible oxidation (+ 1.28V), which has a 
cathodic-anodic peak separation (LlEp) of 60mV. If the redox active sites in a molecule are non-
interacting, it is reasonable to expect that the current-potential response for a given electrochemical 
method will have the same form as a single-step charge transfer for a monomeric centre.226,227 
For two non-interacting centres the difference in standard potentials is given by (RT/nF)ln4, or 
(35.61/n)mV at 298K.227 Theoretical simulations of cyclic voltamograms have been described by 
Myers et at. 228 and expanded on by Taube et al. 227 These simulations have estabilished that a 
two-step process of dElf2=35.61m V has the same shape and current of a single-step charge 
transfer of 2n electrons and correlates with the peak separation dEp=58.5mV.227 In the present 
case, this implies that the oxidations of the two Ru(II) centres of 131 occur at almost the same 
potential and, hence, is virtually indistinguishable from a one step two electron process. Thus 
there is effectively no coupling of the metals, via the 1t-system of the ligand, as compared with the 
strong coupling of 64, 121. This contrasts with the biruthenium complex of 26, for which a very 
weak metal-metal interaction (dElf2=50mV) was reported.1 54 Molecular modelling studies 
(CHEM 3D Plus) have suggested an inter-metal separation of 13.3A for this complex. Overlap of 
the 1t sytems of 26 is disrupted by rotation about the 6,6' bond, thus weakening the interaction. 
94 
In the present case, the inter-metal separation is similar (l2.8-13.6A), although 1t system overlap 
is now hindered by rotation about, not one, but two inter-ring bonds (H2-H4' and H6-H4'), 
which accounts for the negligible metal-metal interaction. 
The first reduction (-O.98V) of 131 is a reversible two electron process implying 
si multaneous reductions of the two pyrimidine rings of the bridge. A third (-1.54 V) reduction of 
131 may correspond to reduction of the bpy ligands, although the resultant reduction species 
undergoes absorption to the electrode surface. 
A large segmental ligand, which has analogous bisbidentate-tridentate coordination ability 
to 110, has recently been shown to effect the self-assembly of a supramolecular helical complex, 
with Fe(IT) coordinated centrally between two bidentate coordinated Ag(I) ions. 165 Formation of a 
trinuclear complex from 131, in which a terpyridyl-ruthenium unit is coordinated in the tridentate 
site of the bridging ligand, would be interesting. However, molecular models of the binuclear 
complex 131 indicated that the central coordination site is too sterically demanding to allow 
coordination of a Ru(terpy)2+ unit. Hence, preparation of a trinuclear complex was not attempted. 
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Chapter 5 
Complexes of 
2,6-Bis-(l-pyrazolyl)-l ,5-naphthyridine. 
Complexes of 2,6-Bis-(l-pyrazolyl)-l ,5-naphthyridine. 
5.1. Introduction .. 
In chapter 4, the biruthenium(II) complex 121 was shown to exhibit a similar metal-metal 
interaction (Lllil/2=160mV) t~ [Ru(bpYhh(bpm)4+ (.6.El/2=160mV), despite a larger distance 
between the metals of 6.2A. Also, since the ligand is a weaker n-acceptor than dpp, the metal-
metal interaction is less than in the complex [Ru(bpyhh(dpp)4+ , where the metals are at a 
distance of 6.7 A. In contrast, the related pentaheterocycle 110 has been shown to exhibit a two 
electron oxidation which is indistinguishable from a one step two electron process. Hence, at a 
greater inter-metal separation, in this case 12.8-13.6A, the metals are non-interacting. 
132 
Figure 5.1. 
The new compound 132 is a potential bridging ligand which should allow for an inter-
metal separation smaller than that of 131, but larger than that of 121. The naphthyridine ring 
system has relatively low-lying n* orbitals and, despite the increase in inter-metal separation, 
should enable efficient metal-metal coupling in binuclear complexes of 132. In addition, 132 has 
the advantage of being a bis bidentate chelating ligand and should thus give rise to stable 
complexes, whilst the two n-excessive pyrazole rings of the ligand should have interesting 
effects on the physicochemical properties of its complexes. Some ligands incorporating azole 
rings have already been discussed in chapter 2. This chapter describes the synthesis of 132 and 
includes a study of the mono- and biruthenium complexes of the ligand. 
5.2. Results and Discussion. 
The four step synthesis of 132 is shown in Scheme 5.1. In the first step, condensation of 
the commercially available reagents 3-aminopyridine and glycerol, by the method of Albert,229 
gave 1,5-naphthyridine (133). 
The di-N-oxide 134 was readily obtained by heating a mixture of 133, hydrogen peroxide 
and acetic acid. This method was derived from the synthesis of the mono-N-oxide of 
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4,4'-bipyridine, as described by Moran et al.230 Forty years ago, Hart reported the chlorination 
of both the mono- and di-N-oxides (134) of 133, in refluxing POCI3. In both cases a single 
isomer was produced, with substitution of chlorine occurring adjacent to the nitrogen.231 
However, Ellis et al. later reported that 2-chloro-1,5-naphthyridine and 
4-chloro-1,5-naphthyridine were obtained in equal amounts from the corresponding 
mono-N-oxide, under the same conditions. In Hart's synthesis of 2,6-dichloro-1,5-naphthyridine 
(135), 134 was reluxed in POCl3 for 20 minutes, whereupon the solution was cooled and poured 
onto ice and aqueous ammonia to give a precipitate of 135. In the present case, a mixture of 134 
in POCl3 was refluxed for 6 hours, whereupon the solvent was evaporated at reduced pressure 
and the residue treated with ice and aqueous ammonia and extracted with chloroform. The 1 H 
NMR spectrum of the chloroform extract indicated a mixture of compounds, of which 135 was 
identified as the major component, with a number of other mono- and dichlorinated compounds 
present, in particular 2,8-dichloro-l ,5-naphthyridine (136). 
3' 
f.X):N ~:)4 "" "'.;::: 5' I 
C .& #3 U N N 'I I 4 ....::N 
K+N-
I,;!; 0(Ny CI 
• ~~1~3 diglyme CI N 4 6WN ; 1 3 7~ ~ ~ N CI 
CI 
132 135 136 
Scheme 5.1. 
The symmetrical isomer 135 and unsymmetrical isomer 136 were isolated by 
chromatography on silica and readily distinguished on the basis of their 1 H NMR spectra. The 
spectrum of 135 consists of two doublets (H3 and H4), whilst that of 136 consists of four 
doublets (H3, H4, H6 and H7). 
The final step in Scheme 5.1 is analogous to the preparation of 53 in chapter 2. Reaction 
of two equivalents of potassium pyrazolate with 135, allows substitution of pyrazole for chlorine 
to give the doubly bidentate ligand 2,5-bis-(l-pyrazolyl)-1,5-naphthyridine (132). This new 
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compound was characterised by mass spectrometry and by 1 H NMR spectroscopy, in both 
CDCb, and in CD3CN. For both spectra, the pyrazole rings were assigned on the basis of the 
smaller H3'/H4' coupling constant, relative to that of H4'/H5'. The H3 and H4 protons of the 
naphthyridine rings form an AB-quartet in CDCl3 (8.40, 8.46ppm). In CD3CN, the difference in 
the chemical shift of H3 and H4 is less than the coupling constant. Hence, H3 and H4 appear as 
a singlet at 8.84ppm. 
Mono- and di-ruthenium complexes can be readily prepared by reaction of 132 with one 
or two equivalents of ruthenium(II) (Scheme 5.2), in an analogous manner to the syntheses of 
structurally related complexes described earlier in this work. 
3" 
Scheme 5.2. 
137L=bpy 
138L=dmb 
139 L=bpy 
140L=dmb 
2+ 
The monoruthenium complex, 137, and its dmb equivalent, 138, were obtained as yellow 
and orange solids, respectively. In addition, column chromatography, on alumina, was required 
to separate 138 from traces of the corresponding dinuclear complex 140, which formed during 
the synthesis of the mononuclear complex. Mass spectrometry and 1 H NMR spectroscopy were 
used to characterise 137 and 138. 
The IH NMR spectrum of 137 is shown in Figure 5.2 (top) and comprises 26 non-
equivalent protons, with some overlap of tpe bpy!signals at 8.1-8.2ppm. The pyrazole ring 
'" :; :")f{\' 
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Figure 5.2 IH NMR Spectra of 137 (top) and 138 (bottom). 
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protons, of 132, can be clearly observed in the spectrum and were assigned on the basis of 
coupling constants and chemical shifts. The assignments of the coordinated ring, H3' (7.32ppm), 
H4' (6.04ppm) and HS' (9.01ppm) and the non-coordinated ring H3" (7.8Sppm), H4" (6.66ppm) 
and HS" (8.7Sppm) were confinned by 1D TOCSY irradiations of H4' and H4". The CIS values 
(Table S.1) of the coordinated ring can be attributed to a-donation of electron density from 
ligand to metal (H4' and HS'), chelation induced conformational changes (HS') and to ring 
current anisotropy effects (H3'). 
Table S.1. IH NMR Chemical Shifts a of 137,138 and 132. Coordination Induced Shiftsb of 137 
and 138. 
H3 H4 H7 H8 H3' H4' HS' H3" H4" HS" 
137 8.47 8.69 8.02 7.S7 7.32 6.94 9.01 7.8S 6.66 8.7S 
132 8.49 8.49 8.49 8.49 7.90 6.67 8.84 
CISb -0.02 +0.20 -0.47 -0.92 -0.S8 +0.27 +0.17 -O.OS -0.0] -0.09 
Bpy ligands 
H3 H4 HS H6 
8.61 8.17 7.42 8.19 
8.S3 8.16 7.S4 8.03 
8.44 8.03 7.47 7.64 
8.S6 8.13 7.40 7.68 
H3 H4 H7 H8 H3' H4' HS' H3' H4" HS" 
138 8.46 8.67 8.06 7.61 7.29 6.93 9.00 7.86 6.66 8.76 
132 8.49 8.49 8.49 8.49 7.90 6.67 8.84 
CISb 
-0.03 +0.18 -0.43 -0.88 -0.6] +0.26 +0.16 -0.04 -0.01 -0.08 
Dmb ligands 
H3 4-CH3c HS H6 
8.44 2.S2 7.22 7.96 
8.40 2.59 7.24 7.48 
8.39 2.6] 7.38 7.81 
8.3 ] 2.63 7.27 7.46 
a For deuteratcd acetonitrile solutions. b CIS = Ocomplex-Oligand. C Not assigned 
The protons of the naphthyridine rings were assigned as H3 (8.47ppm), H4 (8.69ppm), 
H7 (8.02ppm) and H8 (7.S7ppm). A long range 5J coupling (lHz) across the naphthyridine ring 
system allows the coupled protons H4 and H8 to be distinguished from H3 and H7, which 
exhibit only 3 J coupling. In addition, H4 and H8 can be differentiated since H8 lies over a 
pyridine ring and is therefore shielded anisotropically (-0.92ppm), whilst H4 exhibits a positive 
CIS values (+0.2Oppm) as a result of the net donation of electron density from ligand to metal. 
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Similarly, H7 (-0.47ppm) is shielded anisotropically and is upfield of H3 (-0.02ppm), which 
exhibits the effects of chelation induced conformational changes. An nOe can also be observed 
from H5' to H3, since the coordinated pyrazole and the naphthyridine rings are held rigidly 
coplanar by the chelate ring, thus confirming the assignment of H3. The assignments for the 
naphthyridine ring system were also confirmed by lD TOCSY spectra. 
The proton chemical shifts and CIS values for 137 are summarised in Table 5.1. Included 
in the table are the chemical shifts of the bpy protons, for which the four spin systems were 
assigned by lD TOCSY irradiations of the bpyH3 (S.4-S.6ppm) and bpyH6 (7.64 and 7.6Sppm) 
protons. In this case, irradiation of the desired protons with a lSO° pulse also results in the 
irradiation of nearby protons, thus complicating the individual sub-spectra. By comparing two 
or more traces, it was possible to deduce the erroneous peaks in each of the sub-spectra, thus 
assigning each of the bpy ring spin systems. 
The problem of irradiating nearby protons in the lD TOCSY spectra of 137 can be 
alleviated with the dmb analogue 138. The IH NMR spectrum of 138 (Figure 5.2 bottom) is 
considerably simplified, relative to that of 137, as a result of the absence of overlap due to the 
bpyH4 protons. Nearly all of the signals in the spectrum are well isolated and Figure 5.3 shows 
the complete assignment of the 1 H NMR spectrum of 138 by ID TOCSY spectra. The 
naphthyridine and pyrazole spin systems can be located by irradiations of H7 (trace I), H4 
(trace II), H5" (trace III) and H5' (trace IV), whilst the remaining four subspectra (trace V -Vill) 
clearly show that all the dmb rings can be readily assigned. For example, by irradiation of the 
two isolated dmbH6 protons (trace V and VI) two dmb rings may be located. Similarly, 
irradiating dmbH3 (S.31ppm) locates the third ring (trace VII), whilst the fourth ring can be 
located by the difference of traces VII and VIII, with trace VIII obtained by irradiating the two 
closely spaced dmbH6 protons at 7.46 and 7.4Sppm. As has been mentioned previously, this 
technique does not assign the individual dmb or bpy rings to their stereochemical environment in 
the complexes. In the spectrum of 138, the ligand 132 was assigned in a similar manner to that 
described for 137. 
UV /VIS absorption spectroscopy and cyclic voltammetry were used to probe the 
electronic properties of the complexes 137 and 138. The results of these studies are summarised 
in Table 5.2. The lowest energy absorption in the UV/VIS spectrum of 137 (43Snm) and 138 
(442nm) can be assigned as MLCT bands with the slightly lower energy of 138 being due to 
d-orbital destabilisation by the electron donating dmb ligands. These absorptions are 
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unsymmetrical and are probably due to a combination of the MLCT transitions 1[-1[*(132) and 
1t-1[*(bpy), for 137, or 1[-1[*(132) and 1[-1[*(dmb), for 138. Relative to Ru(bpY)32+, electron 
transfer from metal to ligand appears more difficult for the complexes of 132. 
The ligand 132 exhibits a reversible one electron reduction of the naphthyridine system at 
-1.78V. Hence, the 1[* orbitals of 132 are lower in energy than those of bpy (-2.l8V).1O The 
electrochemistry of 137 and 138 consists of a reversible one electron oxidation at + 1.27 and 
+I.l7V, respectively. The greater ease of oxidation ofthe dmb complex, 138, relative to the bpy 
complex, 137, has already been seen in related complexes in this work and is attributed to the 
electron donating ability of the dmb methyl groups. 
T bl 52 Ab a e .. sorpllOn aXIma an e ox f M . a dRd P otenna s 0 an . I b f 137 d 138 
A Eox Bredl Ere<i2 Bred3 Ere<i4 LlEox-red 
Ru(bpy) 32+ 451 +1.27 -1.31 -1.50 -1.77 - 2.58 
137 438 +1.27 -1.13 c -1.44 -1.62 -1.89 2.40 
138 442 +1.17 -1.24c -1.69 d -1.90 2.41 
a In nanometres. b In volts vs seE in acetonitrile. c Irreversible. d Two electron 
The first one electron reduction of each of the complexes (-1.13 and -1.24V) is 
irreversible, which may be a result of reduction of 132, followed by dissociation of a pyrazole 
group from the reduced ligand. This behaviour has been observed both in this work, in the 
complexes of 53, and in structurally related complexes, by others. 12 The remaining reductions 
are reversible and may be attributed to reduction of the dmb or bpy ligands. 
The binuclear complexes 139 and 140 were prepared as shown in Scheme 5.2 and 
obtained as red solids, which were characterised by mass spectrometry and 1 H NMR 
spectroscopy. Figure 5.4a shows the IH NMR spectrum of 139 which consists of 21 non-
equivalent protons. Compared with the spectrum of 137, the number of signals for the bridging 
ligand is now halved due to the higher symmetry of the binuclear complex. Thus both pyrazole 
rings are equivalent and the long-range coupling constant of H4 and H8 is absent, since these 
two protons are equivalent, as are H3 and H7. The pyrazo1e ring protons, H3' (7.30ppm), H4' 
(6.90ppm) and H5' (8.79ppm), were readily assigned by the smaller H3'/H4' coupling constant, 
relative to that of H4'/H5', whilst the naphthyridine protons H3 (8.01ppm) and H4 (7.76ppm) 
were distinguished by the observed nOe from H5' to H3 (Figure 5.4b). Both H3 and H4 have 
negative CIS values, with that of H4 larger since this proton is closer to a shielding pyridine ring 
than is H3. In a similar manner to the assignment of the bpy rings of 137 and the dmb rings of 
105 
Ui 
,........,~......-.-~,.....,............,,.....~i •.•• f.i •• I;i.I', •• '" 11"""""il'I'I'~I""""'" I tltl" Ili1'1""1"-"I.I ,r\ 
8.4 8.2 8.0 1.8 1.& 7.4 ;.2 1.0 6.8 PI"" 
Figure 5Aa IH NMR Spectrum of 139. 
H3 
H4' 
H5' 
.. 1.1 I.' 1.1 1.1 . ,. ..• . .. ?f '.1 .~. ".. 
Figure 5Ab nOe Difference Spectrum of 139 
I l ' i i • Iii I , I ' , I , j , , •• , lit I J t J I j i ¥ ( • itt 1 t i f I iii ttl I • [ t 1 I 'I 1 I I t I , ' Iii I j t til I , , , I j t • t I I I I iIi j , t I j t f iIi j • i l \ •• iii 1 i I r"Ti It, 
9 • 0 8 • 8 8 • 6 8 . 4 8 • 2 8 • 0 ,i . 8 1 • 6 1 • 4 i . :2 1 . 0 6 • 8 ppm 
Figure 5.5 ID TOCSY Spectra of 139 
-o 
0\ 
107 
138, the bpy rings of 139 were assigned by 1D TOCSY irradiations of each bpyH3 in tum 
(Figure 5.5). The spectrum of 139 is summarised in Table 5.3. 
Table 5.3. IH NMR Chemical Shiftsa of 132 and 139. Coordination Induced Shiftsb of 139. 
Ligand 132 Bpy ligands 
H3 H4 H3' H4' H5' H3 H4 H5 H6 
139 8.01 7.76 7.30 6.90 8.79 8.62 8.22 7.50 8.28 
132 8.49 8.49 7.90 6.67 8.84 8.56 8.13 7.38 7.56 
CISb -0.48 -0.73 -0.60 +0.23 -0.05 8.51 8.19 7.60 8.07 
8.37 8.03 7.37 7.45 
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. 
In the spectra of Figures 5.4a and 5.5 there is evidence of a minor product and 
particularly with signals for H3 in the nOe (Figure 5.4b). The minor product could not be 
removed by recrystallisation or chromatography. As has been discussed earlier, binuclear 
complexes should exist as meso and racemic diastereoisomers, which, in this case, correspond to 
the major and minor isomers of 139. This would imply that one diastereoisomer predominates, 
which has already been shown to occur in the complexes 64 and 65. 
In addition, the 1 H NMR spectrum of 140, the dmb analogue of 139, indicates a major 
and minor isomer (3:2 ratio). The nOe experiment in Figure 5.6a confirms this by showing an 
enhancement of two doublets for H3 (8.08, 8.lOppm), one for each isomer, when H5' 
(8.75-8.76ppm) is irradiated. Furthermore, the 1D TOCSY spectra of 140 (Figure 5.6b) shows 
that by irradiating these two H3 doublets, the corresponding H4 doublets (7.77, 7.82ppm) can be 
located amongst overlapping dmbH6 signals. The bridging ligand protons for the major and 
minor isomer were assigned by their relative integrals and with the assistance of a 2D COSY 
spectrum, which also confirmed the coupling of H3 and H4. These are summarised in Table 5.4. 
Table 5.4. 1 H NMR Chemical Shiftsa of 132 and 140. Coordination Induced Shiftsb of 140. 
Maior isomer Minor isomer 
H3 H4 H3' H4' H5' H3 H4 H3' H4' H5' 
140 8.10 7.82 7.27 6.90 8.76 8.08 7.77 7.27 6.90 8.75 
132 8.49 8.49 7.90 6.67 8.84 8.49 8.49 7.90 6.67 8.84 
asb -0.39 -0.67 -0.63 +0.23 -0.08 -0,41 -0.72 -0.63 +0.23 -0.09 
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. 
All attempts to separate the isomers by recrystallisation, or ion-exchange chromatograpy 
on sephadex, failed. The dmb protons could not be assigned to either isomer and no particular 
protons could be assigned to a unique stereochemical environment, unlike the case in the spectra 
of 64 and 121, in which the shielding (meso) or deshielding (racemic) environment of a bpyH6 
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proton allowed assignment of the meso and racemic diastereoisomers. However, this effect 
would be smaller in 140, since the RuL22+ units are further apart than in 64 or 121, as has been 
confirmed by studies with molecular models. Hence, the two isomers probably correspond to the 
diastereoisomers of 140, although neither isomer could be unambiguously assigned to the meso 
or racemic forms. Similarly, the diastereoisomer shown in the spectrum of 139 (Figure 5.4a) can 
not be assigned. 
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Figure 5.7 Visible Absorption spectra of 137 (above) and 139 (below). 
The visible absorption spectra of 137 and 139 are shown in Figure 5.7. The spectrum of 
the mononuclear complex has already been described. In the spectrum of 139, an MLCT band 
with a maximum at A=436nm is accompanied by a less intense shoulder at 488nm. These were 
assigned as the transitions d1t-1t*(bpy) and d1t-1t*(132), respectively. The observed red shift of 
the lowest MLCT band in the binuclear complex (488nm), which can be observed in Figure 5.7, 
is typical of a complex in which a metal-metal interaction occurs and is attributed to a lowering 
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of the rc:* orbital of the bridge by back-bonding to the second ruthenium(II) centre. In this case, 
the red shift is smaller than that of the binuclear complexes [Ru (bpy hh(bpm)4+, 35 
[Ru(bpYhl2(dpp)4+ ,126 64 and 121, but larger than the red shift of weakly interacting complexes 
such as [Ru(bpYhh(2S)4+ (2S=2,2':4',4":2",2'''-quaterpyridine) (455nm, 471nm), thus implying 
an intermediate metal-metal interaction for the complex 139. 
The absorption maxima of 139 and also of 140 are summarised in Table 5.5. Analogous 
to 139, the absorption bands of 140 can be attributed to the MLCT transitions drc:-rc:*(dmb) and 
drc:-1t*(132). Also included in Table 5.5 are the redox potentials of both complexes, whilst the 
cyclic voltammogram of 139 is shown in Figures 5.8a and 5.8b . 
T bl 55 Ab a e .. sorptlon M . a dR d P axlma an e ox . 1 b f 139 d 140 otentia s 0 an 
A Boxl Eox2 Bredl Ere<i2 Bred3 Bred4 Bred5 
[Ru (bpy) 2] 2( 5) 4+ 594 +1.53 +1.69 -0.41 -l.08 - -
139 434,482sh +1.29 +1.38 -0.85 -1.46 -1.54 -1.67 -1.78 
140 436,488sh +1.20 +1.29 -0.89 -1.54 -1.64 -1.77 -1.89 
a In nanometres. b In volts vs SeE in acetonitrile. 
Unlike the mononuclear complexes, the first reduction of 139 (-0.85V), and of 140 
(-0.89V), is a reversible one electron process. This reduction can be assigned to reduction of the 
bridging ligand and occurs at a less negative potential than in the mononuclear complex. This 
effect, which is a result of the synergistic lowering of the rc:* orbital of the ligand by the second 
coordinated ruthenium(II), parallels the red shift in the MLCT band, as shown in Figure 5.7. 
Dissociation of the ligand from the reduced complex, which may account for the irreversibility 
of the first reduction of 137 and 138, does not occur for the binuclear complexes. As a 
consequence of the electron donating methyl groups, the n* orbitals of dmb are at higher energy, 
relative to those of bpy. Hence, the last four reductions of 140 are at more negative potentials 
(-1.54, -1.64, -1.77, -1.89V) than in 139 (-1.46, -1.54, -1.67, -1.78V). 
The complexes 139 and 140 each exhibit a reversible two-electron oxidation. Table 5.5 
shows that 140 is more easily oxidised than 139, as has been previously described for 
structurally related dmb complexes in this work. The cathodic-anodic peak-separation 
(.0.Ep=135mV) is smaller than that of complexes with strongly interacting centres, such as 64 
and 121, but larger than the peak separation for a single-step charge transfer of two electrons 
(.0.Ep=58.5mV227), as seen in complexes with non-interacting centres, such as 131. Hence,.0.Ep 
is sufficiently large to indicate coupling of the ruthenium(II) centres via the rc: system of the 
bridging ligand. Polcyn and Shain have shown that if .0.E1I2 is less than 120mV, for a two step 
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Figure 5.Sa Cyclic voltammogram of 139. 
+1.2V +1.5V 
Figure 5.8b Expansion of the oxidation wave in Figure 51Sa. 
proce'ss, the separate peaks are not resolved.233 Hence, ~E1I2 can not be measured directly from 
Figure 5.8a, although the splitting of the oxidations of 139 results in a visible shoulder on both 
the cathodic and anodic peaks of the oxidation wave (Figure 5.8b). 
Richardson and Taube, have shown that an experimental value for ~Ep can be used to 
obtain a value of ~El/2 from a working curve of ~E1f2 versus ~Ep, derived from theoretical 
simulations of voltammograms.227 Furthermore, from a plot of ~E p versus Ep-E1/2I 
(the difference between the most cathodic peak (for reduction) and the half wave potential of the 
first step) a value of Ep-E1I21 can be obtained. For the oxidation of 139, Ep is the most anodic 
peak and EII2 is the half-wave potential of the first oxidation (Eoxl). The values for ~E1I2 
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(96±3mV) and Ep-E1I21 (116mV) were derived from AEp (135mV) using the expanded cyclic 
voltammogram (oxidations) of 139 (V=50mV/sec, x=50cm, y=200cm) (Figure 5.8b). From the 
observed value of Ep (l.403V), the potentials were calculated as E1I2 1=1.403-0.116=1.287V 
(Eoxl) and El/22=1.287+0.096=1.383V (Eox2). The potentials of the first and second oxidations 
of 140 were calculated in an analogous manner. 
Molecular modelling studies (CHEM 3D Plus) of 139 and 140 predict a value of 7.5A for 
the inter-metal separation. Hence, the metals are more separated than in the binuclear complexes 
of 109 (6.2A, AE1I2=160mV) and 40 (5.59A, AE1I2=200mV), which accounts for the decreased 
metal-metal interaction (96±3mV) of 139. However, the rr system of the naphthyridine bridge 
facilitates better inter-metal communication than in related biruthenium complexes, such as 
[Ru(bpyhh(24)4t (AE1I2=80mV) and [Ru(bpYhh(25)4t (AE112 =56mV), 152,153 for which the 
metal-metal distances have been estimated to be 9.0 and 11.26A using CHEM 3D Plus. Hence, 
139 and 140, show intermediate metal-metal interactions with the rigid conformation, low lying 
rr* orbitals of the bridging ligand 132 and the relatively close inter-metal separation contributing 
to the stability of the mixed valence intermediate. 
Chapter 6 
Bis-bidentate 4,4'-Bipyridine Ligands 
and Complexes. 
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Bis-bidentate 4,4'-Bipyridine Ligands and Complexes. 
6.1. Introduction .. 
In the binuclear complexes of 40, 109 and 132, the inter-ring bonds of the bridging ligand 
are coplanar. Thus, despite the trend of increasing inter-metal separation, which contributes to 
the decreasing metal-metal interaction, coupling of the metals can still occur via the undisrupted 
n system of the bridge. In contrast, the binuclear complex 131 has a flexible bridge of the ligand 
110, which, along with the large inter-metal separation (12.8-13.6A), prevents coupling of the 
metals. 
141 
143 
Figure 6.1. 
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Steel et al. have described mononuclear (141) and binuclear (142) ruthenium(II) 
complexes of the ligand 2,2:4',4":2",2'''-quaterpyridine (25) (Figure 6.1).153 In 142, there exists 
the potential for overlap of the n system of each of the bpy subunits of the bridging ligand, 
although the conjugation of the rings is disrupted somewhat by rotation about the 4'-4" bond. 
Hence, the complex exhibits a weak but detectable metal-metal interaction 142 (AEp=85mV, 
6.E1I2=56±3mV). In contrast, a biruthenium complex of the related ligand 2,2':6',2":6",2'''-
quaterpyridine (143) (Figure 6.1) showed no metal-metal interaction, due to thein~bi1ity of the 
ligand to maintain conjugation of the bpy subunits, whilst bridging two octahedral metal 
centres. 234 Similarly, in known bridging ligands that contain isolated bpy subunits, inter-metal 
communication is prevented by the lack of conjugation between bpy subunits that are connected 
by saturated carbon chains. 3, 153,235-237 The study of 142 has also shown that unlike other 
bridging ligands, such as 5 and 15, which have low lying n* orbitals relative to bpy, 25 has 
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similar 1t orbital properties to bpy and thus does not not significantly modify the properties of 
142 relative to Ru(bpy)}2+. 
For the 1 H NMR spectrum of 141 and 142, complete assignment of 25 was prevented by 
overlapping bpy protons.238 In this chapter, we describe the unambiguous assignment of 25, in 
the coordinating mode, by replacing the bpy ligands of 141 and 142 with dmb. An 
unsymmetrical binuclear complex of 25 with both bpy and dmb peripheral ligands, a homoleptic 
complex, a tetranuclear complex and a mixed metal palladium(ll)/ruthenium(ll) complex are 
also described. In most cases the NMR spectroscopy, absorption spectroscopy and cyclic 
voltammetry of the complexes are discussed. 
The complex 142 and a recently reported diruthenium complex of a 
pyridinyl-benzimidazole analogue239 are the only known examples of the use of bis-bidentate 
binucleating ligands containing a 4,4'-bipyridinyl bridge. This chapter also describes two new 
bis-bidentate 4,4'-bipyridine derivatives, 144 and 145, which are pyrazole analogues (Figure 6.2) 
of 25. The syntheses of the ligands and their mononuclear and binuclear ruthenium complexes 
are discussed. 
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The dmb complexes, 146 and 147, were prepared by reacting 25 with one and two 
equivalents of Ru(dmbhCI2, respectively (Scheme 6.1). In contrast, the unsymmetrical 
complex, 148, was prepared by reacting 146 with Ru(bpy)zCl2 (Scheme 6.1). Exact procedures 
are analogous to the preparation of complexes described earlier. All three complexes were 
characterised by mass spectrometry and 1 H NMR spectroscopy. 
The IH NMR spectrum of 146 consists of 26 non-equivalent aromatic protons (Table 
6.1). Many of the protons of 25 that were overlapped by bpy signals in the spectrum238 of 141, 
are isolated in the spectrum of 146, in particular, H3'" (8.56ppm), H4 (8.13ppm), H5 (7.48ppm), 
H5' (7.79ppm), H5/1 (7.87ppm), H5'" (7.52ppm), and H6 (7.83ppm). In the spectrum, the 
25 
147 
4+ 
6" 
5' 
N ~ h6' 
\./ 
Ru(dmb)2 
146 
Ru(bpy)zC12 EtOHlH20 
6'" 
5" ~ h 
N'\. /N 6" 
Ru(dmb)2 
148 
Scheme 6.1. 
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Table 6.1 1H NMR Chemical Shifts a of 25 and 146. Coordination Induced Shiftsb of 146. 
Ligand 25 Dmb ligands 
H3 H4 HS H6 ill' H5' H6' H3d H4c,d HSd H6d 
25 8.S6 8.00 7.S1 8.80 8.91 7.87 8.88 - - - -
146 8.7S 8.13 7.48 7.83 8.88 7.79 7.92 8.42 2.S8 7.29 7.S9 
CISb +0.19 +0.13 -0.03 -0.97 -0.03 -0.08 -0.96 8.42 2.S8 7.29 7.61 
H3'" H4'" HS'" H6'" H3" HS' H6" 8.42 2.60 7.31 7.61 
146 8.S6 8.02 7.S2 8.77 8.90 7.87 8.93 8.42 2.60 7.31 7.66 
CISb +0.00 +0.02 +0.01 -0.03 -0.01 +0.00 +O.OS - - - -
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. c Methyl group d Not assigned. 
protons of the inner-disubstituted rings (H3'-H61 and H3"-H6") of 25 can be distinguished from 
the protons of the outer-monosubstituted rings (H3-H6 and H3'''-H6''') on the basis of their 
relative coupling patterns, since coupling due to H4 is absent from the signals for the inner rings. 
In addition, the H3-H6 and H3'-H6' rings exhibit coordination induced shifts (CIS), and can 
therefore be distinguished from H3"-H6" and H3'''-H6''', which show near zero CIS values. For 
example, the triplets at 8.13 and 8.02ppm were assigned as H4 and H4'" respectively, since H4 
exhibits the greater positive CIS value due to the net effect of a-donation and 1t-backbonding of 
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electron density between ligand and metal. Similarly, both H6 and H6' exhibit large upfield 
shifts (-0.96 to -0.97ppm), relative to H6" and H6'" (+0.01 to +O.OSppm) due to ring-current 
anisotropy effects. A 2D COSY spectrum of 146 confirmed these assignments and allowed the 
remaining protons to be assigned unambiguously. For example, H4 (8.13ppm) correlates with 
signals at 7.48ppm and 8.7Sppm thus assigning HS and H3, respectively, whilst a further 
correlation from HS locates H6. Similarly, H6' shows a strong correlation to a doublet of 
doublets at 7.79ppm (HS') which in turn shows a long-range coupling to a singlet at 8.88ppm 
(H3'). The non-coordinated rings were a'>signed in a similar manner. A combination of electron 
withdrawal, by the metal, and ring-current anisotropy accounts for the CIS of HS (-0.03ppm) and 
HS' (-0.08ppm), whilst the chemical shifts of H3 and H3' are influenced by the change in ligand 
conformation on metal chelation. 
The protons of 25 are more easily assigned when the ligand is in the bridging mode, since 
both halves of the molecule are coordinating to ruthenium and are, hence, equivalent by 
symmetry. Figure 6.3 shows the IH NMR spectra of 142 (top), 147 (middle) and 148 (bottom). 
The spectrum of 147 consists of 19 non-equivalent aromatic protons of which seven belong to 
the bridging ligand 25, half of that in the spectrum of 146. All bridging ligand protons are 
visible and can be assigned by their relative coupling constants and chemical shifts without the 
use of 1D TOCSY or 2D COSY spectra. In comparison, H4, HS' and H6 are overlapped by bpy 
signals in the spectrum of 142 (Figure 6.3 top). 
Alternatively the symmetrical bridging ligand protons can be assigned in the spectrum of 
142 using ID TOCSY spectra (Figure 6.4). In this case, irradiation of H3' (trace I and II) and 
H3 (trace III and IV) locates the spin systems for the inner and outer rings of 25 respectively. 
Similar subspectra can also be obtained for the bpy protons by irradiating bpyH3. 
In contrast, the bridging ligand of 148 is unsymmetrical, since one bipyridine subunit is 
coordinated to a Ru(bpyh2+ unit, whilst the other is coordinated to a Ru(dmbh2+. Thus, some 
of the signals for the bridging ligand protons occur as more complex multiplets in Figure 6.3 
(bottom). For example, two overlapping doublets, corresponding to H3 and H3'" are now 
observed at 8.88ppm, whereas in the spectra of 142 and 147 these two protons are equivalent and 
appear as a doublet. The spectrum of 148 consists of 42 non-equivalent aromatic protons (14 for 
25), which were assigned from 1D TOCSY spectra, in a similar manner to the assignment of 
142, by irradiations of H3, H3', H6, bpyH3 and dmbH3. An analogous complex (124), of the 
ligand 109, was described in chapter 4. 
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Figure 6.3 IH NMR Spectra of 142 (top), 147 (middle) and 148 (bottom). 
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The chemical shifts of 142, 147 and 148 are summarised in Table 6.2 (peripheral ligand 
protons are omitted for simplicity). As a result of their electron donating methyl group, the dmb 
ligands push more electron density onto the metals, by a-donation, than do the bpy ligands. This 
results in a slight increase in the electron density of 25, by the synergic effect of metal-bridging 
ligand 7t-backbonding. Hence, the chemical shifts of 25, in 147, are shielded relative to the 
chemical shifts of 25 in 142. Similarly, the protons in the H3"-HS" and H3'''-HS'" rings are 
shielded relative to those of the H3-H5 and H3'-H5' rings in the IH NMR spectrum of 148, with 
the exception of H6/H6'" and H6'/H6". Here the effect of the different peripheral ligands is less 
pronounced, although the doublet is broadened, relative to that of H6 or H6' in the spectra of 142 
and 147. 
Table 6.2 IH NMR chemical shifta and Coordination Induced Shiftsb of ~-25 in 142,147 and 
148. 
H3 H4 H5 H6 H3' H5' H6' 
25 8.56 8.00 7.51 8.80 8.91 7.87 8.88 
142 8.77 8.17 7.51 7.84 8.89 7.80 7.95 
CISb +0.21 +0.17 +0.00 -0.96 -0.02 -0.07 -0.93 
147 8.75 8.15 7.50 7.84 8.87 7.78 7.95 
CISb +0.19 +0.15 -0.01 -0.96 -0.04 -0.09 -0.93 
148 8.80 8.15 7.50 7.84 8.91 7.78 7.95 
CISb +0.24 +0.15 -0.01 -0.96 +0.00 -0.09 -0.93 
ID'" H4'" H5'" H6'" H3" H5" H6" 
148 8.82 8.17 7.51 7.84 8.93 7.80 7.95 
CISb +0.26 +0.17 +0.00 -0.96 +0.02 -0.07 -0.93 
a For deuterated acetonitrile solutions. b CIS = 0complex-Oligand. 
The factors which account for the CIS values of the mononuclear complex can also be 
invoked to explain the CIS values of the binuclear complexes, namely ring-current anisotropy 
(H6 and H6'), ligand-metal a-donation and metal-ligand 7t-back-bonding (H4) and chelation 
induced conformational changes (H3 and H3'). A combination of the first two factors results in 
the slight shielding of H5 and HS'. The CIS value for H3 (+0.19 to +0.26ppm) is large relative 
to that of H3' (-0.02 to +O.Olppm), implying that these protons experience different effects due 
to chelation induced conformational changes. In the binuclear complexes, the 2,2' and 2"-2'" 
bonds of 25 are cisoid with respect to the nitrogens, whereas in the free ligand they are transoid. 
The latter conformation has been confirmed by the crystal structure of two crystalline 
modifications of 25, which differ only in their molecular packing.240 Each of these structures 
has a crystallographic centre of inversion which requires that the two central rings be 
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obligatorily coplanar, despite the biphenyl-like interactions between the ortho hydrogens. This 
biphenyl-like interaction is also likely to exist in the binuclear complex. Hence, the environment 
of H3'/H3" in the complex is similar to the environment in the free ligand, whereas H31H3'" is 
deshielded in the cisoid conformation of 142, 147 and 148, relative to the shielding transoid 
conformation of 25. 
The meso and racemic diastereoisomers of 147 and 148 are not resolved in the spectra, as 
has been previously reported for 142.153 This contrasts with the spectroscopic resolution of the 
diastereoisomers in binuclear complexes of 40, 109 and 132, as described earlier, and suggests 
that, either the isomerism of binuclear complexes is less easily observed as the distance between 
the chiral metal centres increases, or, only one isomer is present. 
The UVNIS spectra and electrochemistry of the complexes 146, 147, 148 and, for 
comparison, 141,142 and Ru(bpy)J2+ are summarised in Table 6.3. All complexes exhibit 
strong ligand centred absorption bands (A,<400nm) and MLCT absorption bands (A,>400nm) in 
their UVNIS spectra. In the mononuclear complex 146, the lowest energy MLCT (464nm) was 
assigned to the transition dn-n*(25), whilst the accompanying shoulder at higher energy 
(450nm) was assigned as dn-n*(dmb). Hence, the lowest energy MLCT is shifted to lower 
energy relative to that of 141, due to the metal d orbital destabilisation by the electon donating 
methyl groups of the dmb ligands. 
T bl 63 Ab a e sorptIOn maXIma a dRed P an ox 'a1 b otenh s 
Complex A, Eox! Eox2 Bredl Bred2 Bred3 Ered4 Ereds 
Ru(bpy) 32+ 451 +1.27 -1.31 -1.50 -1.77 -
141 455 +1.22 -1.32 -1.51 -1.84 -
146 450sh,464 +1.13 -1.34 -1.67 -1.88 
142 471 + 1.24c (85mV) -1.10 -1.44 -1.57 -1.64 
147 448,490 +1.11 +1.17 -1.13 -1.51 -1.69 c -1.91 c 
148 456,484 +1.12 +1.24 -1.12 -1.50 -1.67 -1.87 c -1.99 
a In nanometres. b In volts vs seE in acetonitrile. c Two electron. 
Destabilisation of the d orbitals can also be seen in the greater ease of oxidation of 146 
(+1.13V) relative to 141 (+1.22V). The oxidation and three reductions of 146 are all reversible 
one electron processes. The first reduction (-1.34V) is similar to that of 141 and is relatively 
unaffected by the dmb ligands. This implies that the first reduction of 141 and 146 corresponds 
to reduction of the ligand 25. Successive reductions are assigned to the dmb ligands. 
The binuclear complexes 147 (490nm) and 148 (484nm) show dn-n*(25) transitions at 
lower energy than 146. This small red shift has previously been observed for 141153 and implies 
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a relatively weak metal-metal interaction, since complexes with strong metal-metal interactions 
usually exhibit greater red shifts. Such red shifts are due to lowering of the energy of the n:* 
orbital of the bridging ligand by the coordination of the second Ru(II). The next lowest MLCT 
can be attributed to transitions from the metal into the peripheral ligands. 
The cyclic voltammogram of 147 consists of a reversible two electron oxidation 
(AEp=85mV centred at 1. 14V), two reversible one electron reductions and two reversible two 
electron reductions. Using the simulated working curves of Richardson and Taube (see chapter 
5),227 a value of 56±3mV for ~EI12 was calculated from AEp. Since the value of AEll2 is 
greater than that for a single step charge transfer of two electrons (AE1I2=35.61/n, n=l), the 
complex can be said to exhibit a weak metal-metal interaction, analogous to that shown 
previously for 142. Furthermore, from plots of ~p versus Ep-~1I21, the oxidation potentials of 
146 were calculated as Eoxl=1.11 V and Eox2=1.17V. 
The first reduction (-1.13V) of 147 can be assigned to reduction of the n:* orbital of the 
bridging ligand, which is at lower energy than 146 for reasons already described. This result 
correlates with the red shift of the MLCT of the binuclear complex. As mentioned in chapters 4 
and 5, Cooper et al. have proposed a relationship between ~E (for the first and second 
reductions) and the number of bonds in the bridging ligand.224 The second reduction of 142 has 
been found to correlate with this relationship153 and this is also the case with 147. Hence, the 
second reduction is centred on the bridging ligand. The remaining reductions were assigned to 
the dmb ligands. 
The coordination of different peripheral ligands to each ruthenium was shown to have a 
significant effect on the IH NMR spectrum of 148. Similarly, the effect of the peripheral 
ligands can also be seen in the cyclic voltammogram of the complex (Figure 6.5a, 6.5b). Figure 
6.5a shows the cyclic voltammogram for 148, whilst Figure 6.5b shows an expansion of the 
reversible two electron oxidation process (V=50mV/sec and X-axis=100mV/cm). A pronounced 
shoulder on the cathodic and anodic peaks implies a significant metal-metal interaction and 
clearly shows that the peripheral ligands can significantly modify the properties of the complex. 
The peak to peak separation ~=170mV is sufficiently large to allow the values ~1I2=120mV, 
Eoxl=+1.12V and Eox2=+1.24V to be determined graphically. Similar values were obtained 
from the working curves of Richardson and Taube.227 The oxidations occur at more or less the 
same potential as the oxidations of the parent mononuclear complex, with oxidation of the 
Ru(dmbh2+ made easier, relative to Ru(bpyh2+, by the destabilising effect that the electron 
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Figure 6.5a Cyclic Voltammogram of 148. 
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Figure 6.5b Expansion of oxidation wave in Figure 6.5a 
donating methyl groups have on the d orbitals of the metal. Hence, each metal is independently 
affected by the peripheral ligands, resulting in a divergence of their d orbitals energies and an 
apparent increase in the metal-metal interaction. This effect was also observed for the complex 
124. The reductions of 148 are comparable to those of 142 and 147 and were assigned to the 
bridging ligand (first and second reductions), and the peripheral ligands (successive reductions). 
Scheme 6.2 details the syntheses for three further complexes of 25. The homoleptic 
complex 149 was prepared by reacting three equivalents of the ligand with Ru(DMSO)4Cl2 and 
characterised by mass spectrometry. As has been discussed in previous chapters, homoleptic 
complexes exist as a 3:1 mixture of the mer and fac isomers. The isomers were not sufficiently 
well resolved in the 1 H NMR spectrum of 149, which contains many broad signals. For 
124 
example, 12 protons, corresponding to H3', H3" and H6", occur as a broad signal at 
8.92-8.95ppm. Tentative assignments of the spectrum were made by comparison with the 
spectrum of 146. 
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Complex 149 exhibits an almost symmetrical MLCT absorption band (Amax=468nm), at 
lower energy than the symmetrical MLCT absorption band of Ru(bpyh2+ (Amax=451nm) 
(Figure 6.6 top). Hence electron transfer from metal to ligand is easier for 149. MLCT 
transitions into both the coordinated mono-substituted and coordinated di-substituted rings of 25, 
account for the reduction in symmetry of the MLCT, relative to Ru(bpyh2+. 
The redox potentials of the complex consist of a reversible one electron oxidation 
(+1.25V) and two reversible reductions (-1.39 and -1.79V), the latter of which is a two electron 
processes. At more negative potentials absorption occurs, with an associated stripping curve in 
the cyclic voltammogram. Relative to Ru(bpYh3+, the complex is easier to oxidise, but slightly 
harder to reduce. 
The tetranuclear complex 150 was prepared by reacting 149 with three equivalents of 
Ru(bpyhCl2 and characterised, as an octahydrate, by elemental analysis. The IH NMR 
spectrum of 150 was complicated and unresolved, due to the presence of the numerous isomers 
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which exist for this complex, and could not be assigned. However, the electronic properties of 
the complex were examined by UV NIS absorption spectroscopy and cyclic voltammetry. The 
UVNIS spectrum (Figure 6.6 bottom) shows strong ligand centred absorptions below 400nm, 
whilst at lower energy an unsymmetrical MLCT absorption band exists (A=482nm). The small 
red shift, relative to the homoleptic complex, indicates a weak metal-metal interaction analogous 
to that of 142 and 147. As many as three MLCT transitions are possible for the complex 
(terminal Ru(II) to bpy, terminal Ru(I1) to 25 and central Ru(II) to 25) and these result in the 
unsymmetrical MLCT band. The transition~ are less well resolved than in the UVNIS spectrum 
of 127 (chapter 4), as a consequence of the weaker metal-metal interactions of 150. 
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Figure 6.6 UVNIS Absorption Spectra of 149 (top) and 150 (bottom). 
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The redox potentials of 150 consist of a reversible three electron oxidation (+1.31 V) 
followed by a one electron oxidation (+ 1. 96V). Hence, oxidation of the three terminal 
rutheniums occurs more readily than oxidation of the central ruthenium, which has also been 
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observed for 127. The greater ease of oxidation of the terminal rutheniums implies that the 
lowest energy MLCT transition is dn(terminal Ru(II))-n*(25) rather than d1t(central 
Ru(II))-1t*(25). Furthermore, a reversible three electron reduction occurs at -0.92V, followed by 
an irreversible multi-electron reduction (-1.44V). The first reduction correlates with reduction of 
the three bridging ligands, whilst the multi-electron reduction is centred on the bpy ligands. 
The third complex shown in Scheme 6.2 is the heterobinuclear complex 151, which was 
prepared by reacting 146 with Pd(PhCNhCh in dichloromethane. The complex was 
characterised by mass spectrometry and was sufficiently soluble in CD3CN to obtain a 1 H NMR 
spectrum which is summarised in Table 6.4. 
The LH NMR spectrum of 151 consists of 28 non-equivalent protons, which were 
assigned by a 2D COSY spectrum, in an analogous manner to the assignment of the spectrum of 
146. Table 6.4 shows that the CIS values for the rings coordinated to palladium differ from 
those for the ruthenium coordinated rings. All CIS values for H3"-H6" and H3"'-H6'" are 
positive, with the exception of those for H3" (-0.23ppm) and H3'" (-0.07ppm), and can be 
attributed to the donation of a electron density from ligand to metal, whilst H6" (+0.45ppm) and 
H6'" (+0.4 7ppm) are additionally deshielded by an adj acent chlorine atom. In contrast, H6 
(-0.95ppm) and H6' (-0.87ppm) lie over pyridine rings and are anisotropically shielded. 
n-Back-bonding, from ruthenium to 25, counters the effect of a-donation from 25 to ruthenium, 
thus lowering the CIS values of the remaining protons, relative to the palladium coordinated ring 
protons (eg H4=+0.18ppm and H4"'=+0.31ppm). The exceptions are the CIS values for H3, H3', 
H3" and H3"', which are due to chelation induced conformational changes. 
Table 6.4 L H NMR Chemical Shifts a of 25 and 151. Coordination Induced Shifts b of 151. 
Ligand 25 Dmb ligands 
ID H4 HS H6 H3' H5' H6' IDe H4c,d HSe H6e 
25 8.56 8.00 7.51 8.80 8.91 7.87 8.88 - - - -
151 8.82 8.18 7.52 7.85 8.99 7.85 8.01 8.43 2.59 7.30 7.61 
CISb +0.26 +0.18 +0.01 -0.95 +0.08 -0.02 -0.87 8.43 2.59 7.30 7.61 
H3'" H4'" H5'" H6'" H3" H5" H6" 8.43 2.61 7.32 7.61 
151 8.49 8.31 7.74 9.25 8.68 8.09 9.35 8.43 2.61 7.32 7.63 
CISb -0.07 +0.31 +0.23 +0.45 -0.23 +0.22 +0.47 - - - -
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. e Not assigned. d Methyl group 
The complex was insufficiently soluble in acetonitrile to be analysed by cyclic 
voltammetry. However, a UV/VIS spectrum of 151 was obtained and exhibits strong ligand 
centred absorptions (A<400nm) and an unsymmetrical MLCT absorption band (Amax=484nm, 
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sh=448nm). The lowest MLCT was assigned as d1t-1t*(25) and exhibits a small red shift, 
relative to that of 146, suggesting a weak metal-metal interaction. The shoulder at higher energy 
can be assigned to the transition d1t-1t*(bpy). 
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The syntheses of the new pyrazole analogues of 25, 2,2'-bis-(1-pyrazolyl)-4,4'-bipyridine 
(144) and 2,2'-bis-(3,5-dimethyl-1-pyrazolyl)-4,4'-bipyridine (145), are shown in Scheme 6.3. 
The first two steps are derived from procedures for the synthesis of related bipyridines.230 
Firstly, 4,4'-bipyridine-di-N-oxide (152) was prepared by heating a solution of 4,4'-bipyridine 
and hydrogen peroxide in acetic acid. The compound was characterised by its 1 H NMR 
spectrum which consists of two doublets at 7.99ppm and 8.40ppm, with the upfield signal 
assigned to the more electron-rich H3/HS. In the second step, refluxing 152 in POCl3 afforded 
2,2'-dichloro-4,4'-bipyridine (153) which was characterised by its IH NMR spectrum. This was 
assigned on the basis that HS is coupled to both H3 (long-range) and H6, and appears as a 
12S 
doublet of doublets (S.Ol ppm), whilst the H6 doublet (S.17ppm) has a larger coupling than the 
H3 doublet (S.67ppm) and can thus be distinguished. 
For the final step, 153 was reacted either with two equivalents of potassium pyrazolate, to 
give 144, or with two equivalents of potassium 3,S-dimethylpyrazolate, to give 145. Both 
ligands were characterised by mass spectrometry, elemental analysis and 1 Hand l3C NMR 
spectroscopy. The numbering of the atoms shown in Scheme 6.3 differs from that of 25, but is 
consistent with the systematic nomenclature of the compounds. 
IH NMR spectra of the ligands were recorded in CDC13 and CD3CN whilst the l3C 
NMR spectra were obtained in CD3CN. In the 1 H NMR spectra of 144 and 145, the pyridine 
protons can be readily distinguished by their relative couplings as described for the spectra of 
153. The larger coupling between H4" (triplet, 6.62ppm) and HS" (doublet, S.70ppm), relative to 
that between H3" (doublet, 7.S7ppm) and H4", enabled the assignment of the pyrazole ring 
protons of 144. A similar coupling of H4" broadens the CH3-S" singlet (2.71ppm), relative to 
the CH3-3" singlet (2.32ppm), in the spectrum of 145. The protonated carbons in the l3C NMR 
spectra were assigned by comparison with the spectrum of 43.11 
The ligands 144 and 145 were recrystallised from CH3CN/CHC13 and CH3CN 
respectively. The resulting crystals were of sufficient quality for the structure of the ligands to 
be determined by X-ray crystallography. 
Figures 6.7a and 6.7b show perspective views and atom labelling of the structures of 144 
and 145 respectively. Table 6.S lists the bond lengths and bond angles with least-squares-
estimated standard deviations in parentheses. For both structures the asymmetric unit comprises 
a full molecule. Hence, the potential molecular symmetry is not recognised in the 
crystallographic symmetry. This contrasts with the two reported240 crystal structures of 25 in 
which the two halves of the molecule are crystallographically related by a centre of inversion 
and are obligatorily coplanar. For 144 and 145, the two non-crystallographically related halves 
of the molecule have remarkably similar bond lengths and angles. However, significant 
differences exist in the torsional angles of the two halves of each molecule and these are 
discussed in detail later. The only significant differences in bond lengths and bond angles 
between the two molecules are those associated with the N(l)-atoms of the pyrazole rings 
wherein the presence of the S-methy 1 substituent in 145 increases the bond lengths and angles 
about this atom relative to those in 144. Such effects are well documented in the literature for 
the crystal structures of pyrazoles.241 
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Figure 6.7a. Perspective view and atom labelling of the structure of 144. 
Figure 6.7b. Perspective view and atom labelling of the structure of 145. 
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Table 6.5. Bond lengths (A)and bond angles (0) for 144 and 145. 
144 145 144 145 
N(1)-C(2) 1.321(2) 1.324(5) N(1)-C(6) 1.334(2) 1.343(4) 
C(2)-C(3) 1.382(2) 1.376(5) C(2)-N(lA) 1.404(2) 1.408(5) 
C(3)-C(4) 1.380(2) 1.374(5) C(4)-C(5) 1.388(2) 1.390(5) 
C(4)-C(4') 1.475(2) 1.470(5) C(5)-C(6) 1.372(2) 1.354(5) 
N(1 ')-C(2') 1.322(5) 1.317(5) N (1 ')-C( 61) 1.335(2) 1.337(4) 
C(2')-C(3') 1.375(2) 1.374(5) C(21)-N(1B) 1.408(2) 1.391(5) 
C(3')-C(4') 1.380(2) 1.378(5) C(4')-C(5') 1.388(2) 1.384(5) 
C(5')-C(6') 1.369(2) 1.372(5) N(IA)-C(5A) 1.349(2) 1.357(5) 
N(lA)-N(2A) 1.359(1) 1.383(5) N(2A)-C(3A) 1.318(2) 1.320(5) 
C(3A)-C(4A) 1.393(2) 1.399(6) C(3A)-C(6A) 1.501(5) 
C(4A)-C(5A) 1.353(2) 1.365(5) C(5A)-C(7 A) 1.483(6) 
N(1B)-N(2B) 1.356(1) 1.368(4) N(1B)-C(5B) 1.349(2) 1.388(5) 
N (2B)-C(3B) 1.319(2) 1.312(5) C(3B)-C(4B) 1.392(2) 1.411(6) 
C(3B)-C(6B) 1.493(5) C(4B)-C(5B) 1.356(2) 1.350(5) 
C(5B)-C(7B) 1.488(5) 
C(2)-N(I)-C(6) 116.2(1) 115.2(4) N(1)-C(2)-C(3) 124.8(1) 125.0(4) 
N(1)-C(2)-N(1A) 115.0(1) 115.1(4) C(3)-C(2)-N( 1 A) 120.2(1) 119.9(4) 
C( 4)-C(3)-C(2) 118.4(1) 118.3(4) C(3)-C(4)-C(5) 117.6(1) 118.1(4) 
C(3)-C(4)-C(4') 120.9(1) 121.3(4) C( 5)-C( 4 )-C( 4 ') 121.5(1) 120.7(3) 
C(6)-C(5)-C(4) 119.3(1) 118.7(4) N(I)-C(6)-C(5) 123.8(1) 124.7(4) 
C(2')-N(1')-C(6') 115.9(1) 116.2(4) N(1 ')-C(2')-C(31) 124.7(1) 124.6(4) 
N(1')-C(2')-N(lB) 115.1(1) 116.3(4) C(3 ')-C(2')-N (IB) 120.1(1) 119.1(4) 
C(2')-C(3')-C( 4') 118.6(1) 119.3(4) C(3')-C( 4')-C(5') 117.5(1) 116.7(4) 
C(3')-C(4')-C(4) 120.3(1) 120.8(4) C(5')-C( 41)-C( 4) 122.1(1) 122.4(4) 
C(6')-C(5')-C( 4') 119.0(1) 119.8(4) N(I')-C(6')-C(5') 124.1(1) 123.4(4) 
C(5A)-N(1A)-N(2A) 112.1(1) 112.3(3) C(5A)-N(1A)-C(2) 127.7(1) 130.8(4) 
N(2A)-N( lA)-C(2) 120.3(1) 116.6(4) C(3A)-N(2A)-N( 1 A) 103.7(1) 103.7(4) 
N(2A)-C(3A)-C(4A) 112.4(1) 111.9(4) N(2A)-C(3A)-C( 6A) 119.9(4) 
C(4A)-C(3A)-C(6A) 128.1(4) C(5 A)-C( 4A)-C(3A) 104.9(1) 106.2(4) 
N(1A)-C(5A)-C(4A) 106.9(1) 105.8(4) N(1A)-C(5A)-C(7A) 126.4(4) 
C(4A)-C(5A)-C(7 A) 127.7(4) N(2B)-N(1B)-C(5B) 112.2(3) 110.8(3) 
N(2B)-N(lB)-C(2') 120.0(1) 118.2(4) C(5B)-N(1B)-C(2') 127.8(1) 130.9(4) 
C(3B)-N(2B)-N(1B) 103.7(1) 105.3(4) N(2B)-C(3B)-C(4B) 112.4(1) 111.5(4) 
N (2B )-C(3 B )-C( 6B) 120.7(4) C( 4 B )-C(3B )-C( 6B) 127.8(4) 
C(5B)-C(4B)-C(3B) 104.9(1) 106.1(4) C(4B)-C(5B)-N(1B) 106.7(3) 106.3(3) 
C( 4B )-C( 5B )-C(7B) 128.8(4) N (1 B )-C( 5B )-C(7B) 124.8(4) 
Table 6.6. Selected torsional angles (0) for 144 and 145. 
144 
N(1)-C(2)-N(1A)-N(2A) 175.0(1) 
N(I)-C(2)-N( lA)-C(5A) 
C(3)-C(2)-N(1A)-N(2A) 
C(3)-C(2)-N(1A)-C(5A) 
C(3)-C(4)-C(4')-C(3') 
C(3)-C(4)-C(4')-C(5') 
C(5)-C( 4 )-C( 4')-C(3') 
C(5)-C( 4)-C( 4')-C(5') 
N(1')-C(2')-N(1B)-N(2B) 
N(1')-C(2')-NOB)-C(5B) 
C(3')-C(2')-N(IB)-N(2B) 
C(3')-C(2')-N(IB)-C(5B) 
154 155 
-2.4(2) 
-4.6(2) 
178.1(1) 
-147.3(1) 
30.9(2) 
30.7(2) 
-151.1(1) 
-171.9(1) 
7.1(2) 
6.6(2) 
-174.3(1) 
Figure 6.8. 
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145 
171.6(5) 
-16.2(8) 
-8.2(6) 
164.1(5) 
-147.4(5) 
34.9(7) 
32.2(7) 
-145.6(5) 
164.4(4) 
-20.5(8) 
-14.8(7) 
160.3(5) 
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The ligands crystallise with all inter-ring bonds in transoid conformations and with the 
pyrazole rings approximately coplanar with their attached pyridine rings. Table 6.6 lists the 
torsional angles for the inter-ring bonds. In the structure of 144, the meanplanes of the pyrazole 
rings are inclined to those of the pyridine rings at angles of 4.4(1) and 8.1(1t, whilst in 145, the 
corresponding angles 01.9(4) and 17.3(4)°) are greater, as a consequence of the sterlc bulk of 
the attached methyl group. However, the effect of the methyl group is considerably less than in 
the recently reported242 structures of I-methyl-4-phenylimidazole (154) (Figure 6.8) and its 1-
methyl-2-phenyl isomer (155), where in the first case the rings are nearly coplanar (7.3° twist) 
but in the second, the adjacent methyl group induces significant (32.3°) twisting about the inter-
ring bond. The present results seem to lend support to the suggestion that such compounds are 
stabilised by intramolecular C(Ar)-H· .. ·N hydrogen bonds, as has recently been proposed for a 
family of 9-azaphenyl-9H-carbazoles.243 The structurally related ligand 2,6-bis-(pyrazol-l-
yl)pyridine (156) has been the subject of a recent X-ray crystal structure determination, which 
showed that this also has the pyrazole rings attached to the pyridine ring in approximately (3.5°) 
coplanar transoid confonnations.244 In addition, the molecular packing of 144 seems to be 
controlled by a system of intermolecular C(Ar)-H ... N interactions, with the molecules packing 
in chains with the pyridine nitro gens interacting with pyrazole hydrogens of adjacent molecules. 
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The central (C(4)-C(4')) bond of both 144 and 145 exists in a transoid conformation with 
significant deviation from coplanarity of the two pyridine rings in both cases (Table 6.6). The 
meanplanes of the pyridine rings are inclined at an angle of 32.0(1)°, in the structure of 144, 
while in the structure of 145 the corresponding angle is 32.9(4)°. This contrasts with the 
structures of 25 in which the central pyridine rings are coplanar. 240 
Conjugation between the 1t-excessive azole ring and the 1t-deficient azine ring has been 
previously proposed to exist in azolylazine ligands. ll ,243 The structures of 144 and 145 provide 
experimental evidence for this proposal. In particular, the bonds linking the pyrazole rings to the 
pyridine rings (1.404(2) and 1,408(2)A in 144 and 1,408(5) and 1.391(5)A in 145) are short 
relative to those in structurally related compounds, such as I-phenylpyrazoles,245 and the rings 
do not deviate significantly from coplanarity, even in the case of 145 which possesses adjacent 
methyl substituents. This is consistent with donation of electron density from the pyrazole to the 
pyridine rings. The resulting polarisation of the pyridine rings would discourage conjugation 
between the central pyridine rings in 144 and 145 and account for the significant twisting about 
the central bond. The magnitude of this latter interaction must be sufficient to counteract the 
stabilisation energy associated with the 1t-1t stacking interactions observed in the planar 
structures of 25.240 It is relevant that in the structure of 156 the rings are coplanar with inter-
ring bond lengths of 1.406A; in this case the pyrazoles compete as electron donors. 
The syntheses of seven ruthenium complexes (157-163) of 144 are shown in Scheme 6,4. 
All complexes were prepared using analogous procedures to those already described for 
structurally related complexes and were characterised by mass spectrometry and 1 H NMR 
spectroscopy. Additionally, l3C NMR spectra were obtained for 159 and 160 and assigned by 
comparison with the spectra of the ligand and the complex Ru( 43)(bpy) 22+ .11 
The 1H NMR spectrum of the mononuclear complex 157 is shown in Figure 6.9, and 
consists of 28 non-equivalent protons. Pyrazole protons were readily distinguished on the basis 
of the smaller H3"-H4" (H3"'-H4"') coupling relative to that of H4"-H5" (H4"'-H5"') and 
assignments were confirmed with the aid of a 2D COSY spectrum (Figure 6.9). In particular, by 
correlations to H4" (6.88ppm) and H4'" (6.63ppm), the COSY spectrum allows the protons that 
are overlapped by other signals to be located unambiguously, namely H3" (7,43ppm), H3'" 
(7.87ppm) and H5'" (8.70ppm). A similar correlation from H4" locates H5" (9.01ppm). Turning 
to the pyridine protons of 144, the doublet at 7.76ppm and the doublet of doublets at 7.67ppm 
are clearly coupled, a..<; shown by raised intensity of the inner peaks in the IH NMR spectrum, 
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2+ 
and can be assigned as H6 and H5 respectively. Hence the remaining doublet of doublets can be 
assigned as H51 (7.71ppm) and correlated to the H6' doublet (S.69ppm) in the COSY spectrum. 
The protons H3 (8.50ppm) and H3' (8.44ppm) were distinguished by long-range correlation to 
H5 and H5' respectively, thus assigning all protons of 144. The COSy spectrum was also used 
to make tentative assignments of the spin systems of the bpy rings. 
The IH NMR spectrum of the dmb analogue, 158, was also a.<;signed with the assistance 
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Figure 6.9 IH NMR and 2D COSY Spectra of 157. 
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Table 6.7 IH NMR Chemical Shifts a of 144 and 157 and Coordination Induced Shifts b of 157. 
Ligand 144 Bpy Ligands 
H3 H5 H6 H3" H4" H5" H3 H4 H5 H6 
144 8.38 7.73 8.63 7.87 6.62 8.70 - - - -
157 8.50 7.67 7.76 7.43 6.88 9.01 8.55 8.11 7.44 7.82 
CISb +0.12 -0.06 -0.87 -0.44 +0.26 +0.31 8.58 8.14 7.48 7.85 
H3' H5' H6' H3'" H4'" H5'" 8.58 8.16 7.55 7.94 
157 8.44 7.71 8.69 7.87 6.63 8.70 8.58 8.16 7.50 8.03 
crs b +0.06 -0.02 +0.06 +0.00 +0.01 +0.00 - - -
Ligand 144 DmbLigands 
H3 H5 H6 H3" H4" H5" H3 H4c H5 H6 
158 8.60 7.65 7.77 7.41 6.87 9.06 8.43 2.59 7.27 7.63 
crs b +0.22 -0.08 -0.86 -0.46 +0.25 +0.36 8.41 2.60 7.32 7.65 
H3' H5' H6' H3'" H4'" H5'" 8.41 2.61 7.36 7.75 
158 8.42 7.76 8.65 7.86 6.61 8.67 8.41 2.62 7.34 7.83 
CISb +0.04 +0.03 +0.02 -0.01 -0.01 +0.03 - - -
a For deuterated acetonitrile solutions. b CIS = bcomplex-bligand. c Methyl group. 
of a 2D COSY spectrum, although in this case the spectrum was more complicated due to the 
overlap of H6 (7.77ppm), H5' (7.76ppm) and H5 (7.65ppm), with the dmbH6 protons, the latter 
of which are shifted upfield relative to the bpyH6 protons of 157. 
The spectra of 157 and 158 are summarised in Table 6.6. The C2'-NI'" bond remains in 
the transoid conformation of the free ligand and the non-coordinating rings are well removed 
from the site of metal chelation. Hence the CIS values for H3'-H6' and H3'"-H5'" are close to 
zero. As a consequence of metal chelation, the conformation about the C2-N 1" bond is now 
cisoid, which is reflected in the CIS values of H3 (+0.12 to +0.22ppm) and H5" (+0.31 to 
+0.35ppm) for both complexes. Ligand to metal a-donation and metal to ligand 7t-back-bonding 
of electron density, which also contributes to the deshielding of H5", is reflected in the CIS 
values for H4" (+0.25 to +0.26ppm), whilst the shielding of H6 (-0.86 to -0.87ppm) and H3" 
(-0.44 to -0.46ppm) are consistent with the effects of ring-current anisotropy. Finally, the slight 
shielding of H5 (-0.06 to -0.08ppm) results from a combination of a-donation and ring-current 
anisotropy. The larger CIS value for H4" (+0.26ppm), relative to that of H4 (+0. 13 ppm) in the 
spectrum of 146, is consistent with pyrazole being a 7t-excessive 1t-donor and hence a weaker 
7t-acceptor than pyridine. 
In 159, the bridging ligand is symmetrical about the 4,4' bond, as a consequence of 
coordination of a Ru(bpYh2+ group to each of the two bidentate sites of 144. This is reflected in 
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the 1 H NMR spectrum of the complex (Figure 6.10), which is simpler than the corresponding 
spectrum of 157 and consists of 22 non-equivalent protons (6 for Jl-144). The spectrum was 
assigned by comparison with the spectrum of 157 and the assignments confirmed by the ID 
TOCSY spectra in Figure 6.11. From the TOCSY spectra the bridging ligand protons were 
located unambiguously by irn!.diating H5" (trace I) and H5 (trace II), whilst the bpy protons were 
located by irradiating bpyH3 (trace III-V). As was the case for 157, a 2D COSY spectrum was 
used to assign the bpy spin systems, although, of course, this does not assign the stereochemical 
environment of the rings. The diastereoisomers of 159 are not resolved in the spectrum, unlike 
in the spectra of 121, where the metals are much closer together. 
J 
Figure 6.10 IHNMR spectrum of 159. 
IH NMR spectra were recorded for the two remaining diruthenium complexes 160 and 
161. The spectrum of 160 was completely assigned, in a similar manner to the assignment of 
157, by a 2D COSY spectrum, whilst the spectrum of the unsymmetrical complex, 161, was 
assigned by comparison with the spectra of 159 and 160, and with the assistance of ID TOCSY 
and 2D COSY spectra. 
Table 6.8 summarises the spectra of the homobinuclear complexes. The bonds between 
the pyrazole and pyridine rings are now cisoid, for each of the two pyrazolylpyridine subunits of 
144, as a consequence of metal chelation. The change in conformation, and the electronic and 
through-space effects of metal chelation, are reflected in the CIS values for the bridging ligand 
v ________ --___________ ..~~ ________ ~ 0.08 s 
_IV_ ...___ .-Jl_. _~MI~ ~~w_b-P-Y-Hj----__ ----------O-.04---S 
!~q. ______ ~_~-._ ••_."_,._.,. ___ ._~_m_.~ 
~...,.I,t""""'. w.w.. ... .. I-Wo'-.,..-.  u_-..... ~~,~, ~ __ """'r"'vt"Ui" l H3 H6 . ~ ._~ ••• _,,-•• _".. ~:~ ~: 
l' 
H3" H4" 
H5" 
~-4 . -.~ ....... ".-.. · ......... _ ....... _ ..___ ,,_ .. _. __ "' ...... __ ~ ..~ .. ~ ... ~)--."' __ .. ~I"......""!"'I"_.-........-____ -"" ... .....,~_.,D4_. __ S 
.~ J 
___ .. J '-____ _ uJl ____ l _ 
iii 1 I til 'I t i '\1 i I j I i \ tit iii I I f \ Iii J i. t ii' f I lit t lit i , f II i I I j f f I j ttl •• I' • i I I ' "\ , ' i 1 , I' , • Itt I I t I j t i it. i 4 t f \ I t \ i j \ • 1 I Itt • , ., \ • i' , , 
9.2 . 9.0 8.8 8.6 8.4 8.2 8.0 I.S 1.6 1.4 1.2 1.0 ppm 
Figure 6.11 1D TOCSY Spectra of 159 
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protons of 159-161. These factors have already been described in more detail for the 
coordinated rings of 157 and 158. The protons of 145 are generally slightly upfield in 160, 
relative to their chemical shifts in 159. This is consistent with the dmb ligands increasing the 
electron density on the ruthenium, which in turn increases the electron density of the bridging 
ligand by 1[-back-bonding. 
Table 6.8 IH NMR Chemical Shiftsa and Coordination Induced Shifts b of J-L-144 in 159, 160 and 
161. 
H3 ill H6 H3" H4" H5" 
144 8.38 7.73 8.63 7.87 6.62 8.70 
159 8.50 7.67 7.81 7.44 6.90 9.02 
CISb +0.12 -0.06 -0.82 -0.43 +0.28 +0.32 
160 8.39 7.66 7.81 7.42 6.89 8.91 
CISb +0.01 -0.07 -0.82 -0.46 +0.27 +0.21 
161 8.40 7.67 7.81 7.44 6.90 8.94 
CISb +0.02 -0.06 -0.82 -0.43 +0.28 +0.24 
H3' ill' H6' H3'" H4'" H5'It 
161 8.39 7.66 7.81 7.41 6.89 8.93 
CISb +0.01 -0.07 -0.82 -0.47 +0.27 +0.23 
a For deuteratcd acetonitrile solutions. b CIS = Ocomplex-Oligand. 
The UV/VIS absorption spectra of all the complexes show strong ligand centred 
absorptions at A<40Onm and MLCT absorption bands at A>400nm. The MLCT bands for the 
mononuclear complexes are symmetrical and, with maxima at 434nm (157) and 438nm (158), 
are at higher energy than the MLCT of Ru(bpyh2+ (451nm). The higher energy MLCT is 
consistent with ruthenium complexes of other pyrazole containing ligands such as 
Ru( 43) (bpyh2+ (442nm) 11 and the complex 87 described in chapter 2. A slight shift, of the 
MLCT, to lower energy is observed with the binuclear complexes (444-448nm), although this is 
not as pronounced as the shift of the MLCT (471nm) in 142)53 Coordination of the second 
Ru(bpYh2+ unit lowers the 1[* orbitals of the bridging ligand and, hence, the red shift indicates 
that the lowest energy MLCT of 159-161 is d1[-1[*(144). If the MLCT was d1[-1[*(bpy) a blue 
shift would be expected, due to the additional electrostatic energy required to remove the optical 
electron from the first metal to the bpy ligand and thus further away from the second metal. The 
small size of the red shift may indicate the LUMO of the mononuclear and binuclear complexes 
are localised on different ligands. 
Reduction of the free ligand 144 occurs at -1.80V, which confirms that the 1[* orbital of 
144 is at lower energy relative to the 1[* orbital of bpy (-2.18V). Redox potentials for 157-161 
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are summarised in Table 6.9, whilst the cyclic voltammograms of 157 and 159 are shown in 
Figure 6.12. The mononuclear complex 157 exhibits a reversible one electron oxidation 
(+1.24V) followed by four successive reversible one electron reductions (-1.40, -1.69, -1.84 and 
-2.17V). In line with the greater ease of reduction of 144, relative to bpy, the first reduction can 
be deemed to be localised on the ligand 144, with the second and third reductions localised on 
bpy. Hence, the complex is slightly easier to oxidise and slightly harder to reduce than 
Ru(bpy) 32+, with the Eox-red values (2.64 and 2.58V) consistent with the lowest energy MLCT's. 
The redox processes of 158 can be similarly assigned, with oxidation easier than in 157 due to 
metal d orbital stabilisation by the dmb ligands. The fourth reduction of 157 (-2.12) and 158 
(-2.17V) may correspond to a second reduction of 144, rather than a second bpy or dmb 
reduction. The ligand 144 is larger than bpy or dmb, in terms of the number of bonds. Hence, 
the coulombic repulsion, experienced by the second added electron, would be expected to be less 
for 144, than for bpy or dmb. 
Table 6.9 Absorption Maximaa and Redox Potentials b for 157-161. 
Amax Eox1 Eox2 Bred1 Bred2 Ered3 Bred4 Bred5 Eox-red 
Ru(bpy) 32+ 451 +1.27 -1.31 -1.50 -1.77 2.58 
157 434 +1.24 -1.40 -1.55 -1.77 -2.12 2.64 
158 438 +1.13 -1.45 -1.69 -1.84 -2.17 2.58 
142 471 +1.24 c (85mV) -1.10 -1.44 -1.57 -1.64 2.34 
159 444 +1.23 +1.29 -1.09 -1.51c -1.63 -1.86c,d 2.32 
160 448 +1.12 +1.18 -1.11 -1.56 -1.71 -1.91 -1.96 2.23 
161 446 +1.14 +1.27 -1.10 -1.73 e 2.24 
a In nanometres. bIn Volts versus SeE. cTwo electron. dIrreversible. e ""five electron 
In the cyclic voltammogram of 159 and 160, the oxidation process appears as a two 
electron wave (L),Ep=85m V) centred at 1.26 and 1.15V respectively. For the observed response, 
the simulations of Richardson and Taube227 reveal two individual one electron transfers 
(L).E1I2=56±3mV), indicating a weak metal-metal interaction for the complex analogous to that 
of 142.153 Analogous to 142, the weakness of the interaction can be attributed to rotation about 
the 4,4' bond which disrupts 7t system overlap of the 2-(1-pyrazolyl)pyridine subunits. The 
extent to which 7t system overlap is disrupted, is undoubtedly less than in 131, where the 
metal-metal interaction is negligible, due to rotation about two of the inter-ring bonds of the 
bridging ligand. In the crystal structures of 144 and 145, the 4,4' bond is transoid, as it is in the 
equivalent bond of both crystalline modifications of 25.240 Assuming this conformation in the 
metal complexes, the inter-metal separation has been estimated to be 11.2 A (using 
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CHEM3D-PLUS and the above crystallographic data). Furthennore, such calculations indicate 
that the metal-metal distance is relatively independent « 0.1 A variation) of this torsional angle. 
In contrast, the metal-metal distance of 131 was shown to vary significantly (12.8-13.6A) with 
the conformation of the bridge. 
~--------------~--------------~!. 
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Figure 6.12 Cyclic Voltammograms of 157 (top) and 159 (bottom) 
For the complex 161, the splitting of the oxidation potentials is greater (AE1I2=130mV) 
than in 159 and 160. The first oxidation correlates with the first oxidation of 160, whilst the 
second oxidation correlates with the second oxidation of. 159. Hence, oxidation of the 
Ru(dmbh2+ unit is easier than for the Ru(bpYh2+ unit, resulting in an apparent increase in the 
metal-metal interaction relative to 159 and 160. As was the case with 124 and 148, the d orbitals 
of the Ru(dmbh2+ unit are higher in energy than those of the Ru(bpYh2+ unit, due to the 
electron donating methyl groups of the dmb ligands which push additional electron density onto 
the metal. 
141 
The first reduction of each of the binuclear complexes (-1.09 to -1.11 V) occurs at a less 
negative potential than in the mononuclear complexes and may be attributed to reduction of the 
bridging ligand LUMO, which is stabilised, relative to the mononuclear complexes, by back-
bonding to the second ruthenium. This also confirms the weak metal-metal interaction and 
correlates with the red shift in the MLCT. Further reductions of 159 occur as a reversible two 
electron reduction (-1.51V, LlEp=85mV), reversible one electron reduction (-1.63V) and an 
irreversible two electron reduction (-1.86V). The corresponding reductions of 160 occur as a 
succession of reversible one electron processes (-1.56, -1.71, -1.91,-1.96V). The difference 
between the first and second reductions for both these complexes is in agreement with the 
relationship of Cooper et. al.,224 which correlates the difference in the first and second bridging 
ligand reductions with the number of bonds in the bridging ligand. Hence, the second reduction 
of 160 can be assigned to the bridging ligand, whilst successive reductions are dmb centred. 
Bpy is more easily reduced than dmb. Thus for 159, the second reduction of the bridging ligand 
and the first bpy reduction occur as a two electron reduction (-1.51V, LlEp=85mV). The second 
reduction of 144 in 161 occurs as part of a multi electron wave centred on -1.73V (LlEp=26OmV). 
The syntheses of two heterobinuclear complexes were shown in Scheme 6.4. The 
complexes 162 and 163 were readily prepared by reacting the corresponding monoruthenium 
complex with one equivalent of Pd(PhCNhCI2' The IH NMR spectrum of 162 consists of 28 
non-equivalent protons (Figure 6.13) and is summarised in Table 6.10. Compared to the 
spectrum of 157, the proton signals for the bridging ligand are well spread, due to the different 
coordination environments of the two metals. Figure 6.14 demonstrates the unambiguous 
assignment of all four spin systems of the bridging ligand, in the 1 H NMR spectrum, by four 
separate 1D TOCSY irradiations of H6' (trace I), H5 (trace II), H5" (trace III) and H5'" 
(trace IV), thus locating the spin systems for each of the four rings. A 2D COSY spectrum, 
similar to that shown in Figure 6.9, was used to assign the bpy ring spin systems. The IH NMR 
spectrum of 163, the drnb analogue of 162, was assigned in a similar manner to the spectrum of 
162 using 1 D TOCSY and 2D COSy spectra. 
The effect of the coordination environment of the Ru(bpYh2+ has already been described 
in detail for the coordinated ring protons of 157 and 158. Similar coordination induced shifts for 
H3-H6 and H3"-H5" are observed for 162. The rings coordinated to palladium exhibit different 
coordination induced shifts. The CIS values of H3'-H6' and H3'I-H5"' generally reflect the (j-
donation of electron density from ligand to metal, although the protons H6' (+0.51 ppm) and H3 111 
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(+0.32ppm) are further deshielded by adjacent chlorine atoms, whilst chelation induced 
conformational changes contribute to CIS values of H3' (-0.09ppm) and H5" (to;05ppm). 
Figure 6.13 IH NMR Spectrum of 162. 
Table 6.10 1 H NMR Chemical Shiftsa of 144 and 162. Coordination Induced Shiftsb.of 162 
Ligand 144 Bpy Ligands 
H3 H5 H6 H3" H4" H5" H3 H4 H5 H6 
144 8.38 7.73 8.63 7.87 6.62 8.70 - - - -
162 8.53 7.72 7.85 7.45 6.91 9.00 8.54 8.12 7.45 7.81 
CISb +0.15 -0.01 -0.78 -0.42 +0.29 +0.30 8.57 8.14 7.48 7.83 
H3' H5' H6' H3'" H4'" H5'" 8.57 8.14 7.54 7.93 
162 8.29 7.96 9.14 8.19 6.92 8.75 8.57 8.16 7.52 8.02 
CISb -0.09 +0.23 +0.51 +0.32 +0.30 +0.05 - - -
a For deuterated acetonitrile solutions. b CIS = Ocomplex-Oligand. 
UV NIS absorption spectra for the two heterobinuclear complexes show strong ligand 
centred transitions (A<400nm) and an MLCT transition (A>400nm). The MLCT absorptions are 
symmetrical (162=442nm, 163=448nm) and exhibit a very slight red shift, relative to the 
corresponding mononuclear complex, thus implying a weak: metal-metal interaction. 
Four complexes (164-167) were prepared from the ligand 145 using procedures 
analogous to those previously described for ruthenium complexes in this work (Scheme 6.5). 
All complexes were characterised by mass spectrometry and 1 H NMR spectroscopy. 
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The 1 H NMR spectrum of 164 is similar to that of 157, except that the pyrazole H3 and 
HS protons are absent from the aromatic region. The spectrum comprises 36 non-equivalent 
signals (24 in the aromatic region). The methyl groups of 145 were readily distinguished on the 
basis of the broadening of the S"-CH3 (2.98ppm) and S"'-CH3 (2.71ppm) singlets, relative to the 
3"-CH3 (l.S8ppm) and 3"'-CH3 (2.29ppm) singlets. Furthermore, whilst S"-CH3 is deshielded 
(+O.27ppm) due to both the cr -donation of electron density from the 7t-excessive pyrazole to the 
metal, and the change in conformation about the C2-N1" bond, the 3"-CH3 lies over a pyridine 
ring and is shielded (-O.74ppm). This bond is transoid, as shown in the crystal structure of the 
free ligand, but cisoid in 164, as a consequence of metal chelation. The aromatic region of the 
spectrum was assigned using a 2D COSY spectrum. The most downfield doublet at 8.64ppm 
was assigned as H6' and was found to correlate with the doublet of doublets at 7.60ppm, thus 
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locating H5'. The coupling of the disubstituted pyridine ring differs from that of the bpy 
pyridine rings and allows the doublet H6 (7.71ppm) and doublet of doublets H5 (7.54ppm) to be 
distinguished from overlapping bpy protons. The COSY spectrum confitmed this assignment by 
an observed correlation between H5 and H6. Long-range correlation from H5' located H3' 
(8.20pp), which is overlapped by bpyH4 signals. Similarly, H3 (8.54ppm) was correlated to H5, 
whilst the spin systems of the bpy rings were also assigned by the COSY spectrum. 
The chemical shifts and CIS values are summarised in Table 6.11. Coordination induced 
shifts for the methyl groups have already been explained. In general, the remaining protons 
exhibit shifts consistent with ligand to metal a-donation and metal to ligand It-back-bonding of 
electron density, although ring current anisotropy accounts for the shielding of H6 and, to a 
lesser extent H5, whilst chelation induced conformational changes contribute to H5" and ill. 
Table 6.11 IH NMR Chemical Shiftsa of 145 and 164. Coordination Induced Shiftsb.of 164 
Ligand 145 Bpy Ligands 
H3 H5 H6 3"-CH3 H4" 5"-CH3 H3 H4 H5 H6 
145 8.20 7.63 8.59 2.32 6.15 2.71 - - - -
164 8.54 7.54 7.71 1.58 6.46 2.98 8.56 8.06 7.44 7.70 
CISb +0.34 -0.09 -0.88 -0.74 +0.31 +0.27 8.58 8.09 7.41 7.83 
H3' H5' H6' H3'" H41l1 H5"' 8.58 8.20 7.54 7.96 
164 8.20 7.60 8.64 2.29 6.16 2.71 8.58 8.15 7.57 8.06 
CISb +0.00 -0.03 +0.05 -0.03 +0.01 +0.00 - - -
a For deuterated acetonitrile solutions. b CIS = Bcomplex-Bligand. 
The 1 H NMR spectrum of the binuclear complex 165 is less complicated than that of 
164, since the ligand is symmetrical about the 4,4'-bond, when in the bridging mode. The 
bridging ligand protons were assigned by comparison with the spectrum of 164. These 
assignments were confirmed by a 2D COSY spectrum, which was also used to locate the spin 
systems of the bpy rings. Similarly, the 1 H NMR spectrum of 166 was completely assigned by 
comparison with the spectrum of 164 and with the assistance of a 2D COSY spectrum. The 1 H 
NMR spectra of 165 and 166 are summarised in Table 6.12. 
The diastereoisomers were not resolved in the spectra of the binuclear complexes. 
However, the mUltiplicities of the dmbH6 at 7.85ppm and the bpyH6 at 8.05ppm are not 
consistent with the normal doublet of the peripheral ligand. In fact the protons appear as two 
partially overlapping doublets. A similar effect was observed in the IH NMR spectrum of 131 
and may imply some resolution of the two diastereoisomers. The effects which account for the 
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CIS values of the coordinated rings in 164 also account for the CIS values of the bridging ligand 
protons of 165 and 166. 
Table 6.12 IH NMR Chemical Shiftsa of 145, 165 and 166. Coordination Induced Shiftsb.of 165 
and 166. 
Ligand 145 Ligand=L 
H3 H5 H6 3 "-CH3 H4" 5"-CH3 H3 H4 H5 H6 
145 8.20 7.63 8.59 2.32 6.15 2.71 
-
- - -
165 8.15 7.49 7.72 1.58 6.47 2.96 8.56 8.12 7.43 7.69 
CISb -0.05 -0.14 -0.87 -0.74 +0.32 +0.25 8.56 8.08 7.41 7.82 
8.58 8.17 7.52 7.93 
8.58 8.16 7.54 8.06 
166 8.16 7.49 7.71 1.59 6.46 2.96 8.41 2.55c 7.27 7.49 
CISb -0.04 -0.14 -0.88 -0.73 +0.31 +0.25 8.41 2.57c 7.24 7.61 
8,41 2.61c 7.33 7.73 
8.41 2.63c 7.38 7.85 
a For deuteratcd acetonitrile solutions. b CIS:;:: Ocomplex-Btigand. c Methyl group not assigned. 
UV /VIS absorption spectroscopy and cyclic voltammetry can be used to probe the 
electronic properties of the complexes 164-166 (Table 6.13). In general, the UVIVIS spectra 
show LC (A<400nm) and MLCT (A>400nm) absorption bands. For the mononuclear complex 
164 the MLCT occurs at 430nm and is symmetrical. Coordinating a second Ru(bpYh2+ unit 
results in a slight red shift of the MLCT (448nm), by lowering the bridging ligand LUMO, thus 
indicating a weak metal-metal interaction. 
The effect of the methyl groups of the pyrazoles can be seen in the oxidation potentials of 
164-166 and is analogous to the effect of the methyl groups of dmb ligands, as previously 
described. For example, in 164, the energy of the d orbital is raised relative to 157, as shown by 
the greater ease of oxidation (by 0.06V) of complex. Similarly, 165 and 166 are easier to oxidise 
than 159 and 160 respectively. It has been previously noted for structurally related complexes 
that methyl groups decrease oxidation potentials by approximately 0.025V per methyl group.I80 
The mononuclear complex also exhibits four reversible one electron reductions, the first 
of which was assigned to reduction of 145, whilst the second and third reductions are bpy 
centred. This assignment was based on the free ligand ligand reduction (-1.87V), which implies 
that 145 has low lying 1t* orbitals relative to bpy (-2.18V). Analogous to 157 and 158, the 
fourth reduction was assigned to 145. 
The binuclear complex 165 exhibits a reversible two electron oxidation centred at 
+1.18V (Lllip=85mV). For 166, the process is similar, but is centred at +1.llV (Lllip=85mV), as 
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a consequence of the peripheral dmb ligands. Thus, as was shown for the binuclear complexes 
147, 159, and 160 already described and which incorporate a 4,4'-bipyridine bridge, oxidation of 
this complex involves two individual one electron transfers with a value for ~112 of 56±3mV. 
Hence, a weak metal-metal interaction occurs via the 1t system of the bridge, with rotation about 
the 4,4'-bond disrupting overlap of the 1t systems of the subunits. Values shown for Eoxl and 
Eox2 were also calculated from the working curves of Richardson and Taube.227 Molecular 
modelling studies (Chern 3D Plus) gave an estimate of the metal-metal distance as ILIA. This 
value was found to vary less than o.lA between the cisoid and transoid conformations of the 
bridge. 
T bl 6 13 Ab a e sorptIOn M . a dR d P . I b f 164 166 aXlma an e ox . otentla s or -
"'max Eoxl Eox2 Eredl Ered2 Ered3 Ered4 Ered5 ~ox-red 
Ru(bpy) 32+ 451 +1.27 -1.31 -1.50 -1.77 2.58 
157 434 +1.24 -lAO -1.55 -1.77 -2.12 2.64 
164 430 +1.18 -1043 -1.57 -1.80 -2.17 2.61 
159 444 +1.23 +1.29 -1.09 -1.52c -1.63 -1.86d 2.32 
160 448 +1.12 +1.18 -1.11 -1.56c -1.71 c -1.91 2.23 
165 448 +1.15 +1.21 -1.14 -1.52c -1.71 -1.82c 2.29 
166 452 +1.08 +1.14 -1.15 -1.54c -1.68 -1.78 -1.93 2.22 
a In nanometres. bIn Volts versus SeE. cTwo electron. dlrreversible. 
Further evidence of the weak metal-metal interaction, can be seen in the shift to less 
negative potentials of the first reduction, which corresponds to reduction of the bridging ligand 
LUMO. Back-bonding to the second Ru(Lh2+ unit lowers the energy of the bridging ligand 
LUMO resulting in easier reduction of the complex and, as shown above, a red shift in the 
MLCT. Since the difference between the first and second reduction potentials correlates with 
the relationship of Cooper et. al.,224 the two electron process, at -1.52V (~p=lOOmV) for 165 
and -1.54 V (6.Ep=90m V) for 166, probably includes the second reduction of the bridging ligand. 
Further reductions are most likely centred on the peripheral ligands. 
Complex 167 was synthesised from 164 as shown in Scheme 6.5. The IH NMR 
spectrum of 167 was tentatively assigned, by comparison with the spectra of 162 and 164 and 
the CIS values for the bridging ligand protons were found to be similar to those of 162. 
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Conclusion 
In this work the use of new and known heterocycles as bidentate ligands has been 
described, with particular emphasis on binucleating ligands. The majority of the complexes 
synthesised have been of ruthenium(II), although for some of the ligands molybdenum(O), 
palladium(II), copper(I), copper(II) and nickel(II) complexes have been synthesised. 
The metal to ligand interactions in the complexes are governed by the specific metal and 
ligand involved. The ligands described here have quite different n-donor/acceptor properties 
compared with bpy. Hence the properties of their ruthenium complexes are significantly 
modified relative to those of Ru(bpYh2+. These properties have been examined by UVNIS 
absorption spectroscopy and cyclic voltammetry. Furthermore, the substituted bipyrimidines 
and 2,4-bis-(1-pyrazolyl)pyrimidine have demonstrated that ligand structure can limit both the 
selection of coordination sites available for metal chelation, and the coordination geometry of 
the metaL 
1 H NMR spectroscopy has been shown to be a useful tool in the characterisation of 
ruthenium complexes, and as a means to probe the specific ligand-metal interactions and deduce 
the structure of such complexes. Proton Coordination Induced Shifts (CIS) due to coordination 
induced conformational changes, inter ligand through-space ring-current anisotropy and ligand 
to metal (j donation and metal to ligand n back-donation have been described for most of the 
complexes. Calculation of such values requires the unambiguous assignment of the IH NMR 
spectrum. For many of the complexes, the spectrum ha'i been simplified by replacing the bpy 
ligands with dmb ligands, which removes any overlap of signals and coupling due to the bpyH4 
proton. In some cases this has allowed complete assignment of the ligand protons, making this 
technique a much cheaper alternative to the use of ds-bpy. More often than not, 1D TOCSY or 
2D COSY spectra were required to assign, or confirm the assignment of, the ligands in the 
complexes. In this respect, the 1D TOCSY is particularly useful since the assignment of 
complete spin systems can be achieved if only one proton of that spin system is isolated in the 
spectrum. This was shown most clearly in the lD TOCSY spectrum of 121 in which irradiating 
the two isolated protons of the bridging ligand 109 located the remaining protons amongst the 
mass of overlapping bpy signals. 
By using a range of different bridging ligands this study has clearly shown the 
dependence of metal-metal interactions on the inter-metal separation in binuclear complexes. 
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For the binuclear complexes of the series of ligands 40, 109, 132, 144, 145, 25 and 110, the 
inter-metal separation increases in the order shown. The interaction in each case has been 
probed by UV/VIS absorption spectroscopy and cyclic voltammetry. In the absence of 
electronic coupling via the bridging ligand, the metal centres undergo oxidation at nearly the 
same potential, as was the case for the biruthenium complex, 131, of the ligand 110, in which the 
flexible bridge holds the two metals at a distance of 12.8-13.6A. Any metal-metal interaction 
leads to asymmetry and the existence of discrete oxidation waves for each metal centre, with the 
splitting of the waves (LlE1f2) and hence, the degree of metal-metal interaction, decreasing with 
increasing separation of the metals. Figure 7.1 shows the expansion of the oxidation waves for 
three of the biruthenium complexes included in this study. The inter-metal separation in the 
complexes increases from top to bottom in the figure. A similar trend has been observed in the 
magnitude of the red shift of the lowest energy MLCT (dn-n*(BL)) for binuclear complexes. 
Metal-metal interactions are not exclusively controlled by the distance between the 
interacting metals but also depend on a number of other factors which are significant to the 
complexes described in this study. For example, the weak interaction in the binuclear complexes 
of 25, 110, 144 and 145 is due in part to the disruption of bridging ligand conjugation by rotation 
about inter-ring bonds. Furthermore, the methyl groups of 40 increase the electron density of the 
bridge in the complex 64 and account for the greater stabilisation of the mixed valence state 
relative to the complex 38, for which the inter-metal separation (5.8;\) is the same. 
Mechanisms for metal-metal interactions, in the form of either an Electron-type 
Superexchange or a Hole-type Superexchange process, have been discussed in recent 
publications. 225 ,246,247 Which mechanism occurs depends on the relative energies of ligand 
LUMO, HOMO and metal d orbitals (Figure 7.2). Electron-type Superexchange, in which 
mixing between the ligand n*-LUMO and the metal d orbitals is the major contribution to the 
metal-metal interaction, occurs when the bridging ligand has low-lying n* orbitals. Where the 
low-lying n* orbitals of the bridging ligand are replaced by electron-rich high-lying n* orbitals, 
the mechanism occurs by Hole-type Superexchange, which is attributable to an electronic 
interaction of the ligand n-HOMO and metal d orbitals. Furthermore, within each mechanism 
the degree of metal-metal interaction depends on the relative energies of the mixing ligand and 
metal orbitals. Thus the metal-metal interaction in 121, which occurs via Electron-type 
Superexchange, is smaller (l60mV, 6.2;\) than in (bpy)zRu(15)Ru(bpy)z4+ (l70mV, 6.7A), due 
to the higher energy of the n* orbitals of 109 relative to 15. 
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Figure 7.1 Oxidation Waves for 121 (top), 139 (middle) and 159 (bottom). 
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The type of spectator ligand that is used in binuclear complexes may also affect the 
metal-metal interaction. The unsymmetrical complexes (bpyhRu(BL)Ru(dmbh4+ (where 
BL=25, 109 and 144) show a larger value for Lllill2 than the corresponding symmetrical 
complexes, since the Ru(dmbh2+ unit is more readily oxidised than the Ru(bpYh2+. This has 
highlighted the role that spectator ligands have to play in such systems as the degree of 
interaction can also be controlled by the appropriate choice of spectator ligand. A recent 
comprehensive review225 has proposed that the strong modification of metal-metal interactions, 
by variation of the spectator ligands, may have important consequences for controlling such 
interactions in multinuclear compounds and for the design of systems featuring switchable 
electron and energy transfer processes. 
In summary the degree of metal-metal interaction in bridged binuclear complexes 
depends on the distance between the metals, the ability of the ligand to delocalise the electronic 
charge, the relative energy of ligand HOMO/LUMO and metal d orbitals, the specific 
mechanism involved and identity of the spectator ligands. The present work has demonstrated 
that it is possible to modify or tune the metal-metal interactions in binuclear complexes, by the 
appropriate choice of bridging and spectator ligands and hence, in much the same way that the 
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properties of Ru(bpy) 32+ have been tuned, in recent years, by replacement of one or more of the 
bpy ligands by a different heterocyclic ligand. 
Metal-metal interactions govern the rate of electron and energy transfer between the 
metal units and the electrochemical properties of the binuclear complexes. The complexes 
described here are potential building blocks for photochemical and electrochemical devices. 
These supramolecular assemblies are one of the greatest challenges facing modern chemistry20 
and control of metal-metal interactions is crucial to the design of such systems. The choice of 
bridging ligands, including those described here, is now extensive enough to allow the synthesis 
of polynuclear complexes with desired 'tailor-made' properties. 
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Experimental 
8.1. General Experimental 
NMR spectra were recorded on a Varian 300 Unity spectrometer with a 5mm or 3mm 
probe and operating at 300MHz and 75MHz for 1H and 13C, respectively. Spectra recorded in 
CDCl3 were referenced relative to internal Me4Si and those recorded in d6-DMSO, (CD3hCO and 
CD3CN were referenced against the solvent signals. When required, nOe, ID TOCSY and two 
dimensional experiments (COSY, HMQC, HMBC) were performed using standard pulse 
sequences and parameters available with the Unity 300 system. UVNIS absorption spectra were 
recorded using a Perkin Elmer Lambda 2 spectrometer for acetonitrile or acetone solutions. 
Molecular modelling was performed on a Macintosh computer using the modelling package 
CHEM 3D Plus™. Ru-N bond distances were assigned an optimum value of 2.06A. 
Cyclic voltammetric measurements were made using either a Par Model 174A polarographic 
analyser coupled to a Par Model 175 universal programmer or a Par Model 173 potentiostat 
coupled to a home-built waveform generator. Measurements were made of solutions containing ca 
1 mM complex in acetonitrile with 0.1 M tetrabutylammonium hexafluorophosphate as the 
supporting electrolyte, using a scan rate of 100 mV s-l (unless otherwise stated) and a glassy 
carbon disk working electrode (area = 0.07 cm2). Ferrocene was used as an internal standard and 
potentials are given versus the saturated calomel electrode (E0t(Fc+lFc) = 0.31 V vs SCE). 
Melting points were determined using an Electrothermal melting point apparatus and are 
uncorrected. Mass spectra were recorded using a Kratos MS80RFA spectrometer with a Mac 3 
data system. Electron Impact spectra were obtained at 70eV with a source temperature of 150°C. 
Fast Atom Bombardment (FAB) spectra were acquired in a nitrobenzyl alcohol matrix using an 
Iontech ZN11FW FAB gun operated at 8KVand 2mV. Elemental analyses were performed by 
the Chemistry Department, University of Otago, Dunedin. 
Radial chromatography was performed on a Chromatotron (Harrison and Harrison) using 
Merck type 60 P.F.254 silica geL Column chromatography was performed with silica gel (grade 
923 lOO-20Omesh), alumina (Grade H 100-200mesh , neutral 100-240 mesh, acidic 150mesh) or 
sephadex-SP C-25 ion exchange resin (40-120)..l) Solvents were purified according to standard 
literature procedures.24S,249 Unless otherwise stated reagents were obtained from commercial 
sources. Ru(bpYhC12,250 Ru(dmbhCI2,251 Ru(DMSO)4Cb,252 Pd(PhCNhCb,253 
Ni(PPh3hCh202 and MO(1l4_C7Hs)(CO)4191 were prepared by literature procedures. Formyl 
camphor254 was prepared by Andrew Watson in this department. 
8.2. Syntheses of Ligands. 
4,41-Dimethyl-2,21-hipyrimidine (40). 
Step 1. 
2-Chloro-4-methylpyrirnidine (56). 
The method of Bennett et al. I88 for the diazotisation of 68 (see later) was applied to 2-
amino-4-methylpyrimidine (54). Accordingly, 54 (5g, 46mMol) was added to concentrated 
hydrochloric acid (30ml) cooled below O°C. Whilst maintaining the temperature at -10°C an 
aqueous solution (l5ml) of sodium nitrite (4g, S8mMol) was added dropwise and the resulting 
mixture left to stir at -10°C for 3 hours. The mixture was neutralised with NaOH, allowed to 
warm to room temperature and extracted with chloroform (3x30ml). The chloroform extracts 
were combined, dried over magnesium sulphate and the chloroform removed in vacuo. The 
resultant yellow solid was dissolved in chloroform (l-2ml) and absorbed onto a silica gel 
chromatography plate. The chloroform fraction was evaporated to give 56 as a clear oil which 
solidified on standing. Yield 2.4Sg (41 %) Mp 48-S0°C. Lit. 48-S0°c.255 IH NMR (CDCI3) 0: 
2.S5 (3H), 4-CH3; 7.14, H5; 8.48, H6. 13C NMR (CDCh) 0: 24.0, 4-CH3; 119.4, C5; 
1S8.9, C6; 161.1, C2; 170.8, C4. The methanol/chloroform (1: 10) fraction gave 2-hydroxy-4-
methylpyrimidine (55) as a yellow solid. Yield 1.0g (20%). This solid (9mMol) was added 
slowly to POCb cooled in ice. The resultant mixture was refluxed for 2 hours, cooled and the 
solvent removed in vacuo. The residue was carefully treated with ice, made alkaline with 
aqueous ammonia and extracted with chloroform. The chloroform fraction was purified by 
chromatography as described above to give additional 56. Yield 0.8g (69%). 
Step 2. 
4,4'-Dimethyl-2,2'-bipyrimidine (40). 
The complex NiO(PPh3h was generated in situ using the 
method of Nasielski et al. 189 A mixture of nickel chloride (0.92g, 
3.9rnMol), triphenylphosphine (4.03g, lS.6mMol) and zinc dust 
(0.36g, S.55mMol), in dry dimethylformamide (20ml), was 
stirred at SO°C under an argon atmosphere. After 1 hour, a 
solution of 56 (0.5g, 3.9InMol) in dimethylformamide (Sml) was 
6 N NJ 5( H ~ 5' IN N- 6' 
40 
added under an argon atmosphere and the mixture left to stir at SO°C for a further 12 hours. The 
resultant brown mixture was poured into aqueous ammonia (80ml, 2M), filtered to remove the 
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precipitate of triphenylphosphine oxide, and the filtrate extracted with chloroform (4x60rnl). The 
chloroform extracts were combined, dried over anhydrous potassium carbonate and concentrated 
(I-2ml), in vacuo. The solution was absorbed onto a silica gel radial chromatography plate and 
el uted with ethyl acetate/petroleum ether (3: 1) to remove excess triphenylphosphine. Compound 
40 was eluted with chloroform and the solvent removed in vacuo to give a white solid. Yield 
163mg (45%). Mp 98-99°C. Calcd for ClOHlON4 C: 64.45, H: 5.41, N: 30.09. Found C: 
63.69, H: 5.42, N: 30.09. Mass spectrum: M+· ca1cd for ClOHlON4: 186.0905. Found: 
186.0904. IH NMR (CDCb) b: 2.74 (6H), 4-CH3; 7.30 (2H), H5; 8.87 (2H), H6. IH NMR 
(CD3CN) b: 2.64 (6H), 4-CH3; 7.42 (2H), H5; 8.83 (2H), H6. IH NMR (DMSO-d6) b: 2.66 
(6H), 4-CH3; 7.61 (2H), H5; 8.91 (2H), H6. 13C NMR (CDCI3) b: 24.1 (2C), 4-CH3; 121.0 
(2C), C5; 157.5 (2C), C6; 162.4 (2C), C2; 168.5 (2C), C4. 13C NMR (CD3CN) b: 23.7 (2C), 
4-CH3; 121.0 (2C), C5; 157.6 (2C), C6; 163.5 (2C), C2; 168.3 (2C), C4. 
4,4' -Bis-t-hutyl-2,2' -hipyrimirline (41). 
Step 1. 
B is-( 4 ,4-dimethy I pentane-I, 3-dionato )copper(II) (67). 
This compound was prepared from pinacolone (66) by the method of Brown et al.200 
Step 2. 
2-Amino-4-t-butylpyrirnidine (68). 
This compound was prepared from 67 by the method of Clark et al.201 
Step 3. 
2-Chloro-4-t -buty lpyrimidine (70). 
As described by Bennett et al.,188 2-amino-4-t-butylpyrimidine (67) (0.91g, 6.0mMol) 
was added to concentrated hydrochloric acid (5ml) cooled below O°C. Whilst maintaining the 
temperature at -lOoC, an aqueous solution (2ml) of sodium nitrite (0.53g, 7.6mMol) was added 
dropwise and the resulting mixture left to stir at -lOoC for 1.5 hours. The mixture was neutralised 
with NaOH, allowed to warm to room temperature and extracted with chloroform (3xlOml). The 
chloroform extracts were combined, dried over magnesium sulphate and the chloroform removed 
in vacuo to give an oil. The oil (in 1-2ml of chloroform) was absorbed onto a silica gel column 
(IOx2cm) and the column eluted with chloroform. Evaporation of the chloroform fraction gave 
41 as a clear oiL Yield 0.36g (35%). IH NMR (CDCI3) b: 1.35 (9H), CH3; 7.26, H5; 8.52, 
H6. The chloroform/methanol (10:1) fraction gave 2-hydroxy-4-(t-butyl)pyrimidine (69) as a 
white solid. Yield 0.20g (22%). Mp 191-193°C. Lit. 194-195°c.188 The compound 69 
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(0.20g, 1.3rnMoI) was added to POCl3 cooled in ice. The resultant mixture was refluxed for 2 
hours, cooled and the solvent removed in vacuo. The residue was carefully treated with ice, 
made alkaline with aqueous ammonia and extracted with chloroform. The extract was dried over 
anhydrous MgS04, concentrated and chromatographed as described above. Evaporation of the 
chloroform fraction gave 70. Yield 45mg (27%). 
Step 4. 
4,4'-Bis-t-butyl-2,2'-bipyrimidine (41). 
A blue solution of Ni(PPh3hCI2 (750mg, 1. 15rnMol), 
PPh3 (601mg, 2.30rnMol), in dry dimethylformamide (20mI), 
was treated with zinc dust (77mg, 1.18rnMol) and stirred for 1 
hour, under a nitrogen atmosphere. During this time the colour 
changed to green, yellow and finally to red. 2-Chloro-4-t-
butylpyrimidine (70) (I96mg, 1.15mMol) was added to the red 
mixture which was stirred for 40 hours. The mixture was poured 
into water (35ml), boiled for 5 minutes and filtered. The filtrate was treated with ammonium 
hexafluorophosphate and the resultant white precipitate filtered and dissolved in 2: 1 
acetonitrile/water (I5ml). Potassium cyanide (I77mg) was added to the solution which was then 
refluxed briefly, cooled and extracted with chloroform (3xI5ml). The extracts were combined 
and the chloroform removed in vacuo. The residue was dissolved in concentrated hydrochloric 
acid (5ml) , extracted with chloroform (3x5ml) to remove triphenylphosphine, then made alkaline 
with aqueous NaOH (2M) and re-extracted with chloroform (3xlOml). The final extracts were 
combined, whereupon evaporation of the solvent gave 41 as an off-white solid, which was 
recrystallised from ethanoIjether. Yield 30mg (9.6%). Mp 114-115°C. Mass spectrum: M+· 
calcd for C16H22N4: 270.1844. Found: 270.1840. IH NMR (CDCI3) 3: 1.48 (I8H), CH3; 
7.45 (2H), H5; 8.91 (2H), H6. l3C NMR (CDCI3) 3: 29.8 (6C), CH3; 38.6 (2C), C(CH3)3; 
117.0 (2C), C5; 156.1 (2C), C6; 163.1 (2C), C2; 179.2 (2C), C4. 
2,2' -Bi-(SS,8R)-S,6, 7 ,8-tetrahydro-8,9,9-trimethyI-
S,8-methanoquinazoline (42). 
Step 1. 
2-Amino-(5S,8R)-5,6,7,8-tetrahydro-8,9,9-trimethyl-5,8-methanoquinazoline (74). 
A mixture of formyl camphor (73) (3.0g, 17rnMol) and guanidine carbonate (1.5g, 
12rnMol) was heated for 1 hour at 120°C. The reaction melt was cooled and ethanol (20mI) 
1S9 
added to give a precipitate of crude 74, which was filtered on a fine porosity funnel. Further 
extraction of the precipitate on the funnel with ethanol (3x20ml) gave 74 as a white solid. Yield 
1.0Sg (89%). 
Step 2. 
2-Chloro-( SS,8R)-S,6, 7 ,8-tetrahydro-8,9,9-trimethy 1-S,8-methanoquinazoline (76). 
The amine 74 (1.0Sg, S.17mMol) was added to concentrated hydrochloric acid (Sm]) 
cooled below o°c. Whilst maintaining the temperature below -1 O°C, an aqueous solution (2ml) of 
sodium nitrite (0.46g, 6.67mMol) was added dropwise, and the resultant mixture left to stir at 
-lOoC for 1.S hours. The mixture was neutralised with NaOH, allowed to warm to room 
temperature and extracted with chlorofonn (3x lOml). The combined extracts were concentrated 
(l-2ml) in vacuo and absorbed onto a silica gel radial chromatography plate, which was eluted 
with chlorofonn to give two bands. The first band was collected, and the solvent removed in 
vacuo, to give 76 as a clear oil, which crystallised on standing. Yield O.SSg (48%). Mp 84-
86°C. Mass spectrum: M+· calcd for C12HlSN2CI: 222.0924. Found: 222.0924. IH NMR 
(CDCb) 0: 0.60 (3H), syn-9-CH3; 1.03 (3H), anti-9-CH3; 1.17, endo-H6; 1.2S, endo-H7; 1.30 
(3H), 8-CH3; 1.96, exo-H7; 2.19, exo-H6; 2.9S, HS; 8.22, H4. The second band was collected 
and the solvent removed in vacuo to give 2-hydroxy-(SS,8R)-S,6,7,8-tetrahydro-8,9,9-trimethyl-
S,8-methanoquinazoline (75). Yield 0.32g (30.3%). Mp 213-21SoC. Mass spectrum: M+· calcd 
for C12H16N20: 204.1263. Found: 204.1261. IH NMR (CDCb) 0: 0.70 (3H), syn-9-CH3; 
1.01 (3H), anti-9-CH3; 1.16, endo-H6; 1.38, endo-H7; 1.24 (3H), 8-CH3; 1.90, exo-H7; 2.12, 
exo-H6; 2.78, HS; 7.44, H4. Compound 75 (0.30g, 1.47mMol) was refluxed in POCl3, as 
described above for 55 and 69, to give additional 76. Yield 18Smg (S7%). 
Step 3. 
2,2'-Bi-(SS,8R)-S,6,7,8-tetrahydro-8,9,9-trimethyl-S,8-methanoquinazoline (42). 
A mixture of nickel chloride (0.32g, 2.4 7mMol), 
triphenylphosphine (1.41g, S.38mMol) and zinc dust 
(0.13g, 2.0mMol), in dry dimethylformamide (lOml), was 
stirred at SO°C under an argon atmosphere. After 1 hour, 
during which time the colour of the mixture changed from 
blue to green and finally to red (NiO(PPh3h189), a solution 
of 76 (0.3g, 1.3SmMol), in dimethylformamide (3ml), was 
42 
6' 
added under an argon atmosphere, and the mixture left to stir at SO°C for a further 12 hours. The 
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resultant brown mixture was poured into aqueous ammonia (50rnl, 2M), filtered to remove the 
precipitate of triphenylphosphine oxide and the filtrate extracted with chlorofonn (3x40rnl). The 
extracts were combined and the solvent removed in vacuo. The residue was redissolved in 
chloroform (1-2ml) and absorbed onto a silica gel radial chromatography plate. Excess 
triphenylphosphine was eluted with petroleum ether/ethyl acetate (1: 1). Compound 42 was 
eluted with chlorofonn and the solvent removed in vacuo to give a white solid. Yield O.l1g ( 
44%). Mp 186-188D C. Mass spectrum: M+· calcd for C24H30N4: 374.2471. Found: 374.2471. 
IH NMR (CDCI3) B: 0.63 (6H), syn-9-CH3; 1.05 (6H), anti-9-CH3; 1.25 (2H), endo-H6; 1.29 
(2H), endo-H7; 1.47 (6H), 8-CH3; 1.95 (2H), exo-H7; 2.23 (2H), exo-H6; 3.02 (2H), H5; 
8.64 (2H), H4. IH NMR (CD3CN) B: 0.66 (6H), syn-9-CH3; 1.11 (6H), anti-9-CH3; 1.18 
(2H), endo-H6; 1.35 (2H) , endo-H7; 1.37 (6H), 8-CH3; 2.03 (2H), exo-H7; 2.28 (2H), exo-
H6; 3.11 (2H), H5; 8.58 (2H), H4. l3C NMR (CD3CN) B: 9.7 (2C), 8-CH3; 18.5 (2C), anti-9-
CH3; 19.5 (2C), syn-9-CH3; 25.61 (2C), C6; 31.4 (2C), C7; 49.6 (2C), C5; 54.9 (2C), C9; 
57.5 (2C), C8; 138.4 (2C), C4a; 147.4 (2C), C4; 162.0 (2C), C2; 179.6 (2C), C8a. 
2,4-Bis-(1-pyrazolyl)pyrimidine (53). 
Potassium pyrazolate was prepared by stirring pyrazole 
(0.46g, 6.7rnMol) and potassium (O.26g, 6.7mMol) in dry 
diglyme (40rnl) at 70D C for 2 hours under a nitrogen atmosphere. 
2,4-Dichloropyrimidine (81) (lg, 6.7mMol) was added to the 
suspension of the pyrazolate salt and the mixture stirred at 120D C. 
Mter 3 days, the mixture was cooled to room temperature and 
filtered to remove KCl. The diglyme was then removed in vacuo 
and the resultant residue rigourously extracted with chlorofonn. 
The chlorofonn was concentrated to give a yellow oil, the IH NMR spectrum of which indicated 
a complex mixture of substituted pyrimidines. The oil was redissolved in chloroform (1-2mI), 
absorbed onto silica gel, and purified by radial chromatography (4 mrn plate). Elution with 
petroleum ether/chloroform (3:1) produced 2 bands, the first of which was found to contain 83 
and unreacted 81 (200mg). By fractionating the band 6mg of pure 83 was obtained. The second 
band contained 80mg of 84. The major product, 53, was eluted with methanol/chloroform 
(1:50) and the solvent removed in vacuo to give a white solid. Yield 450mg (32%). Mp 143-
144°C. Calcd for ClOHSN6 C: 56.6, H: 3.8, N: 39.6. Found C: 56.5, H: 3.6, N: 39.5. Mass 
spectrum: M+· calcd for ClOHsN6: 212.0810. Found: 212.0813. IH NMR (CDCh) B: 6.55, 
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H4'; 6.S6, H4"; 7.82, HS; 7.84, H3'; 7.88, H3"; 8.64, HS'; 8.73, HS"; 8.78, H6. IH NMR 
(CD3CN) 0: 6.62, H4'; 6.67, H4"; 7.84, HS; 7.88, H3'; 7.92, H3"; 8.77, HS'; 8.78, HS"; 
8.83, H6. 13C NMR (CD3CN) 106.3, CS; 109.0, C4'; 109.9, C4"; 128.4, CS"; 130.1, CS'; 
143.9, C3'; 144.7, C3"; ISS.9, C2; IS8.7, C4; 161.3, C6. 
2-Chloro-4-(I-pyrazolyl)pyrimidine (83). 
Preparation as above. White solid. Yield 6mg (O.S%). Due to 
the very low yield, further coupling reactions with 83 were not 
3' 4'CN ~ . 
attempted. Mp 120-122°C. Mass spectrum: M+· calcd for C7H5N4CI: 
180.0203. Found: 180.0209. IH NMR (CDCb) 0: 6.54, H4'; 7.82, 
:; N 
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H3'; 7.87, HS; 8.S9, HS'; 8.63, H6. 
4-Chloro-2-(I-pyrazolyl)pyrimidine (84) 
Preparation as above. White solid. Yield SOmg (6.6%). Due 
to the very low yield, further coupling reactions with 84 were not 
attempted. Mp III-114°C. Mass spectrum: M+· calcd for 
C7HSN4C1: 180.0203. Found: 180.0202. IH NMR (CDC13) 0: 
6.S3, H4'; 7.2S, HS; 7.86, H3'; 8.S9, HS'; 8.64, H6. 
2,2'-Biperimidine (91). 
The compound 91 was prepared from the 
method of Patshorcke and Reid.209 A mixture of 1,8-
diaminonaphthalene (l.Og, 6.3mMol) and 
diethyloxalate (0.47g, 3. 16mMol) was heated (220°C), 
with stirring, in a 100ml round bottom flask and the 
ethanol and water produced was distilled. The reaction 
melt was cooled to room temperature, whereupon 
methanol (40ml) was added to the flask and the 
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resulting mixture stirred for IS minutes. The resultant red solid was filtered, washed with 
methanol and air dried. Yield 0.81g (77%). Mp >360°. Lit. >360°C.209 IH NMR (DMSO-d6) 
0: 6.87 (2H), H9; 6.90 (2H), H4; 7.14 (2H), H7; 7.22 (2H), H6; 7.23 (2H), HS; 7.31 (2H), 
HS; 10.69 (2H), HI. 
2-(2-Pyridinyl)perimidine (93). 
As described by Browne et al.,212 a mixture of 2-
cyanopyridine (3.39g, 37mMol) and sodium ethoxide (0.34g, 
SmMol), in dry ethanol (80ml), was stirred at room 
temperature, in darkness, for 1 hour. Acetic acid (O.Sg) was 
added followed by 1,8-diaminonaphthalene (4.7g, 30mMol). 
Additional acetic acid was added to maintain a pH of S-7 and 
the mixture was stirred in darkness for 2 hours. The ethanol 
H 
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wa'> removed in vacuo and the resultant residue extracted with benzene (Sx40ml). The extracts 
were combined, treated with decolourising charcoal, filtered, and the benzene evaporated to leave 
a red solid. The solid was recrystallised from petroleum ether!chloroform to give deep red 
crystals of 93. Yield I.7g (23%). Mp 161-162DC. Lit. 162-163DC.212 IH NMR (CDCb) 0: 
6.35, H9; 6.90, H4; 7.06-7.22, H6, H7, H8; 7.2S, HS; 7.4S, HS'; 7.87, H4'; 8.43, H3'; 8.62, 
H6'; 9.39, HI. IH NMR (DMSO-d6) 0: 6.81, H9; 6.88, H4; 7.12, H7; 7.18, H6; 7.21, H8; 
7.29, HS; 7.74, HS'; 8.12, H4'; 8.41, H3'; 8.84, H6'; 11.09, HI. IH NMR (CD3CN) 0: 6.61, 
H9; 6.84, H4; 7.12, H7; 7.19, H6; 7.19, H8; 7.28, HS; 7.60, HS'; 8.01, H4'; 8.39, H3'; 8.73, 
H6'; 9.78, H1. 13C NMR (CD3CN) 0: 103.2, C9; 11S.2, C4; 118.6, C7; 118.8, C9b; 120.6, 
C8; 121.S, C3'; 126.3, CS'; 128.4, C6; 129.3, CS; 136.1, C6a; 137.8, C4'; 14S.4, C9a; 148.8, 
C6'; C2 and C2'-not observed. 
I-Methyl-2-(2-pyridinyl)perimidine (94). 
The following synthesis was derived from a procedure 
described by Paragamanian et al. for alkylating NIH 
perimidines.211 To a solution of 2-(2-pyridinyl)perimidine 
(604mg,2.46mMol), in dry glyme (ISml), was added NaH 
(80mg,3.33mMol). Methyl iodide (400mg, 2.82mMol) was 
added and the solution stirred at room temperature for 8 
hours. The glyme was removed in vacuo and the resultant 
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residue extracted with hot dichloromethane (2Sml). The extract was cooled to room temperature, 
diluted with petroleum ether and cooled at ODC overnight. The resultant yellow crystals of 94 
were filtered and air dried. Yield 477mg (75%). Mp 172-174 DC. Mass spectrum: M+· calcd for 
C17H13N3: 259.1109. Found: 259.11OS. IH NMR (CDCb) 0: 3.14, 1-CH3; 6.32, H9; 6.94, 
162 
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H4; 7.23, H6; 7.23, H7; 7.30, HS; 7.32, H8; 7.40, HS'; 7.79, H3'; 7.88, H4'; 8.69, H6'. lH 
NMR (DMSO-d6) 0: 3.17, l-CH3; 6.S6, H9; 6.86, H4; 7.30, H7; 7.3S, H6; 7.37, H8; 7.38, 
HS; 7.66, HS'; 7.87, H3'; 8.11, H4'; 8.79, H6'. lH NMR (CD3CN) 0: 3.1S, l-CH3; 6.47, 
H9; 6.84, H4; 7.2S, H7; 7.29, H6; 7.32, H8; 7.34, HS; 7.S4, HS'; 7.76, H3'; 8.00, H4'; 8.73, 
H6'. lH NMR ((CD3hCO) 0: 3.32, l-CH3; 6.S7, H9; 6.92, H4; 7.31, H7; 7.34, H6; 7.37, 
H8; 7.40, HS; 7.6S, HS'; 7.96, H3'; 8.12, H4'; 8.80, H6'. l3C NMR (CD3CN) 0: 36.4, 1-
CH3; 102.1, C9; 11S.1, C4; 118.0, C9b; 119.4, C7; 120.4, C8; 124.S, 124.8, C3' and CS'; 
128.3, C6; 129.0, CS; 13S.6, C6a; 137.8, C4'; 141.0, C3a; 143.8, C9a; 149.1, C6'; IS4.7, 
C2'; lSS.8, C2. 
2-(2-Pyrimidinyl)perimidine (95). 
Step 1. 
2-Cyanopyrimidine. 
A solution of2-chloropyrimidine (17.2g, lSmMol) and trimethylamine (l9.9g, 37mMol) 
in benzene (120ml) was allowed to stand for S days, as described by Case et al. 256 The resultant 
yellow precipitate of 2-pyrimidinyltrimethylammonium chloride was filtered and dried in a 
vacuum desiccator. Yield 22.7Sg (87%). This solid (7g, 61mMol) was gradually added to, with 
stirring, a mixture of potassium cyanide (8.16g, 12SmMol) and acetamide (l4.3g) at 80°-90°C. 
The resultant brown liquid was heated until gas evolution ceased and cooled to room temperature. 
The cooled melt was dissolved in water (80mI) and extracted with ether. The ether extract was 
dried over magnesium sulphate, and the ether removed in vacuo to give a clear oil which 
solidified on standing. Yield 1.8g (28%). Mp 41°C. Lit. 41-42°c.256 IH NMR (CDCb) 0: 
7.SS, H4; 8.88 (2H), H3 and HS. 
Step 2. 
2-(2-Pyrimidinyl)perimidine (95). 
A mixture of 2-cyanopyrimidine (1.Sg, 14mMol) and 
sodium ethoxide (0. 136g, 2mMol), in dry ethanol (40ml), was 
stirred at room temperature, in darkness, for 1 hour. Acetic 
acid (0.22g) was added followed by 1,8-diaminonaphthalene 
(2.07g, 13mMol). Additional acetic acid was added to 
maintain a pH of S-7 and the mixture was stirred in darkness 
for 2 hours. The ethanol was removed in vacuo and the 
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resultant residue was firstly extracted with benzene (4x30ml). The extracts were combined, 
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treated with decolourising charcoal, filtered and the benzene evaporated to leave a brown solid 
(I.2g) which was shown, by IH NMR spectroscopy, to contain approximately 220mg (6%) of 
the desired product. The residue remaining after extraction with benzene was extracted a second 
time with hot dichloromethane. Evaporation of the dichloromethane extract gave 95 as a red 
solid, which was recrystallised from petroleum ether/chloroform. Yield 585mg (16%). Mp 200- _ 
203°C-decomposition. Mass Spectrum: M+· Calcd for ClsHlON4: 246.0905. Found: 246.0908. 
IH NMR (CDCI3) B: 6.73 (2H), H4 and H9; 7.13 (2H), H6 and H7; 7.18 (2H), H5 and H8; 
7.46, H5'; 8.94 (2H), H4' and H6'; HI not observed. IH NMR (CD3CN) 0: 6.60, H9; 6.86, 
H4; 7.19 (4H), H5, H6, H7 and H8; 9.00 (2H), H4' and H6'; 9.71, HI. 
4,6-Bis-(2-pyridinyl)pyrimidine (109). 
Step 1. 
1,3-Bis-(2-pyridinyl)-1,3-propanedione (113). 
The method of Texidor et al. was used to prepare 113.220 Sodium ethoxide was prepared 
in a three-neck flask from dry ethanol (67m1) and sodium (2.25g, 100mMol) under a nitrogen 
atmosphere. The ethanol was removed in vacuo and 80 ml of dry toluene was transferred to the 
flask, followed by 2-methoxycarbonylpyridine (111) (13.44g, 11 OmMol). 2-Acetylpyridine 
(112) (l6.63g,llOmMol) was slowly added to this mixture whilst maintaining the temperature at 
43-50°C, during which time a colour change, from yellow to red, was observed. An off-white 
solid formed and stirring was continued for 1 hour, followed by heating on a steam bath for 45 
minutes. The off-white solid was filtered, dried and added, with stirring, into a mixture 
containing water (100 ml), acetic acid (100 ml) and ice (336 g) to give a white solid (113), which 
was filtered and dried. Yield 13.9g (62%). IH NMR (CDCb) 8: 4.94 (2H), CH2; 7.45 (2H), 
H5; 7.87 (2H), H4; 8.16 (2H), H3; 8.76 (2H), H6. 
Step 2. 
4,6-Bis-(2-pyridinyl)pyrimidine (109). 
As described by Case et al.,218 113 (4.1g, 18mMol) 
was refluxed in formarnide (50 g) for 6 hours. The mixture 
was concentrated to one half its volume and diluted with 100mI 
of water to give a precipitate. The precipitate was washed with 
water and extracted with ether. The extract was dried over 
magnesium sulphate and the solvent removed in vacuo. The 
residue was sublimed at 90°C (10mm Hg) and the sublimate 
4' 109 
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recrystallised from ether to give white crystals of 109. Yield 0.8 g (20%). Mp Ill-113°C. 
Lit.113-114°c.218 IH NMR (CDCh) 0: 7.44 (2H), HS'; 7.90 (2H), H4'; 8.S3 (2H), H3'; 8.80 
(2H), H6'; 9.37, H2; 9.39, HS. IH NMR (CD3CN) 0: 7.60 (2H), HS'; 8.0S (2H), H4'; 8.61 
(2H), H3'; 8.86 (2H), H6'; 9.38, H2; 9.43, HS. IH NMR (CD3hCO 0: 7.71 (2H), HS'; 8.17 
(2H), H4'; 8.73 (2H), H3'; 8.94 (2H), H6'; 9.47, H2; 9.64, HS. IH NMR (DMSO-d6) 0: 7.73 
(2H), HS'; 8.18 (2H), H4'; 8.63 (2H), H3'; 8.93 (2H), H6'; 9.4S, H2; 9.S3, HS. l3C NMR 
(CD3CN) 0: 113.2, CS; 121.7 (2C), C3'; 126.1 (2C), CS'; 137.8 (2C), C4'; lS0.2 (2C), C6'; 
lS4.1 (2C), C2'; IS9.0, C2; 164.2, C4. l3C NMR (CD3hCO 0: 113.1, CS; 121.6 (2C), C3'; 
126.0 (2C), CS'; 137.6 (2C), C4'; ISO.1 (2C), C6'; lS4.2 (2C), C2'; lS8.9, C2; 164.1, C4. 
2,6-Bis-[ 6- (2-pyridiny 1) -4-pyrimidiny l]pyridine (110). 
Step 1. 
2,6-Diethoxycarbonylpyridine (128). 
2,6-Pyridine-dicarboxy1ic acid (12g, 72mMol) was refluxed in ethanol (60ml) in the 
presence of concentrated sulphuric acid (1.S mJ) for 8 hours. The resulting solution was poured 
into water (300ml), made alkaline with sodium carbonate then extracted with ether (4x100ml). 
The combined extracts were dried over magnesium sulphate and concentrated in vacuo to give 
128 as a clear oil which crystallised on standing. Yield 8.5g (6S%). Mp 42-43°C. Lit 42-
43°C.257 IH NMR (CDCb) 0: 1.47 (6H), CH3; 4.50 (4H), CH2; 8.02, H4; 8.30 (2H), H3 and 
HS. 
Step 2. 
2,6-Bis-[3-(2-pyridinyl)propane-1 ,3-dionato ]pyridine (129). 
Sodium ethoxide was prepared in a three-neck flask from sodium (0.82g) and dry ethanol 
(SOml). The ethanol was removed in vacuo and toluene (SOml), followed by the diester (4g, 
17mMol) were added to the flask. Whilst stirring and maintaining the temperature of the mixture 
at 42°C, 2-acetylpyridine (112) (6.1g, SOmMa I) was slowly added. The mixture was stirred for 
30 minutes, cooled to room temperature and filtered. The resultant solid was dried and poured, 
with stirring, into a mixture of water (36ml), glacial acetic acid (46ml) and ice (120g). The 
yellow precipitate of 129 which formed was filtered, dried and recrystallised from ethanol. Yield 
1.2Sg (20%). Mass spectrum: M+· calcd for C21H15N304: 373.1063. Found: 373.1069. IH 
NMR (CDCb)-major tautomer-o: 4.96, 7.49, 7.90, 8.06, 8.20, 8.32, 8.8l. 
Step 3. 
2,6-Bis-[6-(2-pyridinyl)-4-pyrimidinyIJpyridine (110). 
A mixture of 129 (O.Sg, 
1.34mMol) in formamide (30ml), was 
refluxed for 6 hours. After cooling to 
room temperature, a black precipitate 
formed and was filtered, washed with 
water and air dried. The brown formamide 
solution was concentrated in vacuo and 
diluted with water (40mI) to give additional 
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product. The black solid was extracted with hot methanol and the extract cooled to give an off-
white precipitate, which was filtered. Further recrystallisation from methanol gave an off-white 
solid (110). Yield 61mg (12%). Mp 190-l9SoC decomp. Mass spectrum: M+· calcd for 
C23H15N7: 389.l389. Found: 389.1392. IH NMR (CDCb) 0: 7.46 (2H), HS"; 7.92 (2H), 
H4"; 8.10, H4; 8.S6 (2H), H3"; 8.67 (2H), H3 and HS; 8.84 (2H), H6"; 9.39 (2H), H2'; 
9.62 (2H), HS'. IH NMR (CD3CN) 0: 7.6S (2H), HS"; 8.09 (2H), H4"; 8.27, H4; 8.66 (2H), 
H3"; 8.76 (2H), H3 and HS; 8.9S (2H), H6"; 9.4S (2H), H2'; 9.64 (2H), HS'. In addition, 
the compound 2-[(2-pyridinyl)-4-pyrimidiny1]pyridine-6-carboxamide (130) was isolated from 
the methanol filtrate. Mass spectrum: M+· calcd for CI5HIIN50: 277.0964. Found: 277.0968. 
IH NMR (CDCI3) 0: 7.47, HS"; 7.93, H4"; 8.09, H4'; 8.38, HS'; 8.S8, H3"; 8.73, H3'; 
8.80, H6"; 9.35, H2; 9.39, HS. 
2,6 wBisw(lwpyrazoJyJ)-1,S-naphthyridine (132). 
Step 1. 
1 ,5-N aphthyridine (133). 
3-Aminopyridine (30g, 3I9mMol), sodium m-nitrobenzenesulphonate (140g), water 
(180ml), glycerol (lOOmI) and sulphuric acid (328g) were heated, with stirring, at 13SoC for 20 
hours.229 Water (400ml) was added and the mixture made alkaline with NaOH and steam 
distilled. The distillate was made alkaline and continuously extracted with ether. The extract was 
dried over magnesium sulphate and the ether removed in vacuo. The resultant residue of 133 
was recrystallised from petroleum ether. Yield Sg (12%). Mp 7SoC. Lit. 7soC.229 IH NMR 
(CDCI3) 0: 7.67 (2H). H3; 8.44 (2H), H4; 9.00 (2H), H2. 
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Step 2. 
1,5-Naphthyridine-di-N-oxide (134). 
The method of Hart23 1 was modified as follows. To a mixture of 133 (2.2g, 17mMol) in 
acetic acid (40ml) wa..'i added hydrogen peroxide (lOml, 30%v/v). The mixture was heated (70°-
80°C) with stirring for 4 days and the resultant brown solution was cooled to room temperature 
and filtered. The acetic acid was evaporated in vacuo leaying a brown residue which was 
combined with water (20ml) and made alkaline with sodium carbonate. The resultant yellow 
precipitate of 134 was filtered and dried in a vacuum desiccator. Yield-0.95g (34%). Mp 297-
300°C. Lit. 299-301°C.231 IH NMR (CDCb) 8: 7.53 (2H), H3; 8.51 (2H), H4; 8.57 (2H) , 
H2. 
Step 3. 
2,6-Dichloro-1,5-naphthyridine (135). 
l,5-Naphthyridine-di-N-oxide (134) (600mg, 3.7mMol) wa..'i slowly added to POCb 
cooled in an ice/water bath. The mixture wa..'i refluxed for 6 hours, cooled and the POCl3 
removed in vacuo leaving a brown residue. Ice wa..'i cautiously added to the residue, the resultant 
solution made alkaline with aqueous ammonia, and extracted with chloroform. The extract was 
dried over magnesium sulphate and the solvent removed in vacuo. The residue was found, by IH 
NMR spectroscopy to consist of predominantly 135 and other mono- and dichlorinated side-
products. The residue was redissolved in chloroform (l-2ml), absorbed onto a column of silica 
(lOx2.5cm) and the column eluted with chloroform. Evaporation of the first fraction gave 135 as 
an off-white solid. Yield 260mg (35%). Mp 234-236°C. Lit. 236-238°c.231 IH NMR (CDCl3) 
8: 7.66 (2H), H3; 8.28 (2H) , H4. Similarly, 136 was obtained from the second fraction as an 
off-white solid. Yield 44mg (6%). IH NMR (CDCl3) 8: 7.70, H3; 7.78, H7; 8.38, H4; 8.85, 
H6. The other side products were not isolated. 
Step 4. 
2,6-Bis-(l-pyrazolyl)-l,5-naphthyridine (132) 
Potassium pyrazolate was prepared by stirring 
pyrazole (204mg, 3.0mMol) and potassium (l20mg, 
3.0mMol), for 2 hours, in dry diglyme (lOml) (70°C) , 
under a nitrogen atmosphere. 2,6-Dichloro-1,5-
naphthyridine (135) (260mg, 1.3mMol) was added to the 
suspension of the pyrazolate salt and the mixture stirred at 
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120°C. After 3 days, the mixture was filtered hot and the filtrate allowed to cool to room 
temperature. The resultant precipitate was filtered, extracted with chloroform (25ml) and the 
extract concentrated (3m1) and diluted with methanol. The white precipitate which formed was 
filtered and air dried. By diluting the diglyme filtrate with water (20ml), additional product was 
obtained as an off-white precipitate. The precipitates were combined and recrystallised from 
acetonitrile to give white needles of 132. Yield-155mg (45%). Mp 232-233°C. Mass spectrum: 
M+· calcd for C12HION6: 262.0967. Found: 262.0967. IH NMR (CDCI3) a: 6.56 (2H), H4'; 
7.82 (2H), H3'; 8.40 (2H), 8.46 (2H), H3 and H4; 8.77 (2H), H5'. IH NMR (CD3CN) a: 
6.67 (2H), H4'; 7.90 (2H), H3'; 8.49 (4H), H3 and H4; 8.84 (2H), H5'. 
2,2' -Bis-(I-pyrazolyl)-4,4' -bipyridine (144). 
Step 1. 
4,4'-Bipyridine-di-N-oxide.(152) 
The synthesis of 4,4'-bipyridine mono-N-oxide, as described by Moran et al.,230 was 
modified as follows. Hydrogen peroxide (4m1, 50%) was added to a stirred solution of 4,4'-
bipyridine (5g) in glacial acetic acid (25ml). The solution was heated (70°C) for 7 hours, treated 
with more hydrogen peroxide (4ml) and heated, with stirring, for a further 4 days. The solution 
was cooled to room temperature, poured into water (180ml) and made alkaline with sodium 
carbonate. The resultant yellow precipitate of 152 was filtered and dried in a vacuum desiccator. 
Yield 5g (81 %). IH NMR (DMSO-d6) 0: 7.99 (4H), H3 and H5; 8.40 (4H), H2 and H6. 
Step 2. 
2,2'-Dichloro-4,4'-bipyridine.(153) 
4,4'-Bipyridine-di-N-oxide (152) (2.2g, 12.7mMol) was slowly added to POCl3 (25ml), 
whilst cooling in an ice/water bath, analogous to the preparation of 2-chloro-4,4'-bipyridine, as 
described by Moran et al.230 The mixture was refluxed for 7 days, cooled to room temperature, 
filtered and POCb was removed in vacuo. The resultant residue was treated with ice (20g) and 
made alkaline with potassium carbonate to give a brown precipitate of 153, which was filtered 
and dried in a vacuum desiccator. IH NMR (DMSO-d6) a: 8.01 (2H), H5; 8.17 (2H), H3; 8.67 
(2H), H6. 
Step 3. 
2,2'-Bis-(l-pyrazolyl)-4,4'-bipyridine (144). 
Potassium pyrazolate was prepared by stirring 
pyrazole (0.44g, 6.SmMol) and potassium (0.2Sg, 
6.4mMol) in dry diglyme (30ml) (70°C), for 2 hours, 
under a nitrogen atmosphere. To the suspension of the 
pyrazolate salt was added 153 (0.7g, 3.1mMol) and the 
resultant mixture stirred at 120°C for 2 days. The 
mixture was cooled, filtered and the filtrate concentrated 
to lOml in vacuo. Addition of methanol (2Sml) to the 
diglyme produced yellow crystals of 144. 
Recrystallisation from CH3CN/CHCl3 gave white 
needles suitable for X-ray analysis. Yield 0.127g 
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(14.2%). Mp 186-187°C. Calcd for CI6N12N6 C: 66.66, H: 4.20, H: 29.1S. Found C: 66.27, 
H: 3.88, N: 29.02. Mass spectrum: M+· calcd for CI6H12N6: 288.1123. Found: 288.1121. IH 
NMR (CDCI3) 0: 6.52 (2H), H4"; 7.S3 (2H), HS; 7.79 (2H), H3"; 8.3S (2H), H3; 8.S4 (2H), 
H6; 8.63 (2H), HS". IH NMR (CD3CN) 0: 6.62 (2H), H4"; 7.73 (2H), HS; 7.87 (2H), H3"; 
8.38 (2H), H3; 8.63 (2H), H6; 8.70 (2H), HS". l3C NMR (CD3CN-protonated carbons) 0: 
108.S (2C), C4"; 110.3 (2C), C3; 120.0 (2C), CS; 127.6 (2C), CS"; 142.7 (2C), C3"; 149.7 
(2C), C6; lS0.9 (2C), lS4.8 (2C), C2 and C4. 
2,2 ' -Bis-(3,5-dimethyl-l-pyrazolyl)-4,4' -bipyridine (145). 
Potassium 3,S-dimethylpyrazolate was prepared 
by stirring 3,S-dimethylpyrazole (0.63g, 6.SmMol) and 
potassium (0.2Sg, 6.4mMol) in dry diglyme (30ml) 
(70DC), for 2 hours, under a nitrogen atmosphere. 2,2'-
Dichloro-4,4'-bipyridine (153) (0.7g, 3.1mMol) was 
added to the suspension of the dimethylpyrazolate salt. 
The mixture was stirred at 120DC for 2 days, allowed to 
cool to room temperature, filtered and the filtrate 
concentrated to Sml in vacuo. Methanol (3Sm)) was 
added and the solution was left to cool (ODC) overnight to 
give white crystals (30mg) of 145. Additional 145 
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(180mg) was obtained by the addition of water (20mI) to the filtrate. Recrystallisation from 
CH3CN gave white needles suitable for X-ray analysis. Yield 216mg (20%). Mp 140-141 DC. 
Calcd for C20H20N6 C: 69.75, H: 5.85, N: 24.40. Found C: 69.52, H: 5.76, N: 24.51. Mass 
spectrum: M+· calcd for C20H20N6: 344.1749. Found: 344.1745. IH NMR (CDCl]) 0: 2.32 
(6H), 5"-CH3; 2.68 (6H), 3"-CH3; 6.03 (2H), H4"; 7.46 (2H), H5; 8.19 (2H), H3; 8.52 
(2H), H6. IH NMR (CD3CN) 0: 2.32 (6H), 5"-CH3; 2.71 (6H), 3"-CH3; 6.15 (2H), H4"; 
7.63 (2H), H5; 8.20 (2H), H3; 8.59 (2H), H6. 13C NMR (CD3CN) 0: 13.1 (2C), 5"-CH3; 
14.3 (2C), 3"-CH3; 109.6 (2C), C4"; 113.2 (2C), C3; 119.0 (2C), C5; 142.2 (2C), 148.1 
(2C), C3", C5", C2 or C4; 148.94 (2C), C6; 150.38 (2C), 154.9 (2C), C3", C5", C2 or C4. 
Attempted syntheses. 
4,4'-Dichloro-2,2'-bipyrimidine (82) 
A mixture of nickel chloride (1.57g, 12.1rnMol), triphenylphosphine (6.95g, 26.9rnMol) 
and zinc dust (0.618g, 9.53rnMol), in dry dimethylformamide (35mI), was stirred at 50DC under 
an argon atmosphere,189 After 1 hour, 2,4-dichloropyrimidine (81) (1g, 6.623rnMol) was added 
to the red mixture, whilst maintaining an inert atmosphere, whereupon stirring was continued for 
a further 12 hours (50DC). The mixture was poured into aqueous ammonia (150 mI, 2M) and the 
resultant precipitate filtered. The filtrate was extracted with chloroform (4x80rnl) and the extracts 
combined, dried over potassium carbonate and the solvent removed in vacuo to give a yellow oil. 
The aqueous phase was also refluxed in the presence of potassium cyanide and similarly extracted 
with chloroform to yield a brown oiL Analysis of both oils, by 1 H NMR spectroscopy, indicated 
that the reaction had failed to give the desired product 82. Attempts to dimerize 81 with 
Nio(PPh3h generated from the precursor Ni(PPh3hCI2 in a similar manner to syntheses 
described earlier, were also unsuccessful. 
2-Chloro-4-( I-pyrazoly l)pyrimidine (83). 
To a mixture of pyrazole (137mg, 2.01rnMol) and NaH (50mg, 2.1rnMol), in dry glyme, 
(30ml) was added 81 (300mg, 2.01rnMol). Analysis of the crude reaction mixture, by IH NMR 
spectroscopy, indicated no formation of the desired product 83, or its isomer 84, after stirring at 
room temperature for 24 hours or refluxing the mixture for 24 hours. Alternative solvents THF 
and acetone also gave no reaction. 
4,4'-Bis-(bromomethyl)-2,2'-bipyrimidine. 
A mixture of 4,4'-dimethyl-2,2'-bipyrimidine (71mg, 0.38mMol) and N-
bromosuccinimide (135mg, 0.76mMol) in carbon tetrachloride (lOml) was illuminated with a 
17] 
tungsten bulb (lOOW) for 6 hours. The mixture was filtered and the carbon tetrachloride washed 
with aqueous sodium metabisulphate and dried over magnesium sulphate. Analysis of the 
organic layer by IH NMR indicated that the reaction had failed to give the desired product. 
8.3 Syntheses of Complexes. 
General preparation of ruthenium(II) complexes. 
The compound Ru(bpyh02.2H20 or Ru(dmbhCI2.2H20 was refluxed in ethanol/water 
(3:]) for] hour. The ligand was added and the solution refluxed for 4-6 hours. The mixture wa.<; 
cooled to room temperature, filtered to remove unreacted ligand and concentrated to dryness in 
vacuo. The residue was dissolved in the minimum volume of water and the product precipitated 
by the addition of an aqueous solution of NI4PF6. Diruthenium complexes were prepared by 
using the monoruthenium complex as the ligand or by reacting one equivalent of the ligand with 
two equivalents of ruthenium. Formation of polynuclear complexes generally required reflux 
times of up to 24 hours, for dinuclear complexes, or 48 hours for complexes of higher nuclearity. 
Homoleptic complexes were prepared in a similar manner by refluxing three equivalents of the 
ligand with one equivalent of Ru(DMSO)4Cl2 in ethano11water for 8-20 hours. Complexes were 
purified by chromatography, on either alumina or on sephadex-SP C-25 ion exchange gel, or by 
recrystallisation from either ethano11water or by diffusing ether into a solution of the complex in 
acetonitrile, or by a combination of these methods. 
Assignment of bpy/dmb ligands in the 1 H NMR spectra of Ru(lI) complexes. 
For some of the complexes an attempt has been made to assign some, or all, of the 
protons in each spin system of the bpy or dmb rings. In general, this was achieved using 1D 
TOCSY andlor 2D COSY experiments. The methyl groups are not included in the assignments of 
the dmb rings. Protons of the same spin system are denoted a, b, c, or d (eg: spin system 
a=bpyH3a, bpyH4a etc). All four bpyH6a-d, or dmbH6a-d, protons are usually well spread out 
in the spectra of the complexes. Hence, the spin systems are assigned on the basis of the 
chemical shift of the bpyH6 (dmbH6) proton; Le. bpyH6a is assigned as the most shielded 
proton, with bpyH6b, bpyH6c and bpyH6d assigned in increasing order of chemical shift. 
Tetrakis-(triphenylphosphine)-)..L-( 4,4' -dimethyl-2,2'-bipyrimidine-Nl,N3 t_ 
Nl',N3)-dicopper(l)-diperchlorate (57). 
A mixture of 40 (l8.6mg, 0.1 mMol), Cu (9.0mg, 0.] 5mMol), CU(CI04h.6H20 
(35.0mg, O. ]mMol) and PPh3 (loo.Omg, OAmMol), in methanol (lOml), was refluxed for 1 
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hour. Yellow crystals of 57 were removed by filtration while the solvent was still hot. 
Additional crystals were obtained by cooling the. filtrate. Yield 91.1mg (53%). Ca1cd for 
Cg2H70N40gP4ChCU2.3H20.HCI04 C: 57.40, H: 4.52, N: 3.27. Found C: 57.40, H: 4.41, N: 
3.29. IH NMR (CD3CN) 8: 2.61 (6H), 4-CH3; 7.28 (24H), o-Ph; 7.37 (24H) , m-Ph; 7.46 
(2H), H5; 7.49 (l2H), p-Ph; 8.63 (2H), H6. IH NMR (DMSO-d6) 8: 2.63 (6H), 4-CH3; 7.31 
(24H), o-Ph; 7.46 (24H), m-Ph; 7.56 (l2H), p-Ph; 7.74 (2H), H5; 8.86 (2H), H6. 
Tetracarbonyl-( 4,4' -dimethyl-2,2 I -bipyrimidine-N1,N1 ')-molybdenum (58). 
To a stirred solution of 40 (lOmg, 0.05mMol) in dry THF (lOml) was added, dropwise, 
a green solution of Mo(CO)4C7Hg (12mg, 0.04mMol) in dry THF (4ml). The solution rapidly 
became deep red and was stirred for 1 hour then diluted with ether (5ml) and cooled (ODC) 
overnight. The resultant red precipitate of 58 was filtered and dried. Yield llmg (56%). IH 
NMR (CDCI3) 8: 2.82 (6H), 4-CH3; 7.35 (2H), H5; 9.08 (2H), H6. Repeating the reaction with 
MO(CO)4C7Hg (24mg, 0.08mMol) also gave 58. Yield 14mg (71 %). 
Dichloro-( 4,4' -dimethyl-2,2'-bipyrimidine-N1,N1 ')-palladium(II) (59). 
Palladium chloride (20mg, 0.120mMol) was dissolved in hot HCI (5ml) and added 
dropwise to a hot solution of 40 (23mg, 0.124mMol) in methanol (5ml). The resultant 
precipitate of 59 was filtered and dried in a vacuum desiccator. Yield 34mg (78%). Similarly, a 
two fold excess of palladium chloride (46mg, 0.24mMol) gave 59. Yield 35mg (80%). Ca1cd 
for ClOHlON4Cl2Pd C: 33.04, H: 2.77, N: 15.41. Found C: 32.91, H: 2.77, N: 15.70. IH 
NMR (DMSO-d6) 8: 2.82 (6H), 4-CH3; 7.95 (2H), H5; 9.24 (2H), H6. 
Bis- (2,2' -bipyridine) -( 4,4' -dimethyl-2,2 ,_ bipyrimidine) -ruthenium(II)-bis-
(hexafluorophosphate). 
4,4'-Dimethyl-2,2'-bipyrimidine (40) (20mg, 0.107mMol) was reacted with 
Ru(bpyhCb,2H20 (46mg, 0.090mMol) as described above. The product was obtained a<; a red 
solid. IH NMR analysis showed the product to be a 1:1 mixture of the symmetrical (N1,N1') 
(60) and unsymmetrical (N1,N3') (61) isomers. Yield 86mg (94%). FAB mass spectrum: ca1cd 
for [C30H26N8PF6Ru]+: 745.097. Found: 745.098. 
B is-(2,2' -bipyridine )-( 4,4'-dimethy 1-2,2' -bipyrimidine-N1 ,N1 ')-rutheniutn(II)-bis-
(hexafluorophosphate) (60). 
The symmetrical isomer 60 was obtained in pure form in the separation outlined for 64. 
IH NMR (CD3CN) 8: 2.77 (6H), 4-CH3; 7.44 (2H), H5; 7.45 (2H), bpyH5a, 7.49 (2H), 
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bpyHSb; 7.7S (2H), bpyH6a; 7.87 (2H), H6; 7.93 (2H), bpyH6b; 8.11 (2H), 8.14 (2H), 
bpyH4a and bpyH4b; 8.5S (4H), bpyH3. 
Bis-(2,2'-bipyridine)-(4,4'-dimethyl-2,2'-bipyrimidine-N1,N3')-ruthenium(II)-bis-
(hexafluorophosphate) (61). 
The unsymmetrical isomer 61 could not be isolated in pure form, but was assigned in the 
spectrum of the mixture 60/61. IH NMR (CD3CN) 0: 1.90 (3H), 4'-CH3; 2.76 (3H), 4-CH3; 
7.39, bpyHS; 7.40 (2H), HS and bpyHS; 7.41, bpyHS; 7.46, bpyH6; 7.51, bpyHS; 7.S4 (2H), 
HS' and bpyH6; 7.70, H6; 7.81,7.83, bpyH6; 8.0S, 8.13, 8.16, 8.17, bpyH4; 8.S3, 8.54, 
8.S8, 8.S9, bpyH3; 8.99, H6'. 
Bis-( 4,4' -dimethy 1-2,2' -bipyridine)-( 4,4' -dimethy 1-2,2' -bipyrimidine)-
ruthenium(II)-bis-(hexafluorophosphate). 
4,4'-Dimethyl-2,2'-bipyrimidine (40) (22mg, 0.12mMol) was reacted with 
Ru( dmb hC12.2H20 (63mg, O.llmMol) as described above. The desired product was obtained 
as a red solid. 1 H NMR analysis showed the product to be a 1: 1 mixture of the symmetrical 
(N1,N1') (62) and unsymmetrical (N1,N3') (63) isomers. Yield 73mg (70%). Ca1cd for 
C34H34NgP2F12Ru.2H20 C: 41.60, H: 3.90, N: 11.41. Found C: 41.92, H: 3.96, N: 11.62. 
FAB mass spectrum: calcd for [C34H34NgPF6Ru]+: 801.1S92. Found: 801.1593. 
Bis-(4,4'-dimethyl-2,2'-bipyridine)-(4,4'-dimethyl-2,2'-bipyrimidine-Nl,Nl')-ruthenium(II)-
bis-(hexafluorophosphate) (62). 
The symmetrical isomer 62 was obtained in pure form in the separation outlined for 65. 
IH NMR (CD3CN) 0: 2.S8 (6H), 2.S9 (6H), dmb4-CH3; 2.77 (6H), 4-CH3; 7.29 (2H), 
dmbHSa; 7.31 (2H), dmbHSb; 7.42 (2H), HS; 7.SS (2H), dmbH6a; 7.72 (2H), dmbH6b; 7.86 
(2H), H6; 8.39 (4H), dmbH3. 
Bis-(4,4'-dimethyl-2,2'-bipyridine)-(4,4'-dimethyl-2,2'-bipyrimidine-Nl,N3')-ruthenium(II)-
bis-(hexafluorophosphate) (63). 
The unsymmetrical isomer 63 could not be isolated in pure form, but was assigned in the 
spectrum of the mixture 62/63. IH NMR (CD3CN) 0: 1.90 (3H), 4'-CH3; 2.S4 (3H), 2.S6 
(3H), 2.60 (3H), 2.61 (3H), dmb4-CH3; 2.76 (3H), 4-CH3; 7.22 (2H), dmbHSa and dmbHSb; 
7.33, dmbHSc; 7.34 (2H), dmbHSd and dmbH6a; 7.37, HS'; 7.S2, HS; 7.60, dmbH6b; 7.62, 
dmbH6c; 7.68, H6; 7.90, dmbH6d; 8.37 (2H), dmbH3a and dmbH3b; 8.41 (2H), dmbH3c and 
dmbH3d; 8.97, H6'. 
Tetrakis-(2,21-hipyridine)-Il-( 4,41-dimethyl-2,21-hipyrimidine-N1,N3 1-N1 1 ,N3)-
diruthenium(II)-tetrakis-(hexafluorophosphate) (64). 
The 1: 1 mixture 60/61 (20mg, 0.022mMo1) was reacted with Ru(bpyhCI2.2H20 (6mg, 
0.012mMol) as described above. The chloride salt of the product was absorbed onto a sephadex 
column. A purple band corresponding to unreacted Ru(bpYhCh.2H20 was eluted first with 
water. The symmetrical complex 60 wa~ eluted with O.lM NaCI as an orange band. Yield 8mg 
(41 %-rel. to 60/61). The dinuclear complex 64 was eluted with 0.5M NaCI as a green band and 
both 60 and 64 were precipitated by the addition of aqueous NH4PF6. The ratio of the 
diastereoisomers in 64 varied from 4: 1 to 5: 1. Traces of the minor racemic isomer could not be 
removed from the mixture, despite attempts to purify the major meso isomer, by successive 
fractional recrystallisations (ether/acetonitrile). Yield 10mg (29%-rel. to 60/61). Ca1cd for 
CSOH42N12P4F24Ru2 C: 37.69, H: 2.66, N: 10.55. Found C: 37.64, H: 2.83, N: 10.94. FAB 
mass spectrum: calcd for [CSOH42N 12P3FlSRu2J+: 1449.067. Found: 1449.065. Major 
diastereoisomer (Ail)lH NMR (CD3CN) B: 1.95 (6H), 4-CH3; 7.45 (2H), bpyH5a; 7.46 (2H), 
H5; 7.47 (2H), bpyH5b; 7.51 (2H), bpyH6a; 7.63 (2H), bpyH5c; 7.78 (2H), H6; 7.79 (2H), 
bpyH5d; 7.82 (2H), bpyH6b; 7.87 (2H), bpyH6c; 8.11 (2H), bpyH4a; 8.15 (2H), bpyH4b; 
8.21 (2H), bpyH4c; 8.26 (2H), bpyH4d; 8.55 (4H), bpyH3c and bpyH3d; 8.58 (4H), bpyH3a 
and bpyH3b. Minor diastereoisomer (AAlM)-tentative assignments-1H NMR (CD3CN) B: 1.95 
(6H), 4-CH3; 7.43 (2H), bpyH5; 7.43-7.52 (6H), bpyH5; 7.45 (2H), bpyH6; 7.46 (2H), H5; 
7.57 (2H), bpyH5; 7.73 (2H), bpyH6; 7.87 (2H), bpyH6; 7.91 (2H), bpyH6; 8.12 (2H), 8.14 
(2H), 8.27 (2H) and 8.28 (2H), bpyH4; 8.58 (2H), 8.59 (2H), 8.63 (2H) and 8.67 (2H), 
bpyH3. 
Tetrakis-( 4,41-dimethyl-2,21-bipyridine )-11-( 4,41-dimethyl-2,21 -bipyrimidine-
Nl,N3 1-N1 1 ,N3)-diruthenium(II)-tetrakis-(hexafluorophosphate) (65). 
The 1:1 mixture 62/63 (15mg, 0.016mMol) was reacted with Ru(dmbhCh.2H20 (5mg, 
0.009mMol) as described above. The product, as a chloride salt in aqueous solution, was 
absorbed onto a sephadex column. Excess Ru(dmbhCh,2H20 was eluted with water as a purple 
band followed by an orange band corresponding to the symmetrical mononuclear complex 62, 
the latter being eluted with O.lM NaCI and precipitated by the addition aqueous NH4PF6. Yield 
7mg (46%-rel. to 62/63). Complex 65 was eluted with 0.5M NaCI as a green band and 
similarly precipitated with aqueous NH4PF6. The IH NMR spectrum of 65 indicated a 3:1 
mixture of the meso and racemic diastereoisomers. Neither isomer could be separated by 
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successive fractional recrystallisations (ether/acetonitrile). Yield 8mg (29%). FAB mass 
spectrum: calcd for [C5SH5SN 12P3F lSRu2]+: 1561.192. Found: 1561.192. Major 
diastereoisomer (A~) IH NMR (CD3CN) 0: 1.94 (6H), 4-CH3; 2.56 (3H), 2.58 (3H), 2.64 
(3H) and 2.67 (3H), dmb4-CH3; 7.28 (2H), dmbH5; 7.31 (4H), dmbH5 and dmbH6; 7.42 
(2H), H5; 7.46 (2H), dmbH5; 7.62 (4H), dmbH5 and dmbH6; 7.66 (2H), dmbH6; 7.75 (2H), 
H6; 8.15 (2H), dmbH6; 8.39 (4H), 8.43 (4H), dmbH3. Minor diastereoisomer (~~/AA)­
tentative assignment-1H NMR (CD3CN) 0: 1.94 (6H), 4-CH3; 2.57 (3H); 2.58 (3H), 2.69 (3H) 
and 2.73 (3H), dmb4-CH3; 7.27 (2H), dmbH5; 7.31 (4H), dmbH5 and dmbH6; 7.35 (2H) and 
7.43 (2H), dmbH5; 7.54 (2H), 7.60 (2H) and 7.69 (2H), dmbH6; 7.79 (2H), H6; 8.39 (2H), 
8.43 (2H), 8.49 (2H) and 8.51 (2H), dmbH3. 
[4,4'-Bis-(t-butyl)-2,2'-bipyrimidine-Nl,Nl' ]-tetracarbonyI-molybdenum (71). 
A green solution of MO(CO)4C7HS (l6.4mg, 0.037mMol or 32.8mg, 0.037mMol) in 
THF (2ml) was added dropwise to a stirred solution of 41 (lOmg, 0.037mMol) in THF (5m1). 
The resultant deep red solution was stirred for 2 hours and a layer of petroleum ether was added. 
The solution was left to cool (O°C) overnight to give 71 as a red microcrystalline solid. Yield 
15mg (85%). IH NMR (CDCI]) 0: 1.48 (l8H), CH3; 7.45 (2H), H5; 9.08 (2H), H6. 
Bis-( 4,4'-dimethyl-2,2'- bipyridine)-[ 4,4'-bis-(t-butyl)-2,2'-bipyrimidine 
Nl,Nl' ]-ruthenium(II)-bis-(hexafluorophosphate) (72). 
4,4'-Bis-t-butyl-2,2'-bipyrimidine (41) (l8mg, 0.067mMol) was reacted with 
Ru(dmbhCb.2H20 (34mg, 0.059mMol) as described above. Complex 72 was recrystallised 
from acetonitrile/ether to give a red microcrystalline solid. Yield 36mg (52%). FAB mass 
spectrum: calcd for [C40H46NSPF6Ru]+: 885.2531. Found: 885.2535. IH NMR (CD3CN) 0: 
1.48 (l8H), CH3; 2.59 (6H), 2.60 (6H), dmb4-CH3; 7.29 (2H), dmbH5a; 7.34 (2H), dmbH5b; 
7.56 (2H), dmbH6a; 7.57, H5; 7.74 (2H), dmbH6b; 7.91 (2H), H6; 8.40 (4H), dmbH3. l3C 
NMR (CD3CN) 0: 20.6 (4C), dmb4-CH3; 28.8 (6C), CH3; 38.5 (2C), C(CH3h; 120.6 (2C), 
C5; 125.2 (4C), dmbC3; 128.6 (2C), 128.8 (2C), dmbC5; 150.8 (2C), 150.9 (2C), dmbC4; 
151.1 (2C), 151.6 (2C), dmbC6; 156.8 (2C), 157.0 (2C), dmbC2; 158.7 (2C), C6; 162.7 (2C), 
C2; 179.6 (2C), C4. 
Dichloro- [2,2'-bi-(5S,8R)-5,6, 7,8-tetrahydro-8,9,9-trimethyI-5 ,8-
methanoquinazoline-N3,N3']-palladium(II) (77). 
A hot solution of PdCb (5mg) in HCI (3ml) was added dropwise to a hot solution of 42 
(llmg, 0.06rnMol) in methanol (8ml). The resultant pale yellow precipitate of 77 was filtered 
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and air dried. Yield 9mg (26%). Ca1cd for C24H3oN4ChPd.1.5H20 C: 49.80, H: 5.74, N: 
9.68. Found C: 50.21, H: 5.46, N: 9.76. 
[2,2' -bi-(5S,SR)-5,6, 7 ,S-tetrahydro-S,9,9-trimethyl-5,S-methanoquinazoline-
N3,N3'] -tetracarbonyl-molybdenum (7S). 
A green solution of MO(CO)4C7H8 (l2mg, 0.04mMol) in dry THF was added 
dropwise(4ml), with stirring, to a solution of 42 (20mg, 0.05mMol) in dry THF (lOml). The 
solution rapidly became deep red and was stirred for 1 hour then diluted with petroleum ether 
(6ml) and cooled (O°C) overnight. The resultant red precipitate of 7S was filtered and dried. 
Yield 10mg (43%). Similarly, a two-fold excess of MO(CO)4C7H8 (24mg, 0.08mMol) gave 7S. 
Yield 13mg (56%). IH NMR (CDCI3) 0: 0.65 (6H), syn-9-CH3; 1.09 (6H), anti-9-CH3; 1.27 
(2H), endo-H6; 1.42 (2H), endo-H7; 1.47 (6H), 8-CH3; 2.04 (2H), exo-H7; 2.30 (2H), exo-
H6; 3.07 (2H), H5; 8.81 (2H), H4. 
Bis-( 4,4'-dimethyl-2,2'-bipyridine)-[2,2'-bi-(5S,SR)-5,6, 7,S-tetrahydro-S,9,9-
trimethyl-5,S-methanoquinazoline-N3,N3']-ruthenium(II)-bis-
(hexafluorophosphate) (79). 
Ligand 42 (27.9mg, 0.074mMol) was reacted with Ru(dmbhCh.2H20 (39mg, 
0.068mMol) and the resultant solid recrystallised from acetonitrile/ether, as described above, to 
give orange crystals of 79. Yield 75mg (91 %). Calcd for C52H60N lOP2F12Ru.2CH3CN C: 
51.36, H: 4.97, N: 11.52. Found C: 51.04, H: 5.06, N: 11.34. FAB mass spectrum: ca1cd for 
[C48H54N8PF6Ru]+: 989.316. Found: 989.317. IH NMR showed the complex to exist as two 
diastereoisomers. IH NMR (CD3CN) 0: 0.36 (6H), ~-syn-9-CH3; 0.77 (6H), A-syn-9-CH3; 
0.96 (2H), ~-endo-H6, A-endo-H6, ~-endo-H7 or A-endo-H7; 1.07 (6H), 1.12 (6H), A-anti-9-
CH3 and ~-anti-9-CH3; 1.22 (2H), ~-endo-H6, A-endo-H6, ~-endo-H7 or A-endo-H7; 1.34 
-
(2H), ~-endo-H6, A-endo-H6, ~-endo-H7 or A-endo-H7; 1.41 (2H), 1.45 (2H), ~-8-CH3 and 
A-8-CH3; 1.50 (2H), ~-endo-H6, A-endo-H6, ~-endo-H7 or A-endo-H7; 2.12-2.31 (8H), ~­
exo-H6, A-exo-H6, A-exo-H7 and A-exo-H7; 2.58 (24H), dmb4-CH3; 2.98 (2H), 3.02 (2H), 
A-H5 and ~-H5; 7.27 (8H), dmbH5; 7.51 (2H), 7.54 (4H), dmbH6; 7.65 (2H), 7.68 (2H), 
A-H4 and ~-H4; 7.70 (2H), dmbH6; 8.39 (8H), dmbH3. 13C NMR (CD3CN) 0: 9.4 (2C), 9.5 
(2C), A-8-CH3 and A-8-CH3; 18.2 (2C), 18.3 (2C), A-anti-9-CH3 and ~-anti-9-CH3; 19.1 
(2C), 19.8 (2C), A-syn-9-CH3 and ~-syn-9-CH3; 20.6 (8C), dmb4-CH3; 24.8 (2C), 24.9 (2C), 
A-C6 and A-C6; 31.0 (2C), 31.1 (2C), A-C7 and ~-C7; 49.7 (2C), 49.8 (2C), A-C5 and ~-C5; 
55.5 (4C), A-C9 and ~-C9; 58.1 (2C), 58.2 (2C), A-C8 and ~-C8; 125.16 (4C), 125.23 (2C), 
125.3 (2C), dmbC3; 128.5 (4C), 128.6 (2C), 128.7 (2C), dmbC5; 141.8 (4C), A-C4a and 
~-C4a; 148.7 (2C), 149.0 (2C), A-C4 and ~-C4; 150.5 (2C), 150.6 (4C), 150.64 (2C), dmbC4; 
151.0 (2C), 151.1 (2C), 151.4 (2C), 151.7 (2C), dmbC6; 156.85 (2C), 156.92 (2C), 157.0 
(4C), dmbC2; 162.1 (4C), A-C2 and ~-C2; 180.5 (2C), 180.6 (2C), A-C8a and ~-C8a. 
Dichloro-mercury(II)-bis-( 4,4'-dimethy 1-2,2' -bipyridine)-J.1- [2,2'-b i-(5S ,8R)-
5,6,7 ,8-tetrahydro-8,9,9-trimethyl-5 ,8-methanoquinazoline-Nl,Nl'-N3,N3']-
ruthenium(II)-bis-(hexafluorophosphate) (80). 
A solution of HgCh (4.8mg, 0.18mMol) in acetone (5ml) was added dropwise to a stirred 
solution of 42 (20mg, 0.018mMol) in dichloromethane (lOml). The resultant purple solution 
was concentrated to 5ml and ether (5m!) was added to give a purple precipitate of 80, which was 
filtered and air dried. Yield 16mg (65%). IH NMR (CD3CN)~: 0.36 (6H), ~-syn-9-CH3; 0.77 
(6H), A-syn-9-CH3; 0.96 (2H), ~-endo-H6, ~-endo-H6, A-endo-H7 or A-endo-H7; 1.07 (6H), 
1.12, A-anti-9-CH3 and ~-anti-9-CH3; 1.22 (2H), ~-endo-H6, ~-endo-H6, A-endo-H7 or A-
endo-H7; 1.34 (2H), ~-endo-H6, ~-endo-H6, A-endo-H7 or A-endo-H7; 1.48 (2H), 1.52 (2H), 
~-8-CH3 and A-8-CH3' 1.50 (2H), ~-endo-H6, ~-endo-H6, A-endo-H7 or A-endo-H7; 2.12-, 
2.31 (8H), ~-exo-H6, A-exo-H6, ~-exo-H7 and A-exo-H7; 2.58 (24H), dmb4-CH3; 2.99 (2H), 
3.02 (2H), 3.06 (2H), A-H5 and ~-H5; 7.28 (6H), 7.29 (2H), dmbH5; 7.50 (2H), 7.53 (4H) , 
dmbH6; 7.70 (4H), dmbH6 and A-H4 or ~-H4; 7.74 (2H), A-H4 or ~-H4; 8.39 (8H), dmbH3. 
B is- (2,2' -bi pyridine) -[2 ,4-bis-(l-pyrazoly I)pyrimidine-Nl ,N2'] -ru thenium(II)-
bis-(hexafluorophosphate) (87). 
2,4-Bis-(l-pyrazolyl)pyrimidine (53) (l5.7mg, 0.074mMol) was reacted with 
Ru(bpyhCI2.2H20 (35mg, 0.067mMol) as described above. Complex 87 was obtained as an 
orange solid. Yield 59mg (88%). FAB mass spectrum: calcd for [C30H24N lOPF6Ru]+: 
771.0871. Found: 771.0869. IH NMR (CD3CN) ~: 6.78, H4"; 6.89, H4'; 7.42, bpyH5a; 
7.46, bpyH5b; 7.50, H3'; 7.55, bpyH5d; 7.57, bpyH5c; 7.79 (2H), H5 and bpyH6a; 7.83, 
bpyH6b; 7.86, H6; 8.01, H3"; 8.02, bpyH6c; 8.10, bpyH4a; 8.13, bpyH4b; 8.17 (2H); 
bpyH4c and bpyH4d; 8.24, bpyH6d; 8.53, bpyH3a; 8.56 (3H), bpyH3b, bpyH3c and bpyH3d; 
8.90, H5"; 9.06, H5'. 
Bis- (4,4' -dimethyl-2,2' -bipyridine)- [2,4-bis-(l-pyrazoly l)pyrimidine-Nl,N2']-
ruthenium(II)-bis-(hexafluorophosphate) (88). 
2,4-Bis-(l-pyrazolyl)pyrimidine (53) (14mg, 0.066mMol) was reacted with 
Ru(dmbhCh.2H20 (35mg, 0.061mMol) as described above. The resultant brown solid was 
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recrystallised fonn acetonitrile/ether to give 88 as a microcrystalline product. Yield Slmg (80%). 
FAB mass spectrum: calcd for [C34H32N lOPF6Ru] +: 827.1497. Found: 827.1494. IH NMR 
(CD3CN) a: 2.S8 (3H), 2.S9 (3H), 2.61 (3H), 2.62 (3H), dmb4-CH3; 6.78, H4"; 6.88, H4'; 
7.2S, dmbHSa; 7.29, dmbHSb; 7.34, dmbHSc; 7.38, dmbHSd; 7.47, H3'; 7.S9, dmbH6a; 7.62, 
dmbH6b; 7.79, HS; 7.82, dmbH6c; 7.87, H6; 8.00, H3"; 8.03, dmbH6d; 8.37, dmbH3a; 8.40 
(3H), dmbH3b, dmbH3c and dmbH3d; 8.89, HS"; 9.04, HS'. 
Tri-[2,4-bis-(1-pyrazolyl)pyrimidine-Nl,N2'J-ruthenium(II) 
-bis-(hexafluorophosphate) (89). 
2,4-Bis-(1-pyrazoly1)pyrimidine (53) (20mg, 0.094mMol) was reacted with 
Ru(DMSO)4Clz (13.8mg, 0.029mMol) as described above. Complex 89 was obtained as a 
yellow solid and recrystallised from acetonitrile/ether. Yield 20mg (67%). FAB mass spectrum: 
calcd for [C30H24N18PF6Ru]+: 883.1117. Found: 883.111S. IHNMR (CD3CN) a: 6.80 (4H), 
H4"; 6.93 (2H), 6.96 (2H), H4'; 7.67, 7.72, H3'; 7.83, 7.86 (3H), HS; 7.89, 7.91, H3'; 8.02 
(2H), 8.03 (2H), H3"; 8.06, 8.09, 8.33, 8.3S, H6; 8.91 (4H), HS"; 9.0S, 9.07, 9.08, 9.09, 
HS', 
Dichloro-[2-(2-pyridinyl)perimidine-N3,Nl 'J-palladium(II) (96). 
A hot solution of 93 (29.4mg, 0.12mMol) in methanol (8ml) was added dropwise to a 
hot solution of palladium chloride (20mg, 0.11mMol) in HCI (7ml). The resultant brown 
precipitate of 96 was filtered and dried in a vacuum desiccator. Yield 3Smg (7S%). Calcd for 
C16HllN3C12Pd C: 4S.47, H: 2.62, N: 9.94. Found C: 4S.70, H: 2.73. N: 9.68. IH NMR 
(DMSO-d6)-tentative assignments-a: 6.87, H9; 7.18, H4; 7.29 (4H), HS, H6, H7 and H8; 7.8S, 
HS'; 8.22, H4'; 8.S6, H3'; 8.87, H6; 11.9S, HI. 
Tetracarbonyl-[2-(2-pyridinyl)perimidine-N3,Nl 'J-molybdenum (97). 
A mixture of 93 (S2mg, 0.21mMol) and MO(CO)6 (SSmg, 0.21mMol) in argon purged 
toluene (Sml) was refLuxed for 1.S hours under an argon atmosphere. The solution was cooled to 
room temperature, diluted with ether (20ml) and cooled (O°C) overnight. Purification attempts by 
chromatography on alumina (eluent-acetone) or by recrystallisation (acetone/ether or THF/ether) 
resulted in dissociation of the complex. IH NMR (DMSO-d6) a: 6.89, H9; 7.3S, H8; 7.37, H7; 
7.41, H6; 7.46, HS; 7.62, H4; 7.89, HS'; 8.42, H4'; 8.71, H3'; 9.21, H6'; 11.S3, HI. 
Bis-(2,2' -bi pyridine )-[2-(2-pyridiny l)perimidine-N3,N1'] -ruthenium(II) -bis-
(hexafluorophosphate) (98). 
Ligand 93 (13.Smg, O.OSSmMol) was reacted with Ru(bpyhCI2.2H20 (26mg, 
0.050mMol) as described above. Complex 98 was obtained as a black solid. Yield 34mg 
(72%). IH NMR (CD3CN) D: S.84, H4; 6.63, HS; 6.81, H9; 7.09, H6; 7.16, H7; 7.25, H8; 
7.3S, 7.43, bpyHS; 7.47, HS'; 7.S7, bpyHS; 7.S8, bpyH6; 7.63 (2H), H6' and bpyHS; 7.72, 
7.8S, bpyH6; 8.09, 8.11, 8.0S, bpyH4; 8.17 (2H), H4' and bpyH4; 8.4S, 8.48, 8.S2, bpyH3; 
8.S6, H3'; 8.62, bpyH4; 8.8S, bpyH6; HI not observed. 
Bis-( 4,4'-dimethyl-2,2' -bipyridine)-[2-(2-pyridinyl)perimidine-N3,N1']-
ruthenium(II)-bis-(hexafluorophosphate) (99). 
Ligand 93 (13.Smg, O.OSSmMol) was reacted with Ru(dmbhCI2.2H20 (28.8mg, 
O.OSOmMol) as described above. Complex 99 was isolated as a black solid. Yield 43mg (86%). 
IH NMR (CD3CN) D: 2.S6 (3H), 2.S7 (3H), 2.S8 (3H), 2.63 (3H), dmb4-CH3; S.96, H4; 
6.70, HS; 6.89, H9; 7.17, H6; 7.19, dmbHSa; 7.22, H7; 7.27, dmbHSb; 7.29, H8; 7.38, 
dmbH5c; 7.40, dmbHSd; 7.41, dmbH6a; 7.47, HS'; 7.52, dmbH6b; 7.6S, dmbH6c; 7.66, H6'; 
8.16, H4'; 8.31, dmbH3b; 8.33, dmbH3c; 8.40, dmbH3a; 8.4S, dmbH3d; 8.S8, H3'; 8.61, 
dmbH6d; HI-not observed. 
Dichloro-[1-methyl-2-(2-pyridinyl)perimidine]-palladium(II) (100). 
Palladium chloride (21.2mg, 0.12mMol) was dissolved in hot HCI (Sml) and added 
dropwise to a hot solution of 94 (32.3mg, 0.13) in methanol (Sml). The resultant brown 
precipitate was filtered, dried in a vacuum desiccator and dissolved in the minimum volume of 
DNIF. A layer of methanol was carefully added and after 2 days crystals suitable for x-ray were 
obtained. Yield 17mg (32%). IH NMR (DMSO-d6) D: 3.33 (3H), 1-CH3; 7.0S (2H), H4 and 
H9; 7.S4, 7.S6, HS and H8; 7.S9, 7.64, H6 and H7; 7.89, HS'; 8.12, H3'; 8.30, H4'; 8.98, 
H6'. 
Bis-( 4,4' -dimethyl-2,2' -bipyridine)- [1-methyl-2-(2-pyridinyl)perimidine]-
ruthenium(II)-bis-(hexafluorophoshate) (101). 
I-Methyl-2-(2-pyridinyl)perimidine (94) (14.3mg, O.OSSmMol) was reacted with 
Ru(dmbhCI2.2H20 (30mg, 0.OS2mMol), as described above, to give 101 as a brown solid. 
Yield 39mg (74%). FAB mass spectrum: ca1cd for [C41H37N7PF6Ru]+: 874.180. Found: 
874.182.1H NMR (CD3CN) D: 2.S4 (3H), 2.S8 (6H), 2.64 (3H), dmb4-CH3; 3.74, l-CH3; 
6.13, H4; 6.71, H9; 6.77, HS; 7.19, dmbSHa; 7.2S, H6; 7.28, dmbHSb; 7.31, H7; 7.36, 
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dmbH5d; 7.39, H8; 7,40, H5'; 7.46, dmbH5c; 7,48, dmbH6a; 7.62, dmbH6b; 7.69, H6'; 7.92, 
dmbH6c; 8.08, H4'; 8.25, dmbH3b; 8.30, dmbH3c; 8.33, H3'; 8,41, dmbH6d; 8,46, dmbH3a; 
8.51, dmbH3d. l3C NMR (CD3CN) 0: 20.5, 20.6 (2C), 20.7, dmb4-CH3; 42.3, 1-CH3; 
106.2, C9; 114.8, C4; 120.7, C9b; 121.8, C7; 123.5, C8; 124.80, 124.83, 125.57, 125.63, 
dmbC3; 125.6, 128.0, C3' and C5'; 128.0, 128.5, 128.56,128.61, dmbC5; 128.9, C6; 129.6, 
C5; 134.7, C6a; 136.8, C4'; 142.1, C3a; 147.5, C9a; 150.5 (3C), dmbC6 and dmbC4; 150.6, 
150.8, dmbC4; 151.7, 152.3, 152.7, dmbC6; 153.9, C6'; 155.7, C2'; 157.0, 157.1, 157.3, 
157.8, dmbC2; 161.4, C2. 
Chloro-tris-[I-methyl-2-(2-pyridinyl)perimidine-N3,N3,Nl' ,Nl' ,Nl ']-
ruthenium(II)-hexafluorophoshate (102). 
Ligand 94 (30mg, 0.116mMol) was reacted with Ru(DMSO)4Cb (17mg, 0.035mMol) as 
described above. The resultant solid was chromatographed on a column of alumina (8x2cm) and 
eluted with methanolfchlorofonn (1:50) as a purple band. The band was collected and the solvent 
removed in vacuo to give 102 as a purple solid. Yield 22mg (59%). FAB mass spectrum: calcd 
for [CS1H39N9CIRu]+: 879.237. Found: 879.235. IH NMR «CD3hCO) 0: 2.91 (3H), 2.93 
(3H), 1a-CH3 and 1b-CH3; 4.33 (3H), Ic-CH3; 6.38, H4a; 6,46, H4b; 6.56 (2H), H9a and 
H9b; 6.97, H5c; 7.03 (2H), H5b and H9c; 7.07, H5a; 7.33, H4c; 7,47, H6c; 7,43 (2H), H8a 
and H8b; 7,47 (2H), H6a and H7c; 7,48, H6b; 7.55, H7a or H7b; 7.57, H8c; 7.58, H7a or 
H7b; 7.70, H5'c; 7.79, 7.81, H5'a and H5'b; 8.28 (2H), H4'a and H4'b; 8.37, H4'c; 8.38, 
8.41, H3'a and H3'b; 8.76, H6'a or H6'b; 8.88, H6'c; 9.02, H3'c; 9.29, H6'a or H6'b. 
Notation a-c refers to spin systems of pyridine and perimidine rings. 
Dichloro-2-(2-pyrimidinyl)perimidine-palladium(II) (105). 
Palladium chloride (14.1mg, 0.08mMol) was dissolved in hot HCI (5ml) and added 
dropwise to a hot solution of 95 (20mg, 0.081mMol) in methanol (5ml). The resultant grey 
precipitate of 105 was filtered and dried. Elemental analyses of the complex were unsatisfactory. 
Yield 25mg (73%). 
n is-( 4,4' -dimethyl-2,2'-bipyridine)- [2- (2-pyrimidinyl)perimidine]-
ruthenium(II)-bis-(hexafluorophoshate) (106). 
2-(2-Pyrimidinyl)perimidine (95) (11.4mg, 0.046mMol) was reacted with 
Ru(dmbhCb.2H20 (25.0mg, 0.043mMol), as described above, to give 106 as a brown solid. 
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Yield 42 (97%). FAB mass spectrum: calcd for [C39H34NgPF6Ru]+: 861.1592. Found: 
861.1592. 1 H NMR (CD3CN) i>: 2.57 (3H), 2.58 (3H), 2.60 (3H), 2.63 (3H), dmb4a-CH3, 
dmb4b-CH3, dmb4c-CH3 and dmb4d-CH3; 5.76, H4; 6.71, H5; 6.84, H9; 7.19, H6; 7.22 
(2H), H7 and dmbH5a; 7.29, H8; 7.30, dmbH5b; 7.41 (2H), dmbH5c, dmbH6a; 7.44, 
dmbH5d; 7.52, H5'; 7.63, dmbH6b; 7.65, dmbH6c; 7.92, H6'; 8.36 (2H), dmbH3b, dmbH3c; 
8.38, dmbH3a; 8.43, dmbH3d; 8.65, dmbH6d; 9.02, H4'. 
4,6-Bis-(2-pyridinyl)pyrimidine-dichloro-palladium(II) (114). 
Palladium chloride (15mg, 0.086mMol) was dissolved in hot HCI (5ml) and added 
dropwise to a hot solution of 109 (20mg, 0.086) in methanol (5ml). The resultant precipitate 
was filtered and dried in a vacuum desiccator. Yield 28mg. Elemental analysis indicated a 
mixture of monopalladium (114) and dipalladium complexes (115). Calcd for C14HlON4ChPd 
C: 40.86, H: 2.45, N:13.61. Found C: 30.45, H: 2.15, N: 10.17. 
jl-(4,6-Bis-(2-pyridinyl)pyrimidine)-tetrachloro-dipalladium(II) (115). 
A hot solution of 109 (lOmg, 0.043) in methanol (5ml) was added dropwise to a hot 
solution of papadium chloride (15.2mg, 0.086mMol) in HCI (5ml). The resultant yellow 
precipitate of 115 was filtered and dried in a vacuum desiccator. Yield 20.9mg (83%). Calcd for 
C14HlON4C12Pd2.H20 C: 27.77, H: 1.99, N: 9.23. Found C: 27.87, H: 1.55, N: 9.25. 
4,6-Bis-(2-pyridinyl)pyrimidine-tetracarbonyl-molybdenum(O) (116). 
A mixture of 109 (60mg, 0.256mMol) and Mo(CO)6 (66mg, 0.250mMol), in toluene, 
(lOmI) was degassed for 1 hour, then refluxed for 2 hours under an argon atmosphere. The 
resultant blue solution was cooled to room temperature, evaporated to dryness in vacuo, and the 
residue extracted with acetone. The acetone extract was filtered and the filtrate absorbed onto an 
alumina column (2.5x20cm). The mononuclear complex was eluted with acetone as a purple 
band, collected and concentrated in vacuo to a volume less than 1ml. The solution was diluted 
with ether (5ml) and petroleum ether (5ml) to give a purple precipitate of 116 which was filtered 
and air dried. Yield 80mg (72%). Calcd for ClsH1oN404Mo C: 48.89, H: 2.28, N: 12.67. 
Found C: 49.09, H: 2.26, N: 13.02. 1H NMR ((CD3hCO) i>: 7.80, H5"; 7.95, H5'; 8.25, 
H4"; 8.46, H4'; 8.78, H3"; 8.98, H6"; 9.10, H3'; 9.36, H6'; 9.51, H5; 9.85, H2. IH NMR 
(DMSO-d6) i>: 7.78, H5"; 7.96, H5'; 8.23, H4"; 8.46, H4'; 8.77, H3"; 8.97, H6"; 9.09, H3'; 
9.36, H6'; 9.47, H5; 9.85, H2. 
J-L-4,6-Bis-(2-pyridinyI)pyrimidine-octacarbonyl-dimolybdenum(O) (117). 
A mixture of 109 (40mg, 0.17mMoI) and MO(CO)6 (212.2mg, 0.80mMoI), in argon 
purged toluene (SmI), was refluxed for 6 hours under an argon atmosphere. The green solution 
was cooled to room temperature, diluted with ether (20mI) and cooled (O°C) overnight. The 
resultant blue precipitate was filtered and air dried. The product was dissolved in acetone and 
eluted down a column of alumina (2.Sx20cm). The blue band, which separated from traces of the 
pink mononuclear complex, was collected and the acetone concentrated (20mI). Petroleum ether 
(Sml) was added and the solution cooled (O°C) to give 117 as a dark blue microcrystalline solid. 
Yield 62mg (S6%). Ca1cd for C2zHlON408M02 C: 40.64, H: 1.SS, N: 8.62. Found C: 40.30, 
H: 1.48, N: 8.82. IH NMR ((CD3hCO) 0: 7.98 (2H), HS'; 8.47 (2H), H4'; 9.22 (2H), H3'; 
9.38 (2H), H6'; 9.73, HS; 10.37, H2. IH NMR (DMSO-d6) 0: 7.93 (2H), HS'; 8.50 (2H), 
H4'; 9.21 (2H), H6'; 9.26 (2H), H3'; 9.70, HS; 9.97, H2. 
Reaction of 109 with copper(II) chloride. 
To a solution of CuClz.2HZO (S4.58mg, 0.320mMol) in methanol (SmI) was added 109 
(2Smg, O.l07mMol) in methanol (SmI). The resultant green precipitate was filtered and air dried. 
Yield 14mg (24%). Ca1cd for C14HlON4CI4CU2.2HZO C: 31';19, H: 2.60, N: 10.39. Found C: 
31.16, H: 2.02, N: 10.29. 
Reaction of 109 with copper(I1) perchlorate. 
To a solution of CU(CI04h.6H20 (S2.4mg, 0.140mM0I) in acetonitrile (2ml) was added 
109 (l6.6mg, 0.070mMol) in acetonitrile (2m1). After standing for 3 days, the blue solution 
deposited a blue solid which was filtered and air dried. Additional product precipitated from the 
filtrate when cooled (O°C) overnight. Yield 2Smg (64%). Calcd for C14H14N401OCl2CU C: 
31.27, H: 2.62, N: 10.42. Found C: 30.6S, H: 2.3S, N: 10.31. 
Reaction of 109 with nickel(II) perchlorate. 
To a solution of Ni(CI04)z.6H20 (34.37mg, 0.094mMol) in methanol (Sm1) was added 
109 (llmg, 0.047mMol) in methanol (Sm1). The resultant pale yellow precipitate was filtered 
and air dried. Yield 21mg (8S%). Calcd for C14H14N401OCIZNi C: 31.87, H: 2.67, N: 10.61. 
Found C: 32.11, H: 2.79, N: 10.77. 
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B is-(2,2' -bipyridine )-4,6-bis~ (2-pyridinyl)pyrimidine-ruthenium(II)-bis-
(hexafluorophosphate) (119). 
4,6-Bis-(2-pyridinyl)pyrimidine (109) (40mg, 0.171mMol) was reacted with 
Ru(bpyhCh.2H20 (80.8mg, 0.155mMol) as described above. The solid was chromatographed 
on a column of alumina (8x2.5cm). The product was eluted with dichloromethane/methanol 
(100: 1) as a red band which was collected and the solvent removed in vacuo to give 119 as a red 
solid. Yield 101mg (69%). Calcd for C34H26NgP2F12Ru.H20 C: 42.73, H: 2.95, N: 11.72. 
Found C: 42.86, H: 2.68, N: 11.72. FAB mass spectrum: calcd for [C34H26NgPF6Ru]+: 
793.0966. Found: 793.0968. IH NMR (CD3CN) B: 7.47, 7.48 (2H), 7.49, bpyH5; 7.59, H5'; 
7.65, H5"; 7.78 (2H), 7.84, bpyH6; 7.90, H6'; 8.01, bpyH6; 8.06, H4"; 8.14 (4H), bpyH4; 
8.20, H4'; 8.51, H3"; 8.54, H2; 8.58 (4H), bpyH3; 8.88, H6"; 8.89, H3'; 9.42, H5. 13C 
NMR (CD3CN) B: 115.0, C5; 122.6 C3"; 124.7 (2C), 124.77, 124.8, bpyC3; 126.8, C3'; 
127.3, C5"; 127.9, 128.0, 128.1 (2C) bpyC5; 129.8, C5'; 138.3 (2C), C4" and bpyC4; 138.4 
(4C), C4' andbpyC4; 150.6, C6"; 151.9, C6'; 152.2, C2"; 152.3, 152.4, 152.67, 152.74, 
bpyC6; 155.8, C2'; 157.3 (2C), 157.4 (2C), bpyC2; 160.2, C2; 163.9, C6; 165.2, C4. In 
addition, the binuclear complex 121 was eluted with dichloromethane/methanol (10: 1) as a purple 
band, which was collected and the solvent removed in vacuo to give a purplelblack solid. Yield 
20mg (7%). 
B is- (4,4' -dimethyl-2,2' -bipyridine)-4,6-bis-(2-pyridinyl)pyrimidine-
ruthenium(II)-bis-(hexafluorophosphate).(120) 
4,6-Bis-(2-pyridinyl)pyrimidine (109) (40mg, 0.171mMol) was reacted with 
Ru(dmbhCb.2H20 (llOmg, 0.155mMol) as described above. The resultant solid was 
chromatographed on a column of alumina (8x2.5cm). The product was eluted with 
dichloromethane/methanol (l00:1) as a red band which was collected and solvent removed in 
vacuo to give 120 as a red solid. Yield 65mg (42%). Calcd for C3gH34NgP2F12Ru.H20 C: 
45.93, H: 3.45, N: 11.28. Found C: 44.92, H: 3.43, N: 11.34. FAB mass spectrum: calcd for 
[C38H34NsPF6Ru]+: 849.1592. Found: 849.1597. lH NMR (CD3CN) B: 2.58 (6H), dmb4-
CH3; 2.60 (6H), dmb4-CH3; 7.28 (2H), 7.32 (2H), dmbH5; 7.57 (2H), dmbH6 and H5'; 7.59, 
7.64, dmbH6; 7.65, H5"; 7.79, dmbH6; 7.90, H6'; 8.06, H4"; 8.17, H4'; 8.42 (4H), dmbH4; 
8.51, H3"; 8.52, H2; 8.86, H3'; 8.88, H6"; 9.39, H5. 13C NMR (CD3CN) B: 20.6 (4C), 
dmb4-CH3; 114.9, C5; 122.5, C3"; 125.3 (2C), 125.4 (2C), dmbC3; 126.7, C3'; 127.2, C5"; 
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128.5, 128.7 (3C), dmbC5; 129.6, C5'; 138.3, C4'; 140.0, C4"; 150.6, 150.86 150.92, , 
150.96, 151.27, 151.34, 151.4, 151.8, C6", dmbC4 and dmbC6 or C6"; 152.3, C2"; 152.6, 
C6' or dmbC6; 156.0, C2'; 156.8 (2C), 156.9 (2C), dmbC2; 160.1, C2; 163.4, C6; 165.4, C4. 
In addition the binuclear complex 122 was eluted with dichloromethane/methanol (10:1) as a 
purple band which was collected and solvent removed in vacuo to give a purple solid. Yield 5mg 
(1.6%). 
Tri- [4,6-bis-(2-pyridiny l)pyrimidine] -ruthenium(II)-bis-(hexafIuorophosphate) 
(123) . 
4,6-Bis-(2-pyridinyl)pyrimidine (109) (50.0mg, 0.213mMol) was reacted with 
Ru(DMSO)4CI2 (31.3mg, 0.065mMol) as described above. The resultant red solid was 
chromatographed on a column of alumina (8x2.5cm). The product 123 was eluted with 
dich1oromethane/methanol (100: 1) as a red band which was collected and solvent removed in 
vacuo to give a red solid. Yield 59mg (83%). FAB mass spectrum: calcd for 
[C42H30N12PF6Ru]+: 949.1402. Found: 949.1401. The IH NMR spectrum of 123 indicated a 
3: 1 mixture of meridonal and facial isomers. Attempts to separate the two isomers on sephadex, 
using NaCl (0.01M-0.05M) eluent, were unsuccessful. IH NMR (CD3CN) 0: 7.62 (4H), H5'; 
7.70 (2H), 7.72 (2H), H5"; 7.83, 7.92, 8.10, H6'; 8.12 (4H), H4"; 8.16, H6'; 8.25 (4H), 
H4'; 8.51, H2; 8.54 (4H), H3"; 8.59, 8.82, 8.88, H2; 8.91 (4H), H6"; 8.95, 8.97 (3H), H3'; 
9.57 (3H), 9.58, H5. IH NMR ((CD3hCO) 0: 7.78 (4H), H5'; 7.90 (4H), H5"; 8.19 (4H), 
H4"; 8.34, 8.44, H6'; 8.50 (2H), 8.51 (2H), H4'; 8.61 (2H), 8.62 (2H), H3"; 8.66, 8.74, 
H6'; 8.88, 8.97, H2; 8.99 (4H), H6"; 9.25, 9.30, H2; 9.42 (3H), 9.43, H3'; 9.68, 9.69, 9.70, 
9.71, H5. l3C NMR (CD3CN) 0: 115.5, 115.55, 115.6, 115.7, C5; 123.0 (4C), C3"; 127.1, 
127.2 (2C), 127.3, C5"; 127.6 (4C), C3'; 129.9 (2C), 130.2 (2C), C5'; 139.0 (2C), 139.1 
(4C), 139.2 (2C), C4' and C4"; 150.05, 150.1, 150.16, 150.2, C6"; 151.7 (4C), C2"; 152.9, 
153.3, 153.4, 153.8, C6'; 155.6 (2C), 155.7 (2C), C2'; 160.2, 160.6, 160.7, 161.1, C2; 163.8 
(4C), C6; 165.1 (2C), 165.2 (2C), C4. 
Tetrakis-(2,2'-bipyridine)-f.1-4,6-bis-(2-pyridinyl)pyrimidine-diruthenium(II)-
tetrakis-(hexafIuorophosphate) , (121). 
4,6-Bis-(2-pyridinyl)pyrimidine (109) (20mg, 0.0854mMol) was reacted with 
Ru(bpyhCI2.2H20 (82.7mg, 0.171mMol) and the product recrystallised from ether/acetonitrile, 
as described above. Complex 121 was obtained as a dark purple microcrystalline solid. Yield 
] 15mg (82%). FAB mass spectrum: calcd for [CS4H42N 12P3F18Ru2]+: ] 497.0668. Found: 
1497.0662. The IH NMR spectrum of 121 indicated a 7:6 mixture of two diastereoisomers, 
121a and 121b. The binuclear complex (5mg) was dissolved in 2-3 drops of water/acetonitrile 
(2: 1) and absorbed onto C-25 sephadex. The column was eluted with NaCI (O.lM), followed by 
NaCI (0.3-0.5M) to give a purple band which was split into five fractions. Each fraction was 
treated with aqueous NH4PF6 and the resultant purple precipitate filtered and air dried. 1 H NMR 
analysis showed that the first fraction was slightly enriched in diastereoisomer 121a, whereas the 
fifth fraction was slightly enriched in diastereoisomer 121b. Fractions two to four showed no 
enrichment. Recrystallisation of the first and fifth fractions from ether/acetonitrile failed to 
achieve a greater enrichment of either isomer. Racemic diastereoisomer (!l~.IAA) 121a: 1 H 
NMR (CD3CN) 0: 7.13 (2H), 7.23 (2H), 7.25 (2H), 7.39 (2H), bpyH5; 7.48 (2H), 7.52 (2H), 
7.55 (4H), bpyH6; 7.59 (2H), H5'; 7.70, H2; 7.80 (2H), H6'; 7.99 (2H), 8.08 (2H), 8.1] 
(2H), 8.18 (2H), bpyH4; 8.26 (2H), H4'; 8.36 (2H), 8.44 (2H), 8.53 (2H), 8.55 (2H), bpyH3; 
9.04 (2H), H3'; 9.33, H5. Meso diastereoisomer (M) 121b: IH NMR (CD3CN) 0: 7.22 (2H), 
7.23 (2H), 7.27 (2H), 7.44 (2H), bpyH5; 7.60 (6H), bpyH6; 7.62 (2H), H5'; 7.66, H2; 7.82 
(2H), bpyH6; 7.87 (2H), H6'; 7.97 (2H), 8.10 (2H), 8.12 (2H), 8.20 (2H), bpyH4; 8.30 (2H), 
H4'; 8.46 (2H), 8.49 (2H),8.51 (2H), 8.52 (2H), bpyH3; 9.04 (2H), H3'; 9.35, H5. 
Tetrakis-( 4,4' -dimethyl-2,2' -bipyridine)-).1-4,6-bis-(2-pyridinyl)pyrimidine-
di ruthenium (II) -tetrakis -(hexafluorophosphate) (122). 
4,6-Bis-(2-pyridinyl)pyrimidine (109) (lOmg, 0.042mMol) was reacted with 
Ru(dmbhC12'2H20 (54.2mg, 0.094mMol) and the product was recrystallised from 
acetonitrile/ether, as described above. Complex 122 was obtained as a dark purple 
microcrystalline solid. Yield 75mg (94%). FAB mass spectrum: calcd for 
[C62HssN 12P3F18Ru2]+: 1609.192. Found: 1609.194. The IH NMR spectrum of 122 
indicated the presence of two diastereoisomers, 122a and 122b, in a ratio 5:3, although neither 
could be assigned to the meso or racemic form. 1 H NMR (CD3CN) Bridging ligand isomer 
122a 0: 7.56 (2H), H5'; 7.78 (2H), H6'; 7.97, H2; 8.23 (2H), H4'; 9.01 (2H), H3'; 9.32, H5. 
Bridging ligand isomer 122b 0: 7.58 (2H), H5'; 7.84 (2H), H6'; 8.26 (2H), H4'; 7.97, H2; 
9.02 (2H),.H3'; 9.33, H5. Dmb ligands of 122 0: 2.53 (6H), 2.55 (12H), 2.57 (12H), 2.62 
(l2H), 2.65 (6H), dmb4-CH3; 6.97 (2H), 6.99 (4H); dmbH5; 7.05 (2H), 7.06 (2H), dmbH6; 
7.12 (2H), 7.23 (2H), dmbH5; 7.23 (2H), dmbH6; 7.25 (2H), dmbH5; 7.28 (2H), 7.37 (4H), 
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dmbH6; 7.42 (4H), dmbH5; 7.54 (2H), dmbH6; 8.03 (2H), dmbH6; 8.12 (2H), 8.17 (2H), 
8.19 (2H), dmbH3; 8.35 (2H), 8.37 (2H), 8.38 (6H), dmbH3. 
His- (2,2' -bipyridine )-bis-( 4,4' -dimethyl-2,2' -bipyridine )-~-4,6-bis-(2-
pyridinyl)pyrimidine-diruthenium(II)-tetrakis-(hexafluorophosphate) (124). 
Complex 120 (l7mg, 0.0136mMol) was reacted with Ru(bpyhCh.2H20 (4.4mg, 
0.OO8mMol) as described above and the product recrystallised from acetonitrile/ether as described 
above. Complex 124 was obtained as a dark purple solid. Yield 22mg (95%). FAB mass 
spectrum: calcd for [C5gH50N12P3FlgRu2]+: 1553.1294. Found: 1553.1301. The IH NMR 
spectrum of 124 indicated the presence two diastereoisomers, 124a and 124b, in the ratio 7:6. 
The isomers were distinguished in the spectrum, but could not be assigned to either the meso or 
racemic forms. IH NMR (CD3CN) Bridging ligand isomer 124a 0: 7.56, H5"; 7.60, H5'; 
7.75, H2; 7.77, H6"; 7.80, H6'; 8.24, H4"; 8.25, H4'; 9.04 (2H), H3' and H3"; 9.33, H5. 
Bridging ligand isomer 124b 0: 7.58, H5"; 7.62, H5'; 7.81, H2; 7.85, H6"; 7.87, H6'; 8.26, 
H4"; 8.28, H4'; 9.04 (2H), H3' and H3"; 9.35, H5. Dmb and bpy ligands of 124 0: 2.55 
(3H), 2.56 (6H), 2.57 (3H), 2.61 (6H), 2.63 (3H), 2.65 (3H), dmb4-CH3; 6.95 (2H), dmbH5; 
7.02-7.09 (4H), dmbH5 and dmbH6; 7.13 (2H), bpyH5; 7.22-7.29 (8H), dmbH5, bpyH5 and 
dmbH6; 7.34-7.44 (6H), bpyH5, dmbH5 and dmbH6; 7.50-7.63 (8H), bpyH6, bpyH5; 7.84 
(2H), bpyH6; 7.94 (2H) bpyH4; 8.05-8.13 (6H), bpyH4, dmbH6; 8.19-8.37 (lOH), bpyH3, 
bpyH4, dmbH3; 8.50-8.56 (6H), bpyH3. 
Dichloropalladium(II)-bis-(2,2' -bipyridine) -Jl-[ 4,6-bis-(2-pyridinyl)pyrimidine]-
ruthenium(II)-bis-(hexafluorophosphate) (125). 
A solution of Pd(PhCNhCI2 (6.5mg, 0.017mMol) in dichloromethane was added 
dropwise to a solution of 119 (l5.3mg, 0.016mMol) in dichloromethane. The resultant dark 
blue precipitate of 125 was filtered and air dried. Yield 16mg (88%). Ca1cd for 
C34H26NgP2F12C12RuPd.H20 C: 36.04, H: 2.49, N: 9.89. Found C: 35.48, H: 2.01, N: 
10.12. FAB mass spectrum: calcd for [C34H26NgPF6CI2RuPd]+: 968.9375. Found: 968.9372. 
IH NMR (CD3CN) 0: 7.49, 7.51 (2H), 7.53, bpyH5; 7.71, H5'; 7.76, 7.78, 7.80, bpyH6; 
7.90, H5"; 7.99, H6'; 8.04, bpyH6; 8.16, 8.19 (2H), 8.22, bpyH4; 8.29, H4'; 8.44, H4"; 
8.59, 8.61 (3H), bpyH3; 8.70, H3"; 8.96, H3'; 9.05, H5; 9.10, H2; 9.26, H6". l3C NMR 
(CD3CN) 0: 116.5, C5; 124.8, 124.9 (3C), bpyC3; 126.1, C3" or C3'; 128.1, 128.2, 128.3, 
128.4, bpyC5; 128.7, C3' or C3"; 130.23, 131.4, C5' and C5"; 138.8, C4'; 138.9, 139.0, 
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139.2, 139.3, bpyC4; 142.0, C4"; 151.7, 152.0, bpyC6; 152.4, C6'; 152.7, 153.0, bpyC6; 
153.3, C6"; 153.8, 154.0, C2' and C2"; 156.9 (2C), 157.1 (2C), bpyC2; 159.8, C2; 161.8, 
C4; 167.9, C6. 
Tri-[bis-2,2' -bipyridine-J,l-4,6-bis- (2-pyridiny I) pyrimidine )-ruthenium(II)]-
ruthenium(II) -octa- (hexafluorophospha te) (127). 
Complex 123 (l5mg, 0.014mMol) was reacted with Ru(bpyhCh.2H20 (23.6mg, 
0.045mMol) as described above. The resultant solid was recrystallised from acetonitrile/ether to 
give 127 as a black microcrystaline solid. Yield 35mg (78%). 
Tetrakis- (2,2' bip yridine )-J,l-2,6-bis-[ 6-(2-pyridinyl)-4-pyrimidiny 1] pyridine-
diru thenium(II) -tetrakis (hexafluorphospha te) (131). 
Ligand 110 (lOmg, 0.026mMol) was reacted with Ru(bpyhCI2.2H20 (29.4mg, 
0.057mMol) as described above. The chloride salt of 131 was absorbed onto C-25 sephadex 
column. Excess Ru(bpyhCl2.2H20 was eluted as purple band with O.IM NaCL The product 
was eluted with 0.5M NaCI as a red band. This was collected, treated with aqueous NIf4PF6 and 
the resultant red precipitate was filtered and air dried. Yield 42mg (90%). FAB mass spectrum: 
ca1cd for [C63H47NlSP3F18Ru2]+: 1652.115. Found: 1652.117. IH NMR(CD3CN) 0: 7.48 
(2H) , 7.49 (4H), 7.50 (2H), bpyH5; 7.64 (2H), H5"; 7.79 (2H), 7.81 (2H), 7.86 (2H), 
bpyH6; 7.94 (2H), H6"; 8.05 (8.03) (2H), bpyH6; 8.16 (8H), bpyH4; 8.29, H4; 8.30 (2H), 
H4"; 8.60 (8H), bpyH3; 8.61 (2H), H2'; 8.71 (2H), H3 and H5; 9.14 (2H), H3"; 9.70 (2H), 
H5'. 
Bis-(2,2' -bipyridine )-2,6-bis- (1-pyrazo]yl) -1,5 -naph thyridine-ru thenium(II)-
bis-(hexafluorophosphate) (137). 
Ligand 132 (l5mg. 0.057mMol) was reacted with Ru(bpyhCI2.2H20 (26mg, 
0.050mMol) as described above. Complex 137 was obtained as a yellow solid. Yield 44mg 
(91%). FAB mass spectrum: ca1cd for [C34H26NlOPF6Ru]+: 821.1027. Found: 821.1026. IH 
NMR (CD3CN) 0: 6.66, H4"; 6.94, H4'; 7.32, H3'; 7.40, bpyH5b; 7.42, bpyH5d; 7.47, 
bpyH5a; 7.54, bpyH5c; 7.57, H8; 7.64, bpyH6a; 7.68, bpyH6b; 7.85, H3"; 8.02, H7; 8.03 
(2H), bpyH4a and bpyH6c; 8.13, bpyH4b; 8.16, bpyH4c; 8.17, bpyH4d; 8.19, bpyH6d; 8.44, 
bpyH3a; 8.47, H3; 8.53, bpyH3c; 8.56, bpyH3b; 8.61, bpyH3d; 8.69, H4; 8.75, H5"; 9.01, 
H5'. 
Bis- (4,4' -dimethy 1-2,2' -bi pyridine) -2,6-bis-(1-pyrazolyl) -1 ,5-na phthyridine-
ruthenium(II) -bis-(hexafluorophosphate) (138). 
2,6-Bis-(1-pyrazoly 1)-1 ,S-naphthyridine (132) (1Smg, 0.OS7mMol) was reacted with 
Ru(dmbhCh.2H20 (29mg, O.OSOmMol) as described above. The resultant solid was 
chromatographed on a column of alumina (2.Sx8cm). Complex 138 was eluted with 
chloroform/methanol (2S:1) as an orange band. Yield 4Smg (88%). FAB mass spectrum: calcd 
for [C38H34NlOPF6Ru]+: 877.16S3. Found: 877.16S7. IH NMR (CD3CN) B: 2.S2 (3H), 2.S9 
(3H), 2.61 (3H), 2.63 (3H), dmb4-CH3; 6.66, H4"; 6.93, H4'; 7.22, dmbHSd; 7.24, dmbHSb; 
7.27, dmbHSa; 7.29, H3'; 7.38, dmbHSc; 7.46, dmbH6a; 7,48, dmbH6b; 7.61, H8; 7.81, 
dmbH6c; 7.86, H3"; 7.96, dmbH6d; 8.06, H4; 8.31, dmbH3a; 8.39, dmbH3c; 8.40, dmbH3b; 
8.44, dmbH3d; 8.46, H3; 8.67, H4; 8.76, HS"; 9.00, HS'. 
Tetrakis-(2,2 '-bi pyridine)-1l-2,6-bis-(1-pyrazolyl) -1,5 -na phthyridine-
diruthenium(II)-tetrakis-(hexafluorophosphate) (139). 
Ligand 132 (Smg. 0.019mMol) was reacted with Ru(bpYhCb.2H20 (21mg, 
0.040mMol) as described above. The product was recrystallised from acetonitrile/ether to give 
139 as a red microcrystalline solid. The 1 H NMR spectrum of 139 indicated the formation of a 
single diastereoisomer as a major product, but also showed evidence of a minor product which 
may correspond to the other diastereoisomer. Yield 28mg (88%). FAB mass spectrum: calcd for 
[C54H42N 14P3FlSRu2]+: lS2S.0729. Found: lS2S.0734. IH NMR (CD3CN) B: 6.90 (2H), 
H4'; 7.30 (2H), H3'; 7.37 (2H), bpyHSa; 7.38 (2H) bpyHSb; 7.4S (2H), bpyH6a; 7.S0 (2H), 
bpyHSd; 7.S6 (2H), bpyH6b; 7.60 (2H), bpyHSc; 7.76 (2H), H4; 8.01 (2H), H3; 8.03 (2H), 
bpyH4a; 8.07 (2H), bpyH6c; 8.13 (2H), bpyH4b; 8.19 (2H), bpyH4c; 8.22 (2H), bpyH4d; 
8.28 (2H), bpyH6d; 8.37 (2H), bpyH3a; 8.S1 (2H), bpyH3c; 8.S6 (2H), bpyH3b; 8.62 (2H), 
bpyH3d; 8.79 (2H), HS'. 
Tetrakis-( 4,4' -dimethyl-2,2'-bipyridine)-J.l-2,6-bis-(1-pyrazolyl)-1 ,5-
naphthyridine-diru thenium(II)-tetrakis-(hexafluorop hospha te) (140). 
2,6-Bis-(1-pyrazo.lyl)-1,S-naphthyridine (132) (Smg, 0.019mMol) was reacted with 
Ru(dmbhC12.2H20 (23mg, 0.040mMol) as described above. Recrystallisation from 
acetonitrile/ether gave a red microcrystalline solid which was found, by IH NMR spectroscopy, 
to be a 3:2 mixture of a major and a minor isomer, corresponding to the two diastereoisomer 
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(meso and racemic). Ion-exchange chromatography on sephadex (0.1-0.5M NaCI eluent) failed 
to separate the isomers, neither of which could be unambiguously assigned to the meso or 
racemic diastereoisomers. Protons of the bridging ligand, but not the dmb ligands, were assigned 
to each isomer. Yield 23mg (68%). FAB mass spectrum: ca1cd for [C62H58N 14P3F18Ru2]+: 
1637.198. Found: 1637.201. IH NMR (CD3CN) bridging ligand-major isomer B: 6.90 (2H), 
H4'; 7.27 (2H), H3'; 7.82 (2H), H4; 8.10 (2H), H3; 8.76 (2H), H5'. Minor isomer B: 6.90 
(2H), H4'; 7.27 (2H), H3'; 7.77 (2H), H4; 8.08 (2H), H3; 8.75 (2H), H5'. Dmb ligands B: 
2.51-2.65 (48H), 4-CH3; 7.09-7.35 (18H), H5 and H6; 7.41 (3H), 7.44 (3H), H5; 7.73 (2H), 
7.80 (2H), 7.86 (2H), 8.01 (2H), H6; 8.30- 8.45 (l6H), H3. 
Tetrakis-(2,2' -bipyridine)-Il-(2,2': 4',4": 2f1 ,2 fI' -quaterpyridine)-
diru theniurn(II) -tetrakis-(hexafluorop hosphate) (141). 
The 1H NMR spectrum of 141 153 was assigned unambiguously. IH NMR (CD3CN) B: 
7.46 (4H) , 7.48 (4H), bpyH5; 7.51 (2H), H5; 7.80 (2H), H5'; 7.81 (6H), 7.83 (2H), bpyH6; 
7.84 (2H), H6; 7.95 (2H), H6'; 8.13 (4H), 8.14 (4H), bpyH4; 8.17 (2H), H4; 8.58 (8H), 
bpyH3; 8.77 (2H), H3; 8.89 (2H), H3'. 
Bis- (4,4' -dirnethyl-2,2' -bipyridine)-2,2': 4',4 fI :2" ,2' fI-quaterpyridine-
rutheniurn(II)-bis-(hexafluorophosphate) (146). 
Ru(dmbhCI2.2H20 (35.0mg, 0.061mMol) was reacted with 25 (l9.2mg, 0.064mMol) 
as described above. The complex 146 was obtained as a red solid. Yield 58mg (96%). FAB 
mass spectrum: calcd for [C44H38N8PF6Ru]+: 925.1905. Found: 925.1898. 1H NMR 
(CD3CN) B: 2.58 (6H), 2.60 (6H), dmb4-CH3; 7.29 (2H), 7.31 (2H), dmbH5; 7.48, H5; 7.52, 
H5'''; 7.59, 7.61 (2H), 7.66, dmbH6; 7.79, H5'; 7.83, H6; 7.87, H5"; 7.92, H6'; 8.02, 
H4"'; 8.13, H4; 8.42, dmbH3; 8.56, H3"'; 8.75, H3; 8.77, H6"'; 8.88, H3'; 8.90, H3"; 
8.93, H6". 
Tetrakis-( 4,4' -dimethyl-2,2' -bipyridine)-J.!-(2,2':4',4 fI: 2" ,2' fI-quaterpyridine)-
dirutheniurn(II)-tetrakis-(hexafluorophosphate) (147). 
The mononuclear complex 146 (35.4mg, 0.035mMol) was reacted with 
Ru(dmbhC12.2H20 (20mg, 0.035mMol) as described above. The binuclear complex 147 was 
obtained as a red solid. Yield 51mg (80%). FAB mass spectrum: calcd for 
[C68H62N 12P3F18Ru2]+: 1685.223. Found: 1685.224. 1H NMR (CD3CN) B: 2.58 (12H), 
2.60 (12H), dmb4-CH3; 7.29 (4H), 7.31 (4H) , dmbH5; 7.50 (2H), H5; 7.59 (6H), 7.61 (2H), 
190 
dmbH6; 7.78 (2H), H5'; 7.84 (2H), H6; 7.95 (2H), H6'; 8.15 (2H), H4; 8.42 (8H), dmbH3; 
8.75 (2H), H3; 8.87 (2H), H3'. 
Bis~(2,2' ~bipyridine)~ bis~( 4,4' ~dimethyl-2,2'-bipyridine)­
Jl-(2,2' :4' ,4":2 t, ,2'" -quaterpyridine)-diruthenium(II)-tetrakis-
(h~xafluorophosphate) (148). 
Ru(bpyhCI2.2H20 (19.5mg, 0.037mMol) was reacted with 146 (40.0mg, 0.037mMol), 
as described above, to give 148 as a red solid. Yield 63mg (91 %). FAB mass spectrum: calcd 
for [C64H54N12P3FlSRu2]+: 1629.161. Found: 1629.162. IH NMR (CD3CN) 0: 2.58 (6H), 
2.60 (6H), dmb4-CH3; 7.29 (2H), 7.31 (2H), dmbH5; 7.46 (2H), 7.48 (2H), bpyH5; 7.50, 
H5'''; 7.51, H5; 7.60 (3H), 7.61 (lH), dmbH6; 7.78, H5"; 7.80, H5'; 7.81 (2H), 7.83 (2H), 
bpyH6; 7.84 (2H), H6 and H6'''; 7.95 (2H), H6' and H6"; 8.13 (2H), 8.14 (2H), bpyH4; 
8.15, H4"'; 8.17, H4; 8.42 (4H), dmbH3; 8.58 (4H), bpyH3; 8.80, H3"'; 8.82, H3; 8.91, 
H3"; 8.93, H3'. 
Tris-(2,2' :4',4" :2" ,2"'-quaterpyridine)-ruthenium(II)-bis~ 
(hexafluorophosphate) (149). 
2,2':4',4":2",2"'-Quaterpyridine (25) (lOOmg, 0.32mMol) was reacted with 
Ru(DMSO)4Ch (47mg, O.lmMol) and the resultant solid recrystallised from acetonitrile/ether, as 
described above. Complex 149 was obtained as a red microcrystalline solid. Yield 111mg 
(84%). FAB mass spectrum: calcd for [C6oH42N12PF6Ru]+: 1177.234. Found: 1177.233. The 
IH NMR spectrum was assigned by comparison with the spectrum of 146. Proton signals were 
broadened due to the presence of meridonal and facial isomers, in a 3: 1 ratio respectively. 1 H 
NMR (CD3CN) 0: 7.55 (8H), H5 and H5'''; 7.84 (4H) , H5'; 7.87 (4H), H6; 7.88-7.92 (8H), 
H6' and H5'; 8.04 (4H), H4'''; 8.20 (4H), H4; 8.53 (4H), H3"'; 8.76 (4H), H3; 8.83 (4H), 
H6'''; 8.92-8.95 (8H), H3', H3" and H6". 
Tri-[bis- (2,2'-bipyridine)-Jl-(2,2' :4' ,4":2" ,2"'-quaterpyridine)-ruthenium(II)]-
ruthenium(II)-octakis-(hexafluorophosphate) (150). 
The homoleptic complex 149 20mg (0.015mMol) was reacted with Ru(bpyhCh.2H20 
(25.2mg, 0.048mMol), as described above, to give the tetranuclear complex 150 as a red solid, 
which was recrystallised from acetonitrile/ether. Yield 48mg (93%). Calcd for 
C120H90N24PgF4SRu4.8H20 C: 40.30, H: 2.99, N: 9.40. Found C: 40.39, H: 3.01, N: 9.40. 
Dichloropalladium(II)-bis-(2,2' -bipyridine)-J..L-(2,2':4',4":2",2" '-
q uaterpyridine)-ruthenium(II)-bis-(hexafluorophosphate) (151). 
A solution of Pd(PhCNhCI2 (l0.8mg, 0.028mMol) in dichloromethane was added 
dropwise to a solution of 146 (30mg, 0.028mMol) in dichloromethane. The resultant brown 
precipitate of 151 was filtered and air dried. Yield 16mg (48%). FAB mass spectrum: calcd for 
[C44H3SNsPF6CbRuPd]+: 1103.032. Found: 1103.034. IH NMR (CD3CN) 0: 2.59 (6H), 
2.61 (6H), dmb4-CH3; 7.30 (2H), 7.32 (2H), dmbH5; 7.52, H5; 7.74, H5'''; 7.85 (2H), H6 
and H5'; 8.01, H6'; 8.09, H5"; 8.18, H4; 8.31, H4"'; 8.43 (4H), dmbH3; 8.49, H3'''; 8.68, 
H3"; 8.82, H3; 8.99, H3'; 9.25, H6'''; 9.35, H6". 
B is-(2,21 -bipyridine)-2,21-bis-(1-pyrazolyl)-4,41-bipyridine-ruthenium(II)-bis-
(hexafluorophosphate) (157). 
Ligand 144 (27mg, 0.094mMol) was reacted with Ru(bpyhCb.2H20 (44mg, 
0.085mMol) as described above. The resultant solid was chromatographed on a column of 
alumina (8x2.5cm), whereupon 157 was eluted with chloroform/ methanol (50: 1) as a red band. 
The fraction was collected and the solvent removed in vacuo to give a red solid. Yield 37mg 
(44%). FAB mass spectrum: calcd for [C36H2SNlOPF6Ru]+: 847.11837. Found: 847.11841. 
IH NMR (CD3CN) 0: 6.63, H4'''; 6.88, H4"; 7.43, H3"; 7.44, bpyH5a; 7.48, bpyH5b; 7.50, 
bpyH5d; 7.55, bpyH5c; 7.67, H6; 7.71, H5'; 7.76, H6; 7.82, bpyH6a; 7.85, bpyH6b; 7.87, 
H3'"; 7.94, bpyH6c; 8.03, bpyH6d; 8.11, bpyH4a, 8.14, bpyH4b; 8.16 (2H), bpyH4c and 
bpyH4d; 8.44, H3'; 8.50, H3; 8.55, bpyH3d; 8.58 (3H), bpyH3a, bpyH3b and bpyH3c; 8.69, 
H6'; 8.70, H5"'; 9.01, H51l • The dinuc1ear complex 159 was eluted with chloroform/methanol 
(10: 1) as a red band which was collected and the solvent removed in vacuo to give a red solid. 
Yield 34mg (28%). 
B is-( 4,4' -dimethyl-2,21-bipyridine )_2,21_ bis-(1-pyrazolyl)-4 ,41-bipyridine-
ruthenium(II)-bis-(hexafluorophosphate) (158). 
Ligand 144 (27.5mg, 0.095mMol) was reacted with Ru(dmbhCI2.2H20 (49.9mg, 
0.087mMol) as described above. The product 158 was recrystallised fro1)1 ethanol/water to give 
an orange microcrystalline solid. Yield 85mg (83%). FAB mass spectrum: calcd for 
[C40H36N lOPF6Ru]+: 903.1801. Found: 903.1819. IH NMR (CD3CN) 0: 2.59 (3H), 2.60 
(3H), 2.61 (3H), 2.62 (3H), dmb4-CH3; 6.61, H4'''; 6.87, H4"; 7.27, dmbH5a; 7.32, 
dmbH5b; 7.34, dmbH5d; 7.36, dmbH5c; 7.41, H3"; 7.63, dmbH6a; 7.65 (2H), H5 and 
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dmbH6b; 7.75, dmbH6c; 7.76, H5'; 7.83, dmbH6d; 7.77, H6; 7.86, H3"'; 8.41, dmbH3a; 
8.42, H3'; 8.43 (3H), dmbH3b, dmbH3c and dmbH3d; 8.60, H3; 8.65, H6'; 8.67, H5"'; 9.06, 
H5". 
Tetrakis-(2,2 r _ bipyridine )-J.!-[2,2'. bis-(1-pyrazolyl)-4,4 r -bipyridine]-
diruthenium(II)-tetrakis-(hexafluorophosphate) (159). 
Ru(bpyhCh.2H20 (57mg, O.11mMol) was reacted with 144 (15.0mg, O.052mMol), as 
described above, to give 159 as a red solid. Yield 46mg (52%). FAB mass spectrum: ca1cd for 
[CS6H44N 14P3F 18Ru2]+: 1551.089. Found: 1551.087. 1 H NMR (CD3CN) 8: 6.90 (2H), H4"; 
7.44 (4H), H3" and bpyH5a; 7.47 (2H) , bpyH5b; 7.49 (2H), bpyH5c; 7.53 (2H), bpyH5d; 
7.67 (2H), H5; 7.81 (4H), H6 and bpyH6a; 7.83 (2H) , bpyH6b; 7.93 (2H), bpyH6c; 7.99 
(2H), bpyH6d; 8.11 (2H), bpyH4a; 8.14 (4H), bpyH4b and bpyH4c; 8.16 (2H), bpyH4d; 8.50 
(2H), H3; 8.54 (2H), bpyH3a; 8.57 (6H), bpyH3b, bpyH3c and bpyH3d; 9.02 (2H), H5". 
l3C NMR (CD3CN) 8: 111.1 (2C), C3; 112.4 (2C), C4"; 122.0 (2C), C5; 124.4 (C), 124.6 
(4C), 124.7 (2C), bpyC3; 127.6 (2C), 127.8 (2C), 128.0 (2C), 128.1 (2C), bpyC5; 132.7 (2C), 
C5"; 138.3 (2C), 138.4 (2C), 138.46 (2C), 138.52 (2C), bpyC4; 145.6 (2C), C3"; 146.4 (2C), 
C4; 152.1 (2C), C6; 152.2 (2C), 152.3 (2C), 152.6 (4C), bpyC6; 157.3 (2C), 157.5 (2C), 
157.6 (2C), 157.8 (2C), bpyC2; C2-not observed. 
Tetrakis-( 4,4' -dimethyl-2,2' -bipyridine )-J.!- [2,2' -bis-(1-pyrazolyl)-4,4'-
bipyridine]-diruthenium(II)-tetrakis-(hexafluorophosphate) (160). 
Ligand 144 (14.0mg, 0.049mMol) was reacted with Ru(dmbhC12.2H20 (56.5mg, 
0.098mMol) as described above. Complex 160 was obtained as a red solid. Yield 58mg (65%). 
FAB mass spectrum: ca1cd for [C64H6oN14P3F18Ru2]+: 1663.2138. Found: 1663.2142. IH 
NMR (CD3CN) 8: 2.59 (12H), 2.61 (l2H), dmb4-CH3; 6.89 (2H), H4"; 7.27 (2H), dmbH5a; 
7.31 (4H), dmbH5b and dmbH5d; 7.35 (2H), dmbH5c; 7.42 (2H), H3"; 7.60 (2H), dmbH6a; 
7.62 (2H), dmbH6b; 7.66 (2H), H5; 7.72 (2H), dmbH6c; 7.79 (2H), dmbH6d; 7.81 (2H), H6; 
8.39 (2H), H3; 8.41 (8H), dmbH3a, dmbH3b, dmbH3c and dmbH3d; 8.91 (2H), H5". l3C 
NMR (CD3CN) 8: 20.57, (2C), 20.62 (6C), dmb4-CH3; 110.9 (2C), C3; 112.3 (2C), C4"; 
121.9 (2C), C5; 125.0 (2C), 125.2 (4C), 125.3 (2C), dmbC3; 128.2 (2C), 128.4 (2C), 128.6 
(4C), dmbC5; 132.3 (2C), C5"; 145.1 (2C), C3"; 146.0 (2C), C4; 150.7 (2C), dmbC4; 150.88 
(2C), dmbC6; 150.94 (2C), 151.1 (2C), dmbC4; 151.2 (2C), 151.4 (4C), dmbC6; 152.0 (2C), 
C6; 152.1 (2C), dmbC4; 157.2 (2C), 157.3 (2C), 157.8 (2C), 157.9 (2C), dmbC2; C2-not 
observed. 
Bis-(2,2' -bipyridine)-bis-( 4,4 '-dirnethyl-2,2' -bipyridine)-J..l-[2,2' -bis-(1-
pyrazolyl)-4,4'-bipyridine]-dirutheniurn(II)-tetrakis-(hexafluorophosphate) 
(161). 
Complex 158 (40mg, 0.038mMol) was reacted with Ru(bpyhC12.2H20 (20mg, 
0.038mMol) and the resultant product recrysta1lised from acetonitrile/ether, as described above, to 
give 161 as a red microcrystalline solid. Yield S6mg (84%). FAB mass spectrum: calcd for 
[C6oH52N14P3F18Ru2]+: l607.1S1. Found: l607.1S3. IH NMR (CD3CN) 0: 6.89, H4'''; 
6.90, H4"; 7.27, dmbHSa; 7.29, dmbHSb; 7.30, dmbHSd; 7,34, dmbHSc; 7.41, H3'''; 7.44 
(2H), H3" and bpyHSa; 7.48, bpyHSb; 7.S0, bpyHSd; 7.S4, bpyHSc; 7.61, dmbH6a; 7.63, 
dmbH6b; 7.66, HS'; 7.67, HS; 7.72, dmbH6c; 7.79, dmbH6d; 7.81 (3H), H6, H6' and 
bpyH6a; 7.83, bpyH6b; 7.93, bpyH6c; 8.00, bpyH6d; 8.11, 8.14, 8.1S, 8.16, bpyH4; 8.39, 
H3'; 8.40, H3; 8.41 (4H), dmbH3; 8.S7 (3H), 8.S4, bpyH3; 8.92, HS"'; 8.94, HS". 
Dichloro-palladiurn(I1)-bis-(2,2' -bipyridine )-11-[2,2' -bis-(I-pyrazolyl)-4,4'-
bipyridine]-ruthenium(I1)-bis-(hexafluorophosphate) (162). 
A solution of Pd(PhCNhClz (S.7mg, O.OlSmMol) in dichloromethane was added 
dropwise to a solution of 157 (l4.8mg, O.OlSmMol) in dichloromethane. The resultant 
orange/red precipitate of 162 was filtered and air dried. Yield lS.3mg (87%). IH NMR 
(CD3CN) 0: 6.91, H4"; 6.92, H4'''; 7.4S (2H), H3" and bpyHSa; 7.48, bpyHSb; 7.S2, 
bpyHSd; 7.S4, bpyHSc; 7.72, HS; 7.81, bpyH6a; 7.83, bpyH6b; 7.8S, H6; 7.93, bpyH6c; 
7.96, HS'; 8.02, bpyH6d; 8.12, bpyH4a; 8.14 (2H), bpyH4b and bpyH4c; 8.16, bpyH4d; 8.19, 
H3"'; 8.29, H3'; 8.S3, H3; 8.S4, bpyH3a; 8.S7 (3H), bpyH3b, bpyH3c and bpyH3d; 8.7S, 
HS'''; 9.00, HS"; 9.14, H6'. 
Dichloro-palladiurn(II)-bis-( 4,4' -dimethyl-2,2' -bipyridine )-J..l-[2,2' -bis-(I-
pyrazolyl)-4,4' -bipyridine] -rutheniurn(II)-bis-(hexafluorophosphate) (163). 
A solution of Pd(PhCN)zC12 (9.Smg, 0.02SmMol) in dichloromethane was added 
dropwise to a solution of 158 (2S.3mg, 0.024mMol) in dichloromethane. The resultant red 
precipitate of 163 was filtered and air dried. Yield 16mg (S2%). FAB mass spectrum: calcd for 
[C40H36N lOPF6ClzRuPd]+: 1079.022. Found: 1079.02S. IH NMR (CD3CN) 0: 2.S9 (3H), 
2.60 (6H), 2.62, dmb4-CH3; 6.89, H4"'; 6.91, H4"; 7.28, dmbHSa; 7.31, dmbHSb; 7.38, 
dmbHSd; 7.39, dmbHSc; 7.42, H3"; 7.62, dmbH6a; 7.64' dmbH6b; 7.77, dmbH6c; 7.84, HS; 
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7.86 (2H), H6 and dmbH6d; 8.05, H5'; 8.08, H3"'; 8.40, dmbH3a; 8.43 (3H), dmbH3b, 
dmbH3c and dmbH3d; 8.60, H3'; 8.76, H3; 9.04, H6'; 9.12, H5"'; 9.31, H5". 
Bis-(2,2' -bipyridine)-[2,2'-bis-(3,5-dirnethyl-l-pyrazolyl)-4,4'-bipyridine]-
rutheniurn(II)-bis-(hexafluorophosphate) (164). 
Ligand 145 (33mg, 0.096mMol) was reacted with Ru(bpyhCI2.2H20 (45mg, 
0.086mMol) as described above. The resultant solid was absorbed onto a column of alumina. 
Complex 164 was eluted with chloroform/methanol (25: 1) as a red band. Evaporation of the 
fraction gave a red solid. Yield 50mg (50%). FAB mass spectrum: calcd for 
[C4oH36NlOPF6Ru]+: 903.181. Found: 903.182. lH NMR (CD3CN) 0: 1.58 (3H), 3"-CH3; 
2.29 (3H), 3"'-CH3; 2.71 (3H), 5"'-CH3; 2.98 (3H), 5"-CH3; 6.16, H4"'; 6.46, H4"; 7.41, 
bpyH5b; 7.44, bpyH5a; 7.54 (2H), H5 and bpyH5c; 7.57, bpyH5d; 7.60, H5'; 7.70, bpyH6; 
7.71, H6; 7.83, bpyH6b; 7.96, bpyH6c; 8.06 (2H), bpyH4a and bpyH6d; 8.09, bpyH4b; 8.15, 
bpyH4d; 8.20 (2H), H3' and bpyH4c; 8.54, H3; 8.57 (2H), bpyH3a and bpyH3b; 8.58 (2H), 
bpyH3c and bpyHd; 8.64, H6'. The binuclear complex 165 was eluted with 
chlorofonnlmethanol (10:1) as a red band. Yield 18mg (11 %). 
Tetrakis-(2,2'-bipyridine)-Jl-[2,2'-bis-(3,5-dimethyl-l-pyrazolyl)-4,4'-
bipyridine]-diruthenium(II)-tetrakis-(hexafluorophosphate) (165). 
Ligand 145 (lOmg, 0.029mMol) was reacted with Ru(bpyhC12.2H20 (35mg, 
0.067mMol) and the product 165 recrystallised from acetonitrile/ether as described above to give 
a red solid. Yield 22mg (43%). FAB mass spectrum: calcd for [C60H52N 14P3F18Ru2]+: 
1607.151. Found: 1607.154. IH NMR (CD3CN) 0: 1.58 (6H), 3"-CH3; 2.96 (6H), 5"-CH3; 
6.47 (2H), H4"; 7.41 (2H), bpyH5b; 7.43 (2H), bpyH5a; 7.49 (2H), H5; 7.52 (2H), bpyH5c; 
7.54 (2H), bpyH5d; 7.69 (2H), bpyH6a; 7.72 (2H), H6; 7.82 (2H), bpyH6b; 7.93 (2H), 
bpyH6c; 8.06 (2H), bpyH6d; 8.08 (2H), bpyH4b; 8.12 (2H), bpyH4a; 8.15 (2H), H3; 8.16 
(2H), bpyH4d; 8.17 (2H), bpyH4c; 8.56, bpyH3d; 8.57, bpyH3b; 8.58, bpyH3a; 8.59, 
bpyH3c;. 13C NMR (CD3CN) 0: 11.9 (2C), 3"-CH3; 15.0 (2C), 5"-CH3; 111.5 (2C), C4"; 
114.5 (2C), C3; 121.3 (2C), C5; 124.7 (2C), 124.75 (2C), 124.79 (4C), bpyC3; 127.8 (2C), 
127.9 (2C), 128.1 (2C), 128.2 (2C), bpyC5; 138.2 (2C), 138.28 (2C), 138.33 (2C), 138.5 
(2C), bpyC4; 146.3 (2C), 146.5 (2C), C5" and C4; 152.0 (2C), 152.1 (2C), 152.3 (2C), 
bpyC6; 152.4 (2C), C2 or C3"; 152.6 (2C), bpyC6; 152.7 (2C), C6; 153.1 (2C), C2 or C3"; 
157.27 (2C), 157.23 (2C), 157.4 (2C), 157.5 (2C), bpyC2; 
Tetrakis-( 4,4' -dimethy 1-2,2' -bipyridine)-/l-[2,2' -bis-(3,5-dimethyl-l-pyrazolyl)-
4,4'-bipyridineJ-diruthenium(II)-tetrakis-(hexafluorophosphate) (166). 
Ru(dmbhCI2.2H20 (39mg, 0.067mMol) was reacted with 2,2'-bis-(3,5-dimethyl-1-
pyrazolyl)-4,4'-bipyridine (lOmg, 0.029mMol) and the resultant solid recrystallised from 
acetonitrile/ether as described above. The binuclear complex 166 was obtained as a red 
microcrystalline solid. Yield 35mg (65%) FAB mass spectrum: caIcd for 
[C68H68N 14P3F18Ru2]+: 1719.276. Found: 1719.278. IH NMR (CD3CN) 8: 1.59 (6H), 3"-
CH3; 2.55 (6H), 2.57 (6H), 2.61 (6H), 2.63 (6H), dmb4-CH3; 2.96 (6H), 5"-CH3; 6.46 (2H), 
H4"; 7.24 (2H), dmbH5b; 7.27 (2H), dmbH5a; 7.33 (2H), dmbH5c; 7.38 (2H), dmbH5d; 7.49 
(4H) , H5 and dmbH6a; 7.61 (2H), dmbH6b; 7.71 (2H), H6; 7.73 (2H), dmbH6c; 7.85 (2H) 
dmbH6d; 8.16 (2H), H3; 8.41 (8H), dmbH3a, dmbH3b, dmbH3c and dmbH3d. 
Dichloropalladium(II)-bis-(2,2' -bipyridine)-J.l-[2,2' -bis- (3,5 -dimethy 1-1-
pyrazolyl)-4,4'-bipyridineJ-ruthenium(II)-bis-(hexafluorophosphate) (167) 
To a solution of 164 (l4.7mg, 0.014mMol) in CH2Cb (3ml) was added, dropwise, a 
solution of Pd(PhCNhC12 in CH2C12 (2ml). The red precipitate of 167 was filtered and air 
dried. Yield 15.5mg (90%). FAB mass spectrum: calcd for [C4oH36N lOPF6CbRuPd]+: 
1081.019. Found: 1081.020. IH NMR (CD3CN) 8: 1.58 (3H), 3"-CH3; 2.64 (3H), 3"'-CH3; 
2.87 (3H), 5'''-CH3; 3.00 (3H), 5"-CH3; 6.45, H4"'; 6.48, H4"; 7.42 (2H), bpyH5; 7.57 
(3H), H5 and bpyH5; 7.69, bpyH6; 7.78, H6; 7.80 (2H), H5' and bpyH6; 7.97, bpyH6; 8.00, 
H3'; 8.07, bpyH6; 8.08, 8.12, 8.18 (2H), bpyH4; 8.25, H3; 8.54, 8.55, 8.59 (2H), bpyH3; 
9.24, H6'. 
A.ttempted complex syntheses. 
Reaction of 93 with Ru(DMSO)4CI2. 
2-(2-Pyridinyl)perimidine (93) (30mg, 0.122mMol) was reacted with Ru(DMSO)4Cb 
(18mg, 0.037mMol) as described above. The product was obtained as a black solid. Yield 36mg 
(89%). The IH NMR spectrum of the solid was too complicated to assign. Neither IH NMR 
spectroscopy nor elemental analysis could confinn the fonnation of the desired product. 
B is-( 4,4'-dimethy 1-2,2'-bipyridine )-(2-2'-biperirnidine )ruthenium(II)-bis-(hexafluorphosphate) 
(103) and Tetrakis-( 4,4'-dimethy l-2,2'-bipyridine )-/l-(2-2'-biperimidine )diruthenium(II)-
tetrakis-(hexafluorphosphate) (104) 
A mixture of 91 (20mg, 0.060mMol) and Ru(dmbhCb.2H20 (32mg, 0.055mMol) in 
ethylene glycol was refluxed for 6 hours. The solution was cooled and treated with aqueous 
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N~PF6. The resultant black precipitate was shown, by IH NMR spectroscopy, to be a mixture 
of monodentate complexes. Attempts to separate this mixture by chromatography on alumina 
were unsuccessful. Addition of one more equivalent of Ru(dmbhC12.2H20 and K2C03 (3Orng) 
failed to give the dinuclear complex 104, with a similar complicated mixture of monodentate 
complexes being obtained. 
Tetrakis-(4,4'-dimethyl-2,2'-bipyridine)-~-[2-(2-pyrimidinyl)perimidinateJ-ruthenium(II)-tris­
(hexafluorophoshate) (107). 
The ligand 95 (11.4mg, 0.046mMol) was reacted with Ru(dmbhCI2.2H20 (SOmg, 
0.087mMol) as described above. The 1 H NMR spectrum of the resultant solid indicated a 
mixture of complexes. Although the mononuclear complex 106 could be distinguished in the 
spectrum, the dinuclear complex 107 could not. Chromatography of this mixture on a column of 
alumina succeeded in separating 106 by eluting with chlorofonnlmethanol (2S: 1). Elution with 
chloroform/methanol (10: 1), methanol and finally acetonitrile gave fractions which were found, 
by IH NMR spectroscopy, to contain mixtures of polynuclear complexes, but not 107. 
Similarly, chromatography on sephadex was successful in separating 106, by eluting with 0.2M 
NaCl. However, eluting with 0.SM-0.8M NaCI failed to give 107. In both cases, a significant 
quantity of brown solid was irreversibly absorbed onto the column material. 
Alternatively, 95 (lOmg, O.OlmMol) was reacted with Ru(dmbhCI2.2H20 (6mg, 
0.01 mMol) as described above. As described above, attempts to purify the resultant solid on 
sephadex or alumina could isolate 106, but not 107. 
The above reactions were repeated in the presence of a small quantity of K2C03 (Smg) to 
deprotonate the ligand. Similarly, 107 could not be detected in the resultant mixture of products. -
Bis-(2,2'-bipyridine)-4,6-di-(2-pyridinyl)pyrimidineruthenium(lI)-tetrachloromolybdenum-bis-
(hexafluorphosphate) (126). 
To a solution of 119 (2Smg, 0.027mMol) in dichloromethane (Sml) was added a solution 
of MO(CO)4(1l4-C7Hg) (lOrng, 0.033mMol) in dichloromethane (Sml). The resultant red solution 
was stirred for 36 hours. IH NMR analysis indicated that only 3% of 119 had been converted to 
126. 
A mixture of 119 (2Smg, 0.027mMol) and MO(CO)6 (14mg, 0.OS3mMol) in argon 
purged toluene (20ml) was refluxed for 6 hours. No reaction was observed. 
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8.4. Crystallography 
Intensity data were collected with a Nicolet P4s four-circle diffractometer using graphite-
monochromatised Mo Ka radiation (A 0.7107A). Cell parameters were determined by least-
squares refinement using the setting angles of at least 20 accurately centred reflections (28) 200). 
Throughout data collections (m scans) the intensities of three standard reflections were monitored 
and this showed no significant crystal decomposition. The intensities were corrected for Lorentz 
and polarisation effects but no corrections for absorption were deemed necessary. 
All structures were solved by direct methods using SHELXS-90258 and refined on p2 by 
full-matrix least squares procedures using SHELXL-93.259 All non-hydrogen atoms were 
refined with anisotropic displacement parameters. Hydrogens were included in calculated 
positions with the rotational orientations of the methyl groups deduced from circular Fourier 
syntheses. All hydrogens were assigned isotropic displacement parameters 1.3 times the 
isotropic equivalent of their carrier carbons. All data were used in the refinements; the functions 
minimised were Lw(Fo2 - Fc2), with w = [a2(Fo2) + aP2]-1 where P = [max(Fo2) + 2Fc2]/3. All 
calculations were performed on an IBM RISC 6000 computer. Final atomic coordinates and 
equivalent isotropic displacement parameters (defined as one third of the trace of the 
orthogonalised Dij tensor) are given in Tables 8.1-8.7. 
Crystal Data for 100 at 185 K. - C17H13N3CI2PdM 436.6, tric1inic, space group pi, 
a 7.358(2), b 9.295(3), c 12.052(4)A, a 99.88(2), p 94.16(3), Y 104.56(2)0, V 780.2(4)A3, 
F(OOO) 432, Dc(Z=2) 1.859gcm-1, ~(Mo Ka) 15.3cm-1, approximate crystal dimensions 0.28 by 
0.11 by O.Olmm, 28max 500, goodness of fit on p2 1.04, wR (all 2743 data, a=0.0454) 0.101, 
conventional R [1862 data with I > 20'(1)] 0.056 for 209 parameters. 
Crystal Data for 144 at 130 K. - C16H 12N 6, M 288.3, triclinic, space group 
Pi,a 8.061(1), b 9.024(1), c 1O.680(1)..\., a 102.032(8), p 107.931(6), Y 107.355(7)°, 
V 665.8(1)A3, F(OOO) 300, Dc(Z=2) 1.438gcm-1, ~(Mo Ka) 0.93cm-1, approximate crystal 
dimensions 0.81 by 0.38 by 0.21mm, 28max 50°, goodness of fit on F2 1.00, wR (all 2288 
data, a=0.0258) 0.0787, conventional R [1847 data with I> 20'(1)] 0.0288 for 200 parameters. 
Crystal Data for 145 at 130 K. - C20H20N6, M 344.4, orthorhombic, space group 
P212121, a 7.077(2), b 13.906(4), c 16.697(5)A, V 1643(1)A3, F(OOO) 728, Dc(Z=4) 
1.392gcm-1, ~(Mo Ka) 0.88cm-1, approximate crystal dimensions 0.84 by 0.07 by 0.07mm, 
28max 50°, goodness of fit on p2 0.69, wR (all 1896 data, a=0.0207) 0.0762, conventional R 
[985 data with I> 20'(1)] 0.0395 for 240 parameters. 
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Table 8.1. Atomic coordinates and equivalent isotropic displacement parameters (A2) for 100. 
Atom 104 x 104 y 1()4 z 103Ueq 
Pd(1) 7707(1) 6290(1) 6329(1) 17(1) 
CI(1) 7293(3) 7062(2) 4638(2) 26(1) 
CI(2) 7752(4) 8678(2) 7249(2) 32(1) 
C(1) 4877(12) 1523(10) 7820(8) 27(2) 
N(1) 6255(10) 3004(8) 8204(6) 22(2) 
C(2) 7109(12) 3855(9) 7469(7) 17(2) 
N(3) 7980(10) 5343(8) 7759(6) 19(2) 
C(3A) 8416(12) 6020(10) 8921(7) 20(2) 
C(4) 9586(12) 7471(10) 9259(8) 25(2) 
C(5) 9998(14) 8143(12) 10412(7) 33(2) 
C(6) 9234(14) 7367(12) 11214(8) 40(3) 
C(6A) 8060(14) 5848(12) 10897(7) 32(2) 
C(7) 7169(15) 4972(14) 11679(9) 40(3) 
C(8) 6098(15) 3557(14) 11348(8) 42(3) 
C(9) 5740(13) 2839(11) 10180(8) 32(2) 
C(9A) 6510(12) 3636(10) 9380(7) 23(2) 
C(9B) 7630(13) 5163(11) 9731(7) 26(2) 
N(1') 7505(10) 4134(8) 5556(6) 20(2) 
C(2') 7237(12) 3149(10) 6282(7) 19(2) 
C(3') 7328(11) 1658(9) 5928(7) 19(2) 
C(4') 7611(12) 1176(10) 4835(7) 25(2) 
C(5') 7752(12) 2157(10) 4088(7) 25(2) 
C(6') 7727(12) 3655(10) 4485(7) 22(2) 
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Table 8.2. Atomic coordinates and equivalent isotropic displacement parameters (A2) for 144. 
Atom 1Q4x 104y 1Q4 z 1Q3Ueq 
N(1) 4744(1) 11375(1) 6628(1) 22(1) 
C(2) 3363(2) 9975(1) 5741(1) 18(1) 
C(3) 2000(2) 9820(1) 4504(1) 18(1) 
C(4) 2083(2) 11216(1) 4145(1) 19(1) 
C(5) 3518(2) 12699(1) 5070(1) 23(1) 
C(6) 4787(2) 12717(2) 6278( 1) 24(1) 
N(I') -1764(1) 10909(1) 227(1) 21(1) 
C(2') 3(2) 12003(1) 839(1) 18(1) 
C(3') 1274(2) 12190(1) 2122(1) 19(1) 
C(4') 727(2) 11116(1) 2804(1) 19(1) 
C(5') -1107(2) 9932(1) 2165(1) 21(1) 
C(6') -2287(2) 9904(2) 916(1) 22(1) 
N(1A) 3341(1) 8585(1) 6141(1) 19(1) 
N(2A) 1905(1) 7098(1) 5366(1) 24(1) 
C(3A) 2307(2) 6118(2) 6062(1) 25(1) 
C(4A) 3964(2) 6940(2) 7265(1) 24(1) 
C(5A) 4585(2) 8517(2) 7287(1) 22(1) 
N(1B) 562(1) 12989(1) 62(1) 19(1) 
N(2B) 2402(2) 14008(1) 511(1) 24(1) 
C(3B) 2416(2) 14707(2) -456(1) 26(1) 
C(4B) 629(2) 14159(2) -1514(1) 25(1) 
C(5B) -530(2) 13058(1) -1151(1) 22(1) 
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Table 8.3. Atomic coordinates and equivalent isotropic displacement parameters (A2) for 145. 
Atom 104 x 104 y 104 z 103Ueq 
N(1) 2520(6) 395(2) 2742(2) 21(1) 
C(2) 2781(7) 1280(3) 2472(2) 21(1) 
C(3) 2531(6) 2105(3) 2915(2) 19(1) 
C(4) 1965(6) 2015(3) 3699(2) 17(1) 
C(5) 1706(6) 1094(3) 4003(2) 21(1) 
C(6) 2023(7) 332(3) 3517(2) 22(1) 
NO') 1028(5) 4457(3) 5195(2) 18(1) 
C(2') 1685(7) .3637(3) 5475(2) 19(1) 
C(3') 2014(6) 2833(3) 5017(2) 16(1) 
C(4') 1654(6) 2865(3) 4206(2) 20(1) 
C(5') 931(6) 3717(3) 3907(2) 19(1) 
C(6') 684(6) 4489(3) 4409(2) 20(1) 
N(IA) 3350(6) 1345(3) 1666(2) 23(1) 
N(2A) 3389(5) 2256(2) 1334(2) 22(1) 
C(3A) 4094(7) 2114(3) 612(2) 22(1) 
C(4A) 4553(6) 1148(3) 481(2) 24(1) 
C(5A) 4067(7) 669(3) 1164(2) 20(1) 
C(6A) 4356(7) 2949(3) 53(2) 26(1) 
C(7A) 4299(7) -369(3) 1339(2) 25(1) 
N(1B) 2034(5) 3599(2) 6294(2) 20(1) 
N(2B) 2269(6) 2716(2) 6641(2) 21(1) 
C(3B) 2681(7) 2893(3) 7393(2) 20(1) 
C(4B) 2738(6) 3890(3) 7548(2) 22(1) 
C(5B) 2324(7) 4328(3) 6848(2) 20(1) 
C(6B) 3017(6) 2089(3) 7967(2) 25(1) 
C(7B) 2237(7) 5374(3) 6666(2) 29(1) 
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Table 8.4. Anisotropic displacement parameters (A2) for 144. 
Atom 103 Un 103 U22 103 U33 103 U23 103 U13 103 U12 
N(1) 20(1) 22(1) 18(1) 5(1) 4(1) 5(1) 
C(2) 17(1) 20(1) 17(1) 6(1) 8(1) 6(1) 
C(3) 17(1) 19(1) 16(1) 4(1) 6(1) 5(1) 
C(4) 20(1) 22(1) 17(1) 6(1) 9(1) 9(1) 
C(5) 25(1) 19(1) 22(1) 6(1) 7(1) 6(1) 
C(6) 25(1) 18(1) 21(1) 4(1) 4(1) 2(1) 
N(1') 19(1) 21(1) 20(1) 5(1) 5(1) 7(1) 
C(2') 21(1) 17(1) 19(1) 5(1) 8(1) 9(1) 
C(3') 18(1) 18(1) 19(1) 4(1) 5(1) 6(1) 
C(4') 20(1) 18(1) 18(1) 4(1) 8(1) 9(1) 
C(5') 22(1) 21(1) 21(1) 7(1) 10(1) 9(1) 
C(6') 17(1) 21(1) 23(1) 5(1) 5(1) 5(1) 
N(1A) 16(1) 18(1) 18(1) 6(1) 4(1) 3(1) 
N(2A) 19(1) 19(1) 25(1) 7(1) 4(1) 2(1) 
C(3A) 22(1) 22(1) 30(1) 13(1) 8(1) 6(1) 
C(4A) 22(1) 29(1) 24(1) 15(1) 8(1) 11(1) 
C(5A) 18(1) 28(1) 17(1) 9(1) 5(1) 7(1) 
N(1B) 18(1) 19(1) 18(1) 5(1) 4(1) 6(1) 
N(2B) 21(1) 23(1) 24(1) 9(1) 6(1) 6(1) 
C(3B) 27(1) 25(1) 27(1) 12(1) 11(1) 9(1) 
C(4B) 32(1) 26(1) 19(1) 10(1) 9(1) 13(1) 
C(5B) 23(1) 23(1) 16(1) 5(1) 3(1) 11(1) 
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Table 8.5. Anisotropic displacement parameters (A2) for 145. 
Atom 103 Un 103 U22 103 U33 103 U23 103 U13 103 U12 
N(l) 31(3) 18(2) 13(2) -1(2) 6(2) 0(2) 
C(2) 27(3) 25(3) 10(2) 3(2) -1(2) 1(3) 
C(3) 27(3) 11(2) 18(2) 0(2) -2(2) 0(3) 
C(4) 20(3) 18(2) 12(2) -1(2) 1(2) 1(2) 
C(5) 24(3) 24(3) 13(2) 3(2) -1(2) -3(3) 
C(6) 29(3) 22(2) 14(2) 1(2) 2(2) 3(3) 
N(l') 27(2) 15(2) 13(2) -1(2) 3(2) 1(2) 
C(2') 21(3) 19(3) 19(2) -2(2) 5(2) 1(2) 
C(3') 18(2) 13(2) 16(2) 1(2) 0(2) 2(2) 
C(4') 25(3) 17(3) 18(2) -3(2) -1(2) 0(2) 
C(5') 18(3) 23(3) 17(2) 1(2) -4(2) 1(3) 
C(6') 23(3) 19(3) 17(2) 3(2) -3(2) 1(2) 
N(1A) 35(3) 18(2) 15(2) -2(2) 5(2) -2(2) 
N(2A) 33(3) 15(2) 18(2) 4(2) 1(2) 4(2) 
C(3A) 31(3) 20(3) 15(2) 2(2) 0(2) 5(3) 
C(4A) 30(3) 27(3) 14(2) -4(2) 6(2) 3(3) 
C(5A) 21(3) 23(3) 17(2) 0(2) 3(2) 3(3) 
C(6A) 29(3) 26(3) 21(3) 0(2) 7(2) 0(3) 
C(7A) 33(3) 19(2) 24(2) -4(2) 0(3) 5(2) 
N(lB) 32(3) 16(2) 13(2) 1(2) -1(2) 0(2) 
N(2B) 35(3) 13(2) 16(2) 3(2) 3(2) 2(2) 
C(3B) 27(3) 17(2) 16(2) 0(2) 4(2) 7(3) 
C(4B) 32(3) 15(2) 18(2) -9(2) 0(2) -3(3) 
C(5B) 25(3) 15(2) 19(2) -2(2) -3(2) 0(3) 
C(6B) 34(3) 25(3) 17(2) 5(2) 5(2) 1(3) 
C(7B) 41(3) 25(3) 21(2) -5(2) 1(3) 0(3) 
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Table 8.6. Hydrogen atom coordinates and isotropic displacement parameters (A2) for 144. 
Atom 104 x 104 y 104 z 103Ueq 
H(3) 1031(2) 8779(1) 3915(1) 24 
H(5) 3620(2) 13692(1) 4868(1) 30 
H(6) 5753(2) 13745(2) 6902(1) 32 
H(3') 2503(2) 13042(1) 2529(1) 25 
H(5') -1539(2) 9153(1) 2588(1) 27 
H(6') -3556(2) 9120(2) 515(1) 29 
H(3A) 1552(2) 4978(2) 5775(1) 32 
H(4A) 4533(2) 6492(2) 7925(1) 31 
H(5A) 5688(2) 9407(2) 7977(1) 28 
H(3B) 3522(2) 15496(2) -432(1) 34 
H(4B) 293(2) 14486(2) -2316(1) 32 
H(5B) -1854(2) 12453(1) -1654(1) 28 
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Table 8.7. Hydrogen atom coordinates and isotropic displacement parameters (A2) for 145. 
Atom 104 x 104 y 104 z 103Ueq 
H(3) 2744(6) 2720(3) 2685(2) 24 
H(5) 1314(6) 1001(3) 4542(2) 27 
H(6) 1883(7) -293(3) 3739(2) 28 
H(3') 2485(6) 2261(3) 5256(2) 21 
H(5') 608(6) 3768(3) 3357(2) 25 
H(6') 246(6) 5076(3) 4185(2) 26 
H(4A) 5094(6) 879(3) 11(2) 31 
H(6A1) 3129(9) 3137(11) -170(11) 33 
H(6A2) 5208(28) 2763(6) -383(8) 33 
H(6A3) 4901(31) 3492(6) 347(4) 33 
H(7Al) 4966(31) -680(4) 894(7) 33 
H(7A2) 3053(7) -666(5) 1405(14) 33 
H(7A3) 5030(30) -448(3) 1833(9) 33 
H(4B) 3013(6) 4193(3) 8045(2) 28 
H(6Bl) 2102(24) 2128(11) 8406(9) 33 
H(6B2) 4301(14) 2137(11) 8184(11) 33 
H(6B3) 2870(36) 1473(3) 7689(4) 33 
H(7Bl) 921(8) 5562(4) 6571(13) 38 
H(7B2) 2989(26) 5509(4) 6186(8) 38 
H(7B3) 2743(30) 5739(3) 7119(6) 38 
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